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The immune system protects the body against invading pathogens. For an immune response to
occur, a T cell must encounter a rare antigen-presenting-cell (APC) presenting its cognate antigen.
The time it takes for this encounter depends upon how quickly the T cell is moving, as well as how
many APCs carrying the T cells cognate antigen are present.
First passage processes are used to derive an equation for the encounter time of a T cell with one of
N APCs. Using this time, a rate of encounter is established, and used throughout this thesis. The
encounter rate is dependent upon the radius of the lymph node, the effective radius of the APC, and
the diffusivity of the T cell. However, the diffusivity of T cells has not been clearly established.
In vivo imaging data is used to develop a systematic method for determining the diffusivity of a
population of T cells. Due to in vivo imaging experiments having a limited sized imaging volume,
a confinement effect is observed. The expected squared displacement of imaged cells is calculated,
and the level at which a confinement plateau should be observed is determined.
T cell activation, in lymph nodes, relies upon encounters with APCs, but the number of APCs
required to initiate a T cell response is currently unknown. Using mathematical models, in
combination with experimental work, the probability of T cell-APC encounters can be quantified.
The probability of a T cell, residing in the lymph node for twenty four hours, to interact with APCs
is calculated. Extrapolating the developed models to later times and lower cell numbers than can
be achieved experimentally, a minimum number of APCs required to initiate a T cell response, for
typical human T cell precursor frequencies, is estimated.
It has been proposed that regulatory T cells suppress effector T cells via a three way interaction
with APCs, as a method of preventing autoimmunity. A stochastic model of these interactions
is developed and explored. The steady state of the system is found to depend upon the rate of
encounter of T cells and APCs, as well as the number of APCs. Stochastic effects are observed in
the model, which affect the state of the system, and are not observed in a deterministic approach.
Interactions between T cells and APCs, in lymph nodes, are crucial for initiating cell-mediated
adaptive immune responses. However, how these interactions cause activation of the T cells is not
yet fully understood. Three hypotheses have been proposed for the method of T cell activation.
These hypotheses are investigated, and models developed, in an attempt to quantify the observed
stages of the activation process. It is found that experimental results can, in part, be explained by
a probabilistic approach.
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1Chapter 1
Immunology introduction
1.1 Introduction
This thesis begins with a basic introduction to the human immune system. This is followed by a
more in-depth description of the cell types that are model in this thesis, focusing on there function
and interactions with other cell types. The main cell types used for modelling purposes in this
thesis, and therefore described in this chapter, are: Dendritic cells, T cells, and a specific subset of
T cells known as regulatory T cells. The chapter describes other aspects of the immune system,
such as lymph nodes, which is the area of the immune system where all the modelling in this
thesis takes place. The chapter also describes experimental techniques which are used by my
collaborators and one of which is modelled in this thesis. The chapter concludes with an outline
of the objectives of this thesis.
The main aim of this chapter is to give the reader an overview of the basic immunological concepts
and processes required to understand the work carried out in this thesis. This chapter only begins
to scratch the surface of how the immune system operates. For the reader wanting to know further
details about immunology I refer them to the many excellent textbooks published on the topic,
such as [115].
1.2 The human immune system
The human body includes three layers of defence against microbes; the first of these are physical
and chemical barriers, preventing microbes entering the body, such as the skin, and the mucosal
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epithelial lining of the airways and gut [163]. Only when these barriers are overcome, or evaded,
does the immune system come into play.
The next layer of defence is the innate immune system [5,75,115], which is able to respond quickly
(within hours) to microbial infection with phagocytic cells, such as macrophages. Macrophages
are able to ingest and kill microbes by producing degenerative enzymes and toxic chemicals.
They also secrete cytokines, which are molecules that cause inflammation and recruit cells of the
adaptive immune system [163].
If an invading microbe cannot be eliminated by the innate immune system, the adaptive immune
system becomes activated. The adaptive immune system is more efficient at eliminating infections
as it acts in a specific manner, but it takes days rather than hours to get started. The cells of
the adaptive immune response have the ability to distinguish a specific pathogen and focus their
response against it. Cells involved in the adaptive immune response have specialised antigen
receptors on their surface that are able to recognise and respond to individual antigens on the
surface of microbes [163]. The body contains billions of lymphocytes that possess a vast repertoire
of antigen receptors, allowing the immune system to recognise virtually any antigen a person is
exposed to. The adaptive immune response is also responsible for the generation of memory cells,
which allow a second infection by the same pathogen to be dealt with more quickly and with a
greater cell numbers [163].
The major types of lymphocytes are: B cells, which upon activation differentiate into antibody-
secreting plasma cells, T cells, which differentiate into a variety of classes with differing functions,
which will be discussed later, and natural killer cells, these lack the antigen specificity and act in
an unspecific manner [163].
1.3 Dendritic cells
Dendritic cells (DCs) have long finger-like protrusions used for sampling their surrounding area.
Immature DCs migrate through the bloodstream to enter tissues, and carry specialised receptors on
their surface that are able to recognise common features of many pathogens, which they are able
to phagocytose. Phagocytosis is the process of engulfing and and breaking down an invading
microbe. DCs also take up large amounts of extracellular fluid and its contents [163]. The
pathogens they take up are digested, but their main role is not the clearance of microbes, but rather
to activate other cells to clear the infections. This is achieved by presenting antigens from the
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invading microbes on their surface (Figure 1.1). DCs then migrate to a nearby secondary lymphoid
organ [113, 228, 235, 238], such as a lymph node (LN), where there is a high concentration of
lymphatic cells of varying specificities [241]. T cells that recognise the antigen presented on a
DC can then be activated by the DC due to the expression of co-stimulatory molecules, which are
also required for T cell activation [36, 155, 156, 165, 185, 186]. Recognition of free antigen alone
is not sufficient to activate T cells, the co-stimulatory molecules expressed by the DCs are also
required. Cells that are able to present antigens to inactive T cells and activate them, are known as
antigen-presenting-cells (APCs). Macrophages are also capable of presenting antigen. However,
DCs are specialised in presenting antigen and initiating the adaptive immune response, which is
why they are called professional APCs.
Figure 1.1: Role of dendritic cells in the immune response. Source: Figure 25-5 Molecular
Biology of the Cell ( c©Garland Science 2008 [163]).
A key feature of DCs, which allows efficient sampling within the LN, by T cells, is their extensive
probing activity through the rapid motion of their dendrites. This results in the volume surveyed
by a DC becoming three-fold larger than its size [153]. The dendrites of DCs will also actively
extend towards a T cell [32].
DCs are a subclass of APCs, and a distinction between DCs and APCs is not made in this thesis.
The two terms will therefore be used interchangeably.
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1.4 T cells
T cells are divided into two main subclasses, distinguished by a cell surface protein they express on
their surface from the time they mature in the thymus. Cytotoxic T cells express the CD8 protein,
and are involved in killing infected cells. The class of T cells involved in activating cells they are
cognate to, rather than killing them, express the CD4 protein, and includes helper T cells [163].
In the absence of an infection most lymphocytes circulating in the body are small featureless
cells with few cytoplasmic organelles. These inactivated lymphocytes are known as naive.
Lymphocytes are activated by binding to an APC presenting antigen that is cognate to their
receptor. In the case of T cells, which is the cell type studied in this thesis, this is the T cell receptor
(TCR) [77, 78] (Figure 1.2). After a T cell is activated, it undergoes clonal expansion and the
daughter cells differentiate into several functional classes [34,54]. There are three major classes of
T cells, which fall into the categories of CD4+ or CD8+ T cells. Cytotoxic T cells, which express
the CD8 protein, are responsible for killing cells that are infected with viruses or other intracellular
pathogens. Helper/effector T cells, which express the CD4 protein, provide additional signals that
activate antigen stimulated B cells (Figure 1.2) to differentiate and produce antibody [47, 173].
Regulatory T cells, which express the CD4 protein, regulate the activity of other lymphocytes
and help control the immune response. During the course of the immune response some of the
activated T cells (and B cells) differentiate into memory cells. These are responsible for the long-
lasting immunity that results from the exposure to a disease or vaccination. Memory cells allow
a rapid response to reinfection by the same pathogen and can rapidly differentiate into another T
cell type. The newly activated T cells must then migrate to the site of the infection to assert their
function [139, 160].
Unlike macrophages and DCs that express receptors able to recognise general features shared
by many pathogens, each T cell expresses a receptor that is highly specific. Each T cell
clonotype emerging from the thymus differs from the others in its receptor specificity. The
diversity originates from gene rearrangement in the production of the T cells [158], ensuring that
collectively T cells are able to recognise millions of different pathogens.
Antibodies produced by B cells are able to target pathogens in the blood and extracellular spaces,
however some bacteria, parasites and all viruses replicate inside cells, where antibodies cannot
detect them. The responsibility for eliminating these invaders falls to the T cells. Cytotoxic T
cells are able to target cells infected with virus, as the infected cells express antigen derived from
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Figure 1.2: T and B cell activation. ( c©Garland Science 2008 [163])
the viruses multiplication process on their surface [163].
Naive CD4 T cells are able to differentiate into different types of effector T cells [2, 85], the
three major types being Th1, Th2, and Th17 (Figure 1.3), although more have been described
[102, 185, 220]. All these cell types are involved in combating bacterial infections. Th1 cells are
characterised by the secretion of IFN-γ and are important activators of macrophages, natural killer
cells and CD8+ T cells [214]. Th1 cells are able to deal with macrophages that have become
infected by intracellular bacteria that have evaded the macrophage degradation process. They also
function as helper cells, stimulating the production of antibodies by interacting with B cells and
producing co-stimulatory signals. Th2 cells secrete the cytokines IL-4, IL-13 and IL-25, which
are important for barrier defence at mucosal and epithelial surfaces. Th2 cells activate eosinophils,
basophils, mast cells, and alternatively activated macrophages [227]. Th17 cells produce an array
of cytokines and are responsible for regulating acute inflammation [130]. They also work with
neutrophils in the defence against extracellular bacteria [101, 142].
Naive T cells circulate from the bloodstream into LNs, the spleen and mucosa-associated lymphoid
tissues, and then back into the blood. This process allows an individual T cell to sample the
peptides presented by thousands of DCs daily [42, 180]. The efficiency at which T cells sample
antigen presenting DCs is very high, which is crucial for the initiation of the adaptive immune
response, as only one naive T cell in 104-106 is specific for a particular antigen [42].
CD4+ T cells are dependent on persistent antigen presentation by DCs for full activation and
differentiation, and renewed contacts between daughter cells and antigen-bearing DCs has been
observed [54, 171].
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Figure 1.3: Outline of function of the different classes of T cells. ( c©Garland Science 2008 [163])
1.5 Lymph nodes
Lymphocytes circulate in the blood and the lymph and are also found in lymphoid tissues
and lymphoid organs. The lymphoid organs are organised into the central/primary and
peripheral/secondary lymphoid organs. The primary lymphoid organs are the bone marrow and
thymus, and are the sites where lymphocytes are produced and mature. Secondary lymphoid
organs include the LNs, spleen and Peyer’s patches of the intestine, and are the sites of lymphocyte
interactions.
Lymph nodes are located at the points of convergence of the vessels of the lymphatic system,
and are highly organised lymphoid organs. The afferent lymphatic vessels drain fluid carrying
antigen-bearing cells from infected tissues, as well as pathogens, to the LNs. Free antigens are
able to diffuse through the extracellular fluid to the LNs, and DCs actively migrate there following
chemokine signals [15]. The same chemokines also attract other lymphocytes, which enter from
the blood via high-endothelial-venules [9, 10, 162]. Within the LN, B cells are located in the
follicles, which make up the outer cortex of the LN, and T cells are located in the surrounding
paracortical areas [97], often referred to as T cell zones.
Within the LN, the majority of naive T cells are highly motile, and display complex trajectories
[123, 156] akin to a random walk. Such behaviour allows T cells to thoroughly explore the LN,
however, the elements dictating T cell trajectories are unclear at present. It has been proposed
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Figure 1.4: Lymph node diagram. ( c©Garland Science 2008 [163])
that guidance cues dictating T cell direction might involve the fibroblastic reticular network
and/or chemokine signals [66]. The fibroblastic reticular network is a network comprising of
reticular fibres, fibrous extracellular matrix bundles, and fibroblastic reticular cells, and supports
the entire LN [91]. The role of chemokines in influencing T cell migration has been challenged
by observations of T cell trajectories using two-photon imaging, in which T cell trajectories were
found to be essentially random [155, 156], with a random walk behaviour being found for longer
timescales. In vivo tracking of T cells within LNs found the mean absolute displacement of T
cells increased proportionally with the square root of time, indicating a random walk behaviour.
The mean displacement can therefore be characterised by a motility/diffusion coefficient, this was
found by Miller et al. [156] to be 67µm2min−1 for T cells.
The high motility of T cells, combined with the less motile DCs, which probe their surrounding
area with their dendrites, leads to DCs being able to sample a large fraction of the T cell repertoire
in a short period of time. It has been estimated that between 500 and 5000 T cells are sampled by
each DC every hour [42, 51, 153].
Studies have investigated the dynamics of interactions between antigen-bearing DCs and antigen-
specific T cells. Stoll et al. [212] reported cell-cell contacts and prolonged interactions between
T cells and DCs, followed by activation, dissociation and rapid migration of T cells away from
the DC. A similar sequence of events was also observed in vivo within the LN, where DC-T
cell interactions were observed with CD4+ [154, 201] and CD8+ [42, 110, 152] T cells. Further
investigation is required to achieve a consensus for the duration of DC-T cell interactions [110,
201].
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1.6 T cell selection
The immune system is able to combat virtually any pathogen it is presented with. To achieve such
a large coverage, it must contain a repertoire of T cells able to recognise as many pathogens as
possible. This is achieved through gene rearrangement. Developing T cells undergo a process
of gene rearrangement to generate a unique receptor. This process allows the development of a
large number of TCR structures, able to recognise billions of different antigens. As this process
is random, there is inevitably receptors generated that are not functional, or self reactive. These
receptors are screened through a process of positive and negative selection [106, 137, 200, 211] in
the thymus.
A functional T cell must have a functional receptor, it must therefore recognise self-peptide:MHC
complexes to some extent, to be able to receive a survival signal in the periphery. A self-
peptide:MHC complexes is a complex of the body’s own antigen and a cell surface molecule.
This ensures only thymocytes expressing a useful T cell receptor can survive and mature. This
involves receiving a weak interaction with pMHC complexes that include thymic self-peptide,
as some foreign antigen peptide is likely to exist that has a much stronger binding with such a
receptor in the periphery. T cells without a functional receptor will not be able to undergo weak
interactions and will die from neglect.
Only 10% of T cells pass through positive selection. The other 90% of T cells die by neglect,
as they do not have a functional receptor. Those that do survive, undergo negative selection
[107, 175]. T cells whose receptors recognise self-peptide:MHC complexes too strongly are
given a signal to stimulate cell death, by apoptosis [211]. Negative selection deletes potentially
self-reactive thymocytes, thereby generating a repertoire of peripheral T cells that is largely self
tolerant [209, 211]. Less than 5% of the originally generated T cells survive thymic selection.
Inevitably some cells escape negative selection. These self-reactive cells are controlled by
peripheral tolerance mechanisms [194].
1.7 Regulatory T cells
The immune system is able to discriminate between self and non-self antigens, inhibiting
autoimmune responses, but allowing effective immune responses against microbial antigens. The
immune system is able to establish and sustain unresponsiveness to self antigens, including
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physical elimination of self reactive cells, through a process of thymic selection (Section 1.6).
There is also substantial evidence the T cell mediated suppression of self-reactive T cells is another
essential mechanism of self tolerance [65, 141, 191, 202]. Tolerance to self-antigen is primarily
achieved through thymic selection, but some auto-reactive T cells escape thymic selection or
recognise antigens that are not expressed in the thymus. This regulation is carried out by a
distinct subset of T cells [81] known as regulatory T cells (Tregs), which are functionally defined
as a T cell that inhibits an immune response by influencing the activity of other cell types [81].
There are two groups of regulatory T cells. One subset becomes committed to the Treg lineage
during development in the thymus, these are natural Tregs [192]. The other subset develops in the
periphery from uncommitted naive T cells [148].
Natural Tregs are CD4+, and express the α chain of the IL-2 receptor (CD25) [11, 193], giving
them a high affinity for the IL-2 cytokine. They also express the FOXP3 receptor [76, 109, 125].
Natural Tregs make up about 10-15% of the CD4+ cells in circulation in the human body. Natural
Tregs are potentially self-reactive T cells, that are selected in the thymus. The mode of action of
Tregs in vivo is still not fully understood, and there is a large array of literature which investigates
this [183,217,223,224]. Tregs are believed to act in either a contact-dependent fashion with other
cells, or through the secretion of cytokines, such as IL-10 and TGF-β.
The function of (natural) Tregs is to suppress the activation of self-reactive T cells. Lack of natural
Tregs is known to be the cause of several autoimmune syndromes.
1.8 Experimental techniques
1.8.1 Two-photon laser scanning microscopy
Two-photon laser scanning microscopy (TPLSM) allows the interactions of T cells and DCs to
be viewed within a LN in vivo [41, 156]. Most T cells are located near the surface of the LN, in
the paracortical area, which is approximately 150-200µm below the organ’s surface in mice. A
TPLSM experiment is carried out by acquiring sequential images of a three-dimensional volume
of a LN that contains fluorescently labelled cells. This is achieved by recording the fluorescent
signals emitted by the cells at successive focal planes, and repeating this process every 10-30
seconds for a period of up to a few hours [40]. The data set generated can be viewed as a
time-lapse movie, and important information can be extracted from these videos by manual or
Chapter 1. Immunology introduction 10
automated analysis. TPLSM achieves the same optical sectioning effect as confocal microscopy,
but it uses a different optical principle that increases depth penetration, and reduces phototoxicity
and photo-bleaching [46], making it ideally suited to imaging T cell activation at a single-cell
level [70]. Phototoxicity is the damage caused to cells due to the laser light. Photo-bleaching is the
bleaching of the fluorophores that are used to label cells of interest. A fluorophore is a florescent
chemical compound that is able to re-emit light upon light excitation. In TPLSM two extremely
short (femtosecond) pulses of light are emitted, of infrared frequency, which are absorbed almost
simultaneously by fluorophores, rather than a single photon of visible light emitted in confocal
microscopy. The energy of the photon decreases with increasing wavelength, so the two infrared
photons together provide a similar amount of energy to a blue photon, causing a green photon to
be emitted by the fluorophores, as it would in regular fluorescence. Using two photon excitation
results in fluorescence only at the focal point, due to the fluorescence emission increasing as the
square of light intensity, rather than a linear increase, as observed in confocal microscopy. This
confines photo-bleaching and phototoxicity effects to the focal plane. Using infrared light allows
deeper penetration into the tissue due to its longer wavelength.
There is less phototoxicity using TPLSM compared to other imaging methods. However, the
levels of phototoxicity are not insignificant [108], and are the cause of the limited sized imaging
volume used in TPLSM. The size of an imaging volume is dependent on the experimental setup,
with x and y dimensions typically being up to 250µm, and the z dimension typically being up
to 35µm. The depth that can be imaged is determined by the number of planes in the z-stack.
If the z-planes are further apart, a greater depth of image can be achieved, however if they are
too far apart, cells can reside in the spaces between the planes and will not be observed. The
number of z-planes imaged also affects the time between imaging points. If numerous z-planes
are taken the microscope must scan a larger area before restarting at the first plane for the next
timepoint, resulting in the time between successive timepoints increasing. Taking a smaller time
increment allows the path of cells to be imaged at a higher resolution, but has the drawback of
reducing the volume that can be imaged, and increasing the speed at which phototoxicity occurs,
thereby reducing the overall experiment duration. A balance of z-stack separation, track resolution
and experiment duration must be achieved. TPLSM also requires the LN to be exposed for
imaging to occur. Experiments take place on living mice [152, 155], but results in the mouse
being sacrificed, therefore subsequent imaging on the same mouse cannot be achieved. Recent
advances are experimenting with transplanting LNs to a mouse’s ear, allowing imaging without
harming the mouse, and subsequent imaging on the same mouse to be carried out. This method
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also avoids effects that may occur from operating on the mouse, which may affect the experiment’s
outcome. For an detailed explanation of TPLSM, please refer to these reviews [46, 79].
1.8.2 Flow cytometry
Flow cytometry is an experimental method that is able to measure and analyse multiple physical
characteristics of cells, as they flow in a stream of fluid through a beam of light [163]. The system
is also able to sort cells depending on their characteristics, by applying a charge and deflecting
them. The characteristics that can be measured include; a cell’s relative size, relative granularity
or internal complexity, and relative fluorescent intensity. These are measured by recording how
a cell scatters incident laser light and emits fluorescence. Cells being examined are labelled
with fluorescent markers, which fluoresce depending on the characteristics of each labelled cell.
The number of markers that can be detected by flow cytometry depends upon the complexity of
the machine used. The scattered and fluorescent light is collected by a system of appropriately
positioned lenses, and a combination of beam splitters and filters steer the light to the appropriate
detectors. An electrical signal is produced by the detectors proportional to the optical signal
striking them. The data is sorted and analysed by a computer, and can provide information on sub-
populations within the sample. Cells ranging in size from 0.2 to 150 micrometers can be examined
using flow cytometry. This experimental technique is used by my collaborators to obtain some of
the results presented in Chapter 6.
Figure 1.5: Diagram of flow cytometry. ( c©Garland Science 2008 [163])
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1.9 Objectives of the thesis
In this section, the initial objectives of the thesis are described. Whether or not these objectives
have been met will be evaluated in Chapter 9.
The objectives of this thesis are:
1. Study the theory of first passage processes to apply to encounters between T cells, moving
by Brownian motion within a lymph node, and encounters of APCs. Using this theory,
develop a mean first passage time equation for a uniform randomly placed particle to locate
a uniform randomly placed target.
2. Study the effect of confinement in a limited sized imaging volume, seen in two photon
microscopy experiments, on the observed mean squared displacement of the imaged cells.
An accurate understanding of artefacts introduced by two-photon imaging technology is
crucial to correctly interpreting the data produced.
3. Develop a method to calculate the diffusion coefficient of T cells, using data obtained from
two-photon microscopy experiments. The size of the diffusion coefficient is key to the
response rate of the immune system.
4. Using concepts developed in objectives one, two and three, along with experimental data, I
aim to determine the minimum number of DCs required to initiate a T cell response, given
typical T cell precursor frequencies. The number of DCs present influences the probability
of activation of the T cell response.
5. Extensive literature [49, 133] is available on deterministic models of interactions between
effector and regulatory T cells. Knowing the populations of T cells are usually quite small,
I intend to investigate the effects of a stochastic approach on the interactions of effector and
regulatory T cells.
6. In references [40,42], three hypotheses are proposed for the activation mechanism of T cells:
APC changes, T cell signal integration, and a probabilistic approach . I intend to test these
hypotheses using analytical and computational models, with the aim of determining if any
of the proposed hypotheses can explain experimental results.
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Chapter 2
Introduction to stochastic spatial
modelling and numerical methods
2.1 Introduction
The role of mathematical modelling in immunology was recognised as early as the 1960’s [96,145]
and 1970’s [24, 71, 104, 105, 132, 134, 177, 231], and immunology was one of the first biological
areas to adopt mathematical modelling. Mathematical models in immunology have been used in
areas ranging from antigen receptor interactions [178], to vaccination [7, 114, 124, 150, 161, 170].
Since the introduction of mathematical immunology, the application of mathematical models has
changed from conceptual models of basic reactions to bioinformatic analysis of high throughput
data and simulation-based analysis of complex molecular and cellular systems. Over the last
couple of decades, mathematical immunology has shifted from deterministic ODE-based models
to stochastic models. A deterministic approach predicts an outcome with absolute certainty.
Therefore, it is not able to cope with the inherent variability present in biological system. A
stochastic model provides a probability of an outcome for a given set of initial conditions.
Stochastic models of biological systems are important as they allow random variability to occur,
which is often seen in biological processes. In population level models, where the population
size is sufficiently large, a deterministic formulation can be used, and will be used in this thesis.
However, for small population sizes, extinction of the population may occur, and then it is more
realistic to use a stochastic formulation to model the variation in size, allowing fluctuations to
occur that might result in extinction.
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This chapter introduces the main mathematical techniques used in this thesis. Spatial modelling
is used throughout, therefore a large proportion of this chapter focuses on spatial modelling,
and methods of reducing error between analytical calculations of first passage times and spatial
modelling simulations. The chapter begins by reviewing the various methods proposed for how T
cells move, proposed in [92, 121, 123, 153, 225, 232]. In this thesis T cells are assumed to move
by Brownian motion. A definition of the Wiener process is given [151] and related to movement
by Brownian motion. The chapter goes on to describe the computational algorithm developed in
this thesis, which is used throughout the thesis to simulate cell movement. Errors occurring in the
computational algorithm due to using a discrete timestep size are then addressed. These errors
can occur on the boundary of the target and the boundary of the domain. Algorithms developed
in [119] are introduced to reduce these two sources of error and the efficiency of these algorithms
are tested against analytical calculations of mean first passage times. A method of reducing
the error in computational simulations further by using exponential time-stepping [117–119] is
then reviewed. The aim of reducing the amount of error in the spatial simulations carried out
is to allow a larger timestep size to be used without significantly reducing the accuracy of the
simulation. Using a larger timestep size allows a faster implementation of the simulation, reducing
on computational recourses required.
The Gillespie algorithm [83, 84] is then reviewed as a way of computationally simulating a
stochastic process. The Gillespie algorithm is used in this thesis to simulate interactions between
cells and allows a computationally faster implementation than a spatial algorithm when a spatial
aspect is not explicitly required.
Finally, other modeling efforts undertaken by various people as a way of simulating cell movement
are reviewed. This include the Cellular Potts model and a model of movement on the reticular
network. The chapter concludes with a summary of Chapters 3-8 in this thesis.
2.2 Spatial modelling
2.2.1 How do T cells move?
The question of how T cells move within a lymph node (LN) is a much debated topic. In vivo
imaging techniques, using two-photon microscopy, have allowed movies of T cell movement and
interactions to be generated. This imaging gives the impression that T cells are freely moving
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within the LN. However, it must be remembered that only a limited number of cells have been
labelled, and in reality the environment is very crowded with other cells, the reticular network, and
blood vessels. The movement of cells depends upon their intrinsic motility as well as collisions
and interactions with other cells and their surroundings [232].
Various models for T cell movement have already been proposed: (1) Simple Brownian motion, in
which a T cell’s movement is completely unbiased and follows a random walk [153], (2) persistent
motion, in which a T cell moves in one direction for a short period of time then chooses a new
random direction to move in, and repeats the process [232], (3) movement on the reticular network,
which proposes T cells move along a pre-defined network within the LN [92, 121, 123, 225].
Persistent motion has been observed in in vivo experiments [232], where T cells were observed
to move in a series of repetitive lunges, repeatedly balling-up and extending, with a period of
about two minutes, moving an average distance of about 20µm in each cycle, with peak velocities
of 25µmmin−1. After each lunge, a cell would pause and then take off in another direction. T
cells were found to travel in a fairly consistent direction during each lunge, and even to continue
to move in a consistent direction over several cycles. However, after each pause, there is a high
probability a cell will change direction. Therefore, T cells display a random walk behaviour when
visualised over tens of minutes, even though on shorter times scales their motion appears to be
more linear.
Some two-photon microscopy experiments have found T cells move along the strands of the
fibroblastic reticular cell (FRC) network [16]. Individual T cell trajectories obtained from these
studies suggest motion is random and not directed by chemical gradients over large distances. It
was found that the mean displacement of a T cell from its starting position increases linearly with
the square root of time, indicating a random walk nature of movement. It was concluded that,
even though T cells appear to move along the FRC network, due to the structure of the network,
and the frequent crossing points, movement along the network appears to be a random walk [16].
The reticular network model has the advantage of reducing the volume cells can move within,
thereby potentially increasing the rate of encounters. It does however raise lots of other problems
in setting up the mathematical system, such as: How many nodes where cells can change direction
should there be? How many connections should there be between nodes? How far apart should
nodes be? How do cells pass each other on the network? Methods of modelling the network have
been devised in [73]. However, as the number of nodes and connections tend to infinity the model
in [73] will approach a Brownian motion model.
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In this thesis, T cell movement is modelled as a simple Brownian motion, as this is the simplest
of the theories to model, and the general consensus of the experimental results reviewed in this
section and models reviewed in Section 2.6 seems to be that cell movement is like Brownian
motion on long timescales.
Beauchemin et al. [22] developed a model to simulate T cells moving along the FRC network by
having cells move for an amount of time at a given velocity in a straight line, then pause for a given
time and choose a new direction. They also used the same model to simulate cells moving without
a pause time, and found both approaches agreed with experimental data, the latter just needing a
slightly higher velocity. They conclude that, the addition of a pause time does not significantly
improve the agreement between the experimental data and numerical results. Thus, the spatial
modelling in this thesis is implemented without a pause time.
A characteristic of Brownian motion is that a particle may at first move rapidly away from
its starting point but then may backtrack, resulting in its absolute displacement increasing at a
progressively slower rate as time increases. The mean displacement, of a population of particles
undergoing Brownian motion, from the origin grows as function of the square-root of the time.
For example: in 1ms a population of uniformly randomly moving particles may have a mean
displacement of 1µm, in 100ms this increases to 10µm, and to move 100µm will take a mean
time of 10s. This relationship is determined by the diffusion coefficient, D, of the particle, giving
a formula for the mean distance, d, travelled in time, t, of
d =
√
6Dt.
The factor 6 applies for diffusion in three dimensions, it changes to 4 in two dimensions, and 2 in
one dimension.
2.2.2 The Wiener process
Let us begin by considering a one-dimensional symmetric random walk such that, in each time
unit, a particle is equally likely to take a unit step either to the left or the right. Now suppose we
speed up this process by taking smaller and smaller timesteps in smaller and smaller time intervals.
If we go to the limit in the correct manner Brownian motion is obtained.
Brownian motion is also known as the Wiener process, or the Wiener-Einstein process [221].
The term Brownian motion acknowledges Robert Brown, who in 1827 noticed pollen grains
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suspended in water moved constantly in a zigzag motion under a microscope. In 1905 Albert
Einstein stated laws governing Brownian motion using principles from the kinetic energy theory
of heat. However, it was Norbert Wiener’s research in 1923 that laid the mathematical foundation
for Brownian motion. Therefore, the process is often named after Wiener. Melsa and Sage [151]
related the Wiener process to the concept of Brownian motion.
Suppose W (t) is the displacement of a small particle from the origin at time t. The displacement
that occurs in the time t1 to t2 is small, and the frequency of direction changes is large. By
applying the central limit theorem to the sum of a large number of these small disturbances, it can
be assumed thatW (t2)−W (t1) has a Gaussian density. The density of the particle’s displacement
does not depend on the time of the observation, it just depends on the length of the time interval.
Therefore the probability density of the displacement from time t1 to t2 is the same as from time
t1 + t to time t2 + t.
Definition: The stochastic process {W (t)}, t ∈ [0,∞), is a Wiener process if W (t) depends
continuously on t, W (t) ∈ (−∞,∞), and the following three conditions hold [8]:
• For 0 ≤ t1 < t2 <∞, W (t2)−W (t1) is normally distributed with mean zero and variance
t2 − t1, that is, N(0, t2 − t1).
• For 0 ≤ t0 < t1 < t2 < ∞, the increments W (t1) − W (t0) and W (t2) − W (t1) are
independent.
• Prob{W (0) = 0} = 1.
The Wiener process can easily be expressed in multiple dimensions (Bt), as each of the Cartesian
components of the Wiener process in n dimensions is an independent Wiener process,
Bt = (W
(1)
t ,W
(2)
t , ...,W
(n)
t ),
where W (i)t , i = 1, · · · , n, is a one-dimensional Wiener process.
2.2.3 Computational algorithm
To model interactions of cells moving by Brownian motion within a LN, it is necessary to devise a
spatial model of cell movements and interactions. This spatial model will be used in various forms
throughout this thesis. Algorithms used in the spatial model, described below, are given in the
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appendix. To create a model in which T cells move, within a LN, in search of antigen-presenting
cells (APCs), the following steps need to be implemented.
Step 0 (Initialisation):
• Firstly, place APCs, of effective radius b, and T cells, modelled as point particles, uniformly
randomly within a sphere of a given radius, R (A.1). The APC’s radius accounts for the
APC having dendrites, which are assumed to sample a spherical region of radius equal to
the mean dendrite length [17](Figure 2.1). The radius of a T cell is added to the APC’s
radius to give an effective radius for the APC, allowing T cells to be modelled as point
particles.
Figure 2.1: Illustration of sampling volume of an APC. Reproduced from [17].
Step 1 (Movement):
• APCs remain stationary and T cells move by Brownian motion, simulating a random walk.
• A fixed discrete timestep size, δt, is chosen and each T cell picks a distance to move in
the x, y and z dimension from a Gaussian distribution with mean zero and variance 2Dδt,
which is obtained from the definition of the Wiener process stated in section 2.2.2 with the
relation xt =
√
2DW
(1)
t , D is the diffusivity of the T cells (A.4).
• If a T cell moves outside the radius of the LN (Figure 2.2), it is reflected back in by
multiplying each of the x, y and z positions by 2Rr − 1, where r is the T cell’s distance
from the centre of the LN.
Step 2 (Encounters):
• The position of each T cell relative to its closest APC is checked to determine if they have
encountered each other.
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• If the separation distance is less than b, which incorporates the size of the APC and the T
cell, then an encounter will have occurred.
• If the separation distance is greater than b, an algorithm is used to calculate the probability
of an encounter occurring during a timestep. If this probability is greater than a uniform
random variable, between zero and one, an encounter will have occurred (A.6).
• Upon encountering an APC, a T cell can bind to the APC. If this occurs, a time to remain
bound is picked from a given distribution, with a set mean binding time. An exponential
distribution is used in this thesis.
Step 3 (Unbinding):
• After the simulation time is incremented, the same time increment must be subtracted from
the amount of time bound cells are to remain bound.
• If the time to remain bound is less than δt, the T cell is unbound from the APC it is attached
to.
• When a T cell unbinds various scenarios may occur. The T cell can be placed uniformly
randomly within the LN, and a new uniform random position chosen if they occupy the
same volume as that occupied by the APCs. This is useful for testing first passage time
equations that assume an approximately uniform random starting position of a particle. A
T cell can be placed at the edge of an APC’s zone of attraction. This seems the most likely
biological outcome, but as the movement of the T cell is uniformly random, there is a high
probability of the T cell rebinding. This can be overcome by having a deactivation time for
T cells after binding, in which they cannot rebind. If this time is long enough, the T cell
should be in an uniform random position when it is able to bind again.
Step 4 (Update):
• To improve the efficiency of simulations, instead of each T cell checking its distance from
every APC after each timestep, a T cell only needs to check its distance from the APC it is
closest to (A.5).
• This is achieved by compiling a list of the closest APC to each T cell. The list of closest
APCs does not need to be updated every timestep. The update frequency will depend upon
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the diffusivity of the T cells, and the number of APCs. A larger diffusivity and/or and greater
number of APCs will require the update interval to be smaller to prevent the closest APC to
a T cell significantly changing.
• We must now return to step 1, and continue in this way until some predefined criteria are
met, such as a specific time being exceeded or cell numbers reaching a specific value.
In step 0, when placing the APCs, the arrangement in relation to each other must be considered.
APCs can be simply placed uniformly randomly, allowing two APCs to occupy the same volume.
This outcome is not desirable in our simulations, therefore the APCs are placed so they either
occupy completely separate volumes, or they may be allowed to have a slight overlap equivalent
to the radius of the T cell. The overlap amount could even be made larger, as in reality the
shapes of the APCs would fluctuate (A.2). This is achieved by first placing the cells uniformly
randomly within the domain and replacing the cells that do not obey the desired cell overlap rules.
Placing APCs with a position that is dependent upon the position of the APCs already placed
results in a distribution of APCs that is not uniform random across the whole of the domain,
as each subsequent APC has a smaller and smaller volume which it can occupy. This does not
pose a problem for the computational modelling, it does however pose a problem for comparison
with analytical models. However, when the volume of the domain is large and the volume of
the APCs are small, and low in number, the error caused by this not truly uniform placement of
APCs is minimal. For larger APCs numbers, as considered in Chapter 6, the error becomes more
significant, and a method of compensating for this error is proposed in Chapter 6.
In step 3, the simplest way to reduce the binding times is to reduce the binding times of each cell
by the timestep size, every time the simulation time is incremented, however this proves to be
computationally inefficient. A more efficient way of reducing the binding times is to record the
amount of time since the last binding or unbinding event occurred (tpassed), and if this is greater
than the minimum binding time of all the bound cells, their binding time will be reduced by tpassed.
This procedure must also be undertaken before binding a new cell (A.3). In this model, APCs can
be given various numbers of binding sites, and interactions can occur depending on the type of
cells that are bound to an APC. This occurs, for example, in the cross-regulation model (Chapter
7).
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2.3 Error reduction algorithms
The implementation of discrete timestepping in spatial simulations introduces errors. The error
in simulations is calculated by comparing the mean first passage time (MFPT) obtained from the
simulations to the analytical solution for the MFPT (3.3.13). Using the spatial modelling algorithm
in the previous section, the MFPT is over estimated, due to the strictly positive probability that
an excursion is made inside the target region during a timestep that starts and ends inside the
region (see Figure 2.2), or outside the domain (see Figure 2.4) in a timestep that starts and ends
inside the domain [19, 23, 86, 87, 117, 118, 144, 157]. To reduce these errors, algorithms are used
to calculate the probability of encountering an APC during a timestep, and the probability to have
hit the outer boundary during a timestep. These algorithms allow a larger timestep size to be used
without introducing significant amounts of error, thereby improving the computational speed of
the simulation. Error reduction algorithms are described in the next sections.
2.3.1 Target encounters
Figure 2.2 illustrates the situation that results in overestimation of the MFPT at the surface of the
target. The blue path can be reproduced by decreasing the timestep size, but a smaller timestep size
d1
d0
Figure 2.2: Diagram showing the situation that causes overestimation of the MFPT at the target.
The green circle represents the APC/target, d0 and d1 are the distance from the centre of the target,
to the T cell, before and after the timestep. The red line indicates the path the particle has taken in
the simulation and the blue line indicates a possible path the particle could have taken if a smaller
timestep size was used, resulting in the particle encountering the target.
results in more computational time being needed to execute the program. To determine the size of
the error in the spatial code, a simple code that moves one T cell until it finds a stationary APC
in the centre of a sphere was implemented. A mean time to encounter the APC over a number
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of realisations was calculated for varying timestep sizes and compared to the MFTP calculated
analytically (3.3.10), to calculate the error in the simulation. Using this data, a curve of the form
β
√
δt could be fitted, as it was suspected the error would change as a function of
√
δt [86]. This
gave an equation for the error of 13.77
√
δt (Figure 2.3). Therefore the error in the simulation is
proportional to
√
δt, where δt is the timestep size.
The error occurs because a T cell may encounter an APC during a timestep. To overcome this
problem, an algorithm, developed by [86, 119], can be introduced to calculate the probability of
the T cell encountering an APC during a timestep. The equation used to calculate the probability
of encountering a target during a timestep is
P(encounter) = exp
(
−d0d1
Dδt
)
, (2.3.1)
where d0 is the distance from the T cell to the centre of the APC at the start of the timestep, d1
is the distance at the end of the timestep, and D is the diffusion coefficient of the T cell. This
algorithm can be implemented in the spatial code and a new error calculated by comparison to the
MFPT equation (3.3.10). Fitting a curve to the new error gives an equation for the error of 6.00δt
(Figure 2.3). The error in the code using this error reduction algorithm has now been reduced to
be proportional to δt.
Figure 2.3: Plot showing the error as the timestep size is varied, without the error reduction in
blue, with a curve of the form β
√
δt fitted to the data (yellow), and with error reduction in red,
with a curve of the form βδt fitted to the data (yellow). Parameters used: R = 1, D = 0.5,
b = 0.02. Number of realisations for each data point = 105.
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This method greatly reduces the error. However, the algorithm is not exact, and there is still
error in the algorithm as it assumes a flat boundary rather than a curved boundary. Error is also
introduced from a similar problem occurring on the boundary of the LN that the T cell is moving
within, which will be addressed in the next section.
2.3.2 Boundary collisions
As with encountering an APC, error is also introduced at the boundary of the LN due to discrete
timestepping. That is, during a timestep a T cell could have collided with the boundary, resulting
in the MFTP being overestimated. This is illustrated in Figure 2.4.
r1
r0
Figure 2.4: Diagram showing the situation that causes overestimation of the MFTP at the boundary
of the domain. The black curve represents the boundary, r0 and r1 are the distances from the centre
of the domain before and after the timestep. The red line shows the path the particle has taken,
and the blue line a potential path the particle could have taken if a smaller timestep size was used,
resulting in the particle leaving the domain.
This error can be reduced by using an algorithm to calculate the probability of a T cell hitting the
boundary during a timestep. To do this we first need to define
dw = r1 − r0,
where r0 is the distance from the centre of the LN to the T cell at the start of the timestep, and
r1 is the distance at the end of the timestep. The distance the T cell moves away from its starting
position in one timestep is a random variable, given by
max =
dw
2
+
(
dw2 − 2dt log(urv)
2
) 1
2
,
[119] where urv is a uniform random variable, between zero and one [12–14]. To determine if
the T cell has hit the boundary we need to check if r0 + max is greater than the radius of the LN
(R). If this occurs, we calculate a new distance; newr = dw−max +R, and multiply each of the
x, y and z components by newr/r1 to reflect the T cell off the boundary and back into the LN.
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We can examine how effective this method is by comparing the error in a spatial simulation, using
this algorithm, to the results of Figure 2.3. This comparison is shown in Figure 2.5. Fitting a
curve to the error in the data produced with the addition of a surface boundary algorithm gives an
equation for the error of 5.96δt2. The error in the code has now been reduced to be proportional
to δt2.
Figure 2.5: Plot showing the results for the error in the time a T cell takes to encounter an APC,
when an algorithm is only used to reduce the error on the surface of an APC (red), and when an
algorithm is additionally used to reduce the error at the boundary of the LN (green), with curves
fitted to the data (yellow). Parameters used: R = 1, D = 0.5, b = 0.02. Number of realisations
for each data point = 105.
2.3.3 Exponential timestepping
Most numerical methods that are commonly used [45, 128, 143, 182] for solving stochastic
differential equations and in spatial modelling, have a timestep of fixed length. However, it is also
possible to have a timestep with a length that is a random variable [90,168]. For example, a random
variable chosen from an exponential distribution. Using exponential timestepping, over fixed
timestepping, has the advantage that the probability of encountering a sphere during a timestep can
be calculated exactly, using methods from excursion theory [39, 69, 116, 120, 122, 126, 189]. With
exponential timestepping [117–119], instead of using timesteps of fixed size, timesteps that are
drawn from an exponential distribution with a given mean timestep size are used. To implement
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an exponential timestepping algorithm in three-dimensional space, the following steps must be
undertaken:
• Define a factor mod as: mod =
√
−2 log(1− urv1)(g21 + g22 + g23)δtD, where urv1 is a
uniform random variable between zero and one, g1, g2 and g3 are random numbers drawn
from a Gaussian distribution with mean zero and variance one, δt is the mean timestep size,
and D is the diffusion coefficient.
• Define the increment in the z dimension as dz0 = 2urv2−1, where urv2 is another uniform
random variable between zero and one.
• Define an angle as θ = 2piurv3, where urv3 is yet another uniform random variable between
zero and one.
• The increment in the x dimension is given by dx0 =
√
1− dz20 cos(θ).
• The increment in the y dimension is given by dy0 =
√
1− dz20 sin(θ).
• We now need to scale the x, y and z increments by multiplying by the function mod.
Therefore dx = mod · dx0, dy = mod · dy0 and dz = mod · dz0
To determine if a T cell has encountered an APC, or the boundary of the LN, during a timestep,
we must first calculate the distance of the T cell from its nearest APC and the distance of the T
cell to the centre of the LN. Let us denote these as d0 and r0, respectively. We now move the T
cell, as outlined above, and recalculate the distance from the nearest APC, and the distance from
the centre of the LN, and define these distances as d1 and r1.
The probability of encountering an APC is calculated by
P(encounter) = exp(−ν(re − b)) sinh(νb)
sinh(νre)
,
where ν = 1/(δtD), b is the effective radius of an APC, and re = min(d0, d1) [119]. We
then generate a uniform random variable, between zero and one, if it is less than the calculated
probability, the T cell is classified as encountering the APC.
Calculating the probability of hitting, and being reflected off, the boundary of the LN is similar.
We denote the probability by P(reflect) as follows,
P(reflect) = exp(−ν(R− rr))sinh(νrr)
sinh(νR)
,
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where rr = max(r0, r1), and R is the radius of the LN [119]. We then generate a uniform random
variable, between zero and one, and if P(reflect) is less than the random variable, the T cell is
classed as hitting the boundary, and its position must be updated to correct for reflecting off the
boundary. An example of a python code that uses exponential timestepping is shown in B.
Figure 2.6 compares exponential timestepping to fixed timestepping with algorithms to reduce the
error on the surface of the APC and the boundary of the LN.
Figure 2.6: Comparison of error using Gaussian timestepping with algorithms to reduce the error
on the boundary of the APC and the LN (blue) and exponential timestepping (red). Curves have
been fitted to this data (shown in green). Parameters used: R = 1, D = 0.5, b = 0.01. Number of
realisations for each data point = 105.
2.4 Gillespie algorithm
Modelling a system using a deterministic approach regards the time evolution of the system as
a continuous predictable process that is frequently governed by a set of coupled ODEs. The
solution to a system of ODEs, at a given time t, is fixed for a given set of initial conditions. A
stochastic approach regards the time evolution of the system to be continuous, and is governed by
a single differential-difference equation, often referred to as the master equation. The Gillespie
algorithm [83, 84] allows exact numerical calculations within the framework of the stochastic
formalisation without having to deal with the master equation directly. The algorithm uses a
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Monte-Carlo procedure to numerically simulate the time evolution of a given system, and it
correctly accounts for the inherent fluctuations and corrections that are necessarily ignored in the
deterministic formalisation. The algorithm never approximates infinitesimal time increments by
finite steps, and is more realistic for modelling biological systems such as numbers of molecules,
cells, or individuals, as population numbers can only change in discrete integer steps, unlike in the
deterministic approach, which assume population numbers are continuous. Due to the stochastic
nature of the Gillespie algorithm it captures behaviour in which populations can switch from one
steady state to another, which can include extinction, due to random fluctuations in the system.
These fluctuations are especially significant for small cell numbers and are lost in the deterministic
approximation.
In this section we set out to solve the following general problem: If a fixed volume
contains a spatial uniform mixture of n cell species which can interact through m specified
reactions/interactions, then given the initial number of cells in these species, at a specific time,
what will these cell population levels be at any later time? The most common approach to
solving this type of problem is to translate the series of reactions into a set of ordinary differential
equations (ODEs). These ODEs are known as the reaction rate equations. Solving them for the
cell population numbers, given a specific set of initial conditions, is tantamount to solving the
general problem proposed earlier. Analytical solutions to the reaction rate equations can be found
only for rather simple cases, and it is usually necessary to solve these system numerically using
a computer. The usefulness of this approach for biological systems cannot be denied, however, it
does have its drawbacks. The approach assumes the time evolution of a biological process is both
continuous and deterministic. However, the time evolution of a biological process is evidently not
continuous as cell numbers can only change in discrete integer amounts. Nor is the time evolution a
deterministic process as it is impossible, even in principle, to predict the exact population levels at
some future time, unless we take into account the exact positions and velocities of all the molecules
in the system. In many cases the time evolution of a biological system can, to an acceptable degree,
be treated as a continuous deterministic process. However, this should not always be taken for
granted as in some case the reaction rate equations inability to describe the fluctuations in the cell
population levels can lead to serious shortcomings. Moreover, it is not guaranteed that the reaction
rate equations will provide a sufficiently accurate account of the average molecular population
levels, as, except for very simple linear systems, the average molecular population levels will
not exactly satisfy any closed system of equations [83, 84]. The Gillespie algorithm [83, 84] is
a method for computationally solving the time evolution of a biological spatially homogeneous
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system that explicitly takes account of the fact that the system is a discrete, stochastic process
instead of a continuous, deterministic process. The Gillespie algorithm offers an alternative to the
differential reaction rate equations that is free of the difficulties mentioned above.
2.4.1 Physical basis of the stochastic formulation [84]
In general a chemical/biological reaction occurs whenever two or more molecules/cells of
appropriate kind collide in an appropriate manner. Consider a system comprising of a mixture
of two cell types, S1 and S2, which are in equilibrium within a volume, V . For simplicity it is
assumed the cells are spheres of radii r1 and r2 respectively. Therefore, a 1-2 collision will occur
whenever the distance between the centres of the two cells decreases to r12 = r1 + r2. The
traditional method to calculate the rate at which these interactions occur is to begin by choosing
an arbitrary 1-2 pair of cells, and denoting the speed of cell 1 relative to cell 2 as v12. We then
observe that in the next small time interval δt, cell 1 will sweep out relative to cell 2 a ‘collision
volume’ δVcoll = pir212v12δt [84] in the sense that if the centre of cell 2 lies within the δVcoll
at time t, then the two cells will collide in the time interval (t, t + δt). We now estimate the
number of S2 cells that have a centre that lies within δVcoll, divide that number by δt, and take
the limit as δt → 0 to obtain the rate at which the S1 cells collide with the S2 cells. However, as
δVcoll → 0, the number of S2 cells that have a centre within δVcoll will either be 1 or 0, with the
zero possibility becoming more and more likely. Therefore, it is physically meaningless to talk
about the number of cells with centres laying within δVcoll in the limit of vanishingly small δt.
However, as the system is in equilibrium, the cells will at all times be distributed randomly and
uniformly throughout the volume. Therefore, the probability that the centre of an arbitrary S2 cell
will be located within δVcoll at time t will be given by the ratio δVcoll/V , which is true in the limit
of vanishingly small δVcoll. If we average this ratio over the velocity distribution of the two cell
types, it can be concluded that
δVcoll/V = V
−1pir212v12δt,
which equals the average probability that a particular 1-2 cell pair will collide in the next
vanishingly small time interval δt. If at time t there are N1 of the S1 cells and N2 of the S2
cells in V , giving a total of N1N2 distinct 1-2 cell pairs, then it follows that the probability that a
1-2 collision will occur within V in the next infinitesimal time interval (t, t+ dt) is given by
N1N2pir
2
12v12dt.
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Although the number of 1-2 collisions occurring in the infinitesimal time interval cannot rigorously
be calculated, the probability of a 1-2 collision occurring can be. This means the system must be
classified by a ‘collision probability per unit’ time rather than a ‘collision rate’. This is why these
collisions constitute a stochastic process instead of a deterministic process.
2.4.2 The stochastic simulation algorithm
To be able to simulate a biological system of reactions we require a way of specifying when the
next reaction will occur and what kind of reaction it will be. What is required is a method for
generating a pair (dt, µ), where dt is the time increment and Rµ is the reaction that will occur,
from the set of random pairs whose probability density function is P (dt, µ), given by [83]:
P (dt, µ) =

aµ exp(−a0dt) if 0 ≤ dt <∞ and µ = 1, · · · ,M,
0 Otherwise.
(2.4.2)
In which aµ = hµcµ and a0 =
∑M
i=1 hici, where hµ is the number of distinct Rµ cell reactant
combinations available in the state (N1, N2, · · · , Nn), (µ = 1, · · · ,m), and cµ is a constant that
depends on the physical properties of the reacting cells and the system.
It turns out that there is a simple rigorous way of doing this using uniform random numbers.
This achieved as follows [82]: Using two uniform random numbers, u1 and u2, take dt =
(1/a0) ln(1/u1), and take µ to be the integer for which
∑µ−1
i=1 ai < u2a0 ≤
∑µ
i=1 ai. A
rigorous proof can be found in [83]. This procedure generates a random number dt according
to the probability density function P1(dt) = a0 exp(−a0dt) and an integer µ according to the
probability density function P2(µ) = aµ/a0. The stated result follows, roughly speaking, because
P1(dt)P2(µ) = P (dt, µ).
2.4.3 Computational algorithm
This section addresses the computational algorithm developed in [83, 84] used to solve the
time evolution of a biological system. An example of a generalised Gillespie algorithm for
simulating a series of reactions is outlined. For the purposes of this thesis the algorithm
is assumed to be simulating interactions between various cell types. The algorithm in this
subsection is simulating the interaction between n populations of cells with population sizes of
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(N1, N2, ..., Nn). These populations interact following the interactions (R1, R2, · · · , Rm) with
corresponding rates (r1, r2, · · · , rm).
Step 0 (Initialisation): Input desired values for the reaction rates (r1, r2, · · · , rm), for reactions
(R1, R2, · · · , Rm), and initial population numbers (N1, N2, ..., Nn).
Step 1: Calculate the ‘reaction parameters’ (a1, a2, · · · , am) by multiplying the reaction rate by
the size of each of the populations required for that reaction to occur, and the number of each of
the populations required.
Step 2: Calculate two uniform random variables, u1 and u2, in the interval zero to one. Use
these numbers to generate: (i) the time elapsed, dt, for the next reaction to occur by sampling
from an exponential distribution, dt = − log(u1)/
∑m
i=1 ai, and (ii) the reaction that has occurred
in this time interval. To determine the reaction that has occurred, all possible reactions must be
scaled into the interval zero to one. We do this for the first reaction (R1) by assigning the interval
between 0 and a1/
∑m
i=1 ai, then for reactions R2 to Rm the interval from
∑m
i=k ai/
∑m
i=1 ai,
where 2 < k < m. The reaction that occurs is then determined by the interval u2 falls into.
Step 3: Adjust the time elapsed by adding dt, and adjust the population levels to reflect the
occurrence of the reaction determined in step 2. Then return to step 1.
This process continues until a desired time or population number is reached.
2.4.4 Simple example
To illustrate the Gillespie algorithm, let us consider a simple example in which we have two cells
A and B, that bind with rate k+ and unbind with rate k−, producing two cells of type A. We have
the reactions
R1 A+B
k+−→ AB
R2 AB
k−−→ 2A+B.
Step 0: Let us start with population size of NA, NB and NAB for populations A, B and AB
respectively, where AB is the complex of A and B bound to each other. We will continue our
simulation until the time is greater than some maximum time, tstop.
Step 1: We have a1 = k+NANB and a2 = k−NAB .
Step 2: The
∑
i ai = a1 + a2, therefore dt = − log(u1)/(a1 + a2). We have the intervals:
I1 =
[
0, a1(a1+a2)
]
for R1, and I2 =
[
a1
(a1+a2)
, 1
]
for R2. The reaction that has occurred is
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determined using the uniform random number u2.
Step 3: We now increment the time by dt, t = +dt, and adjust the population numbers
accordingly. If u2 ∈ I1, NA = NA − 1, NB = NB − 1 and NAB = NAB + 1, and if u2 ∈ I2,
NA = NA + 2, NB = NB + 1 and NAB = NAB − 1. We now check if t > tstop, if it is, we end
the simulation, if not, we return to step 1.
2.5 Green’s functions
There are many great books on Green’s functions [21, 233], therefore only a brief description
will be given. Green’s functions are used to solve inhomogeneous differential equations, with
boundary conditions. For an arbitrary differential operator L, which in this thesis will always be
the Laplacian, the Green’s function G(x|x′) is defined as
LG(x|x′) = δ(x− x′), (2.5.3)
where δ is the delta function. The solution to Lφ(x) = f(x), is given by
φ(x) =
∫
G(x,x′)f(x′)dx′. (2.5.4)
2.6 Other modelling efforts
2.6.1 Cellular Potts model of the lymph node
The Cellular Potts model (CPM) is a generalisation of the Ising model, which is used to model
magnetic interactions [99]. In the CPM, the domain is divided into a lattice of discrete sites,
and cells are described by the lattice sites they occupy [67]. This method allows the cells to
have complex shapes that can change. However, it does not model the internal structure of the
cell. The motion and interactions of cells is determined by an energy function [57]. The energy
function typically depends upon adhesion between cells, volume of a cell, and the concentration of
chemical attractants. The method is updated using a modified Metropolis Monte-Carlo algorithm
[167]. The Metropolis Monte-Carlo algorithm is a method for obtaining random samples from a
probability distribution for which direct sampling is difficult. A modification is applied for use in
higher dimensions. The Monte-Carlo algorithm chooses random updates for the lattice positions
according to how the energy of the system changes. For example, an optimal cell volume is
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normally set, if a cell’s volume is below the optimal value, the energy of the system would decrease
by increasing the volume of the cell, so the overall volume is closer to the optimal volume. An
increase in the contact area between cells will cause an increase in the energy of the system. If
a cell moves towards a chemical attractant, the energy of the system will decrease, as the cell is
moving in the chemically favoured direction. The algorithm accepts the changes with a probability
defined by the change in the overall energy of the system. Lower energy states are accepted with
a higher probability than higher energy states.
The Cellular Potts model allows detailed simulation of cell membrane movements. This thesis is
concerned with cells interacting, but not with how their membrane structures interact. The cellular
Potts model is therefore not an appropriate model for use in this thesis, as such a high level of
detail is not required.
2.6.2 Movement on the reticular network
It has been proposed that, rather than moving in three-dimensional space, T cells move along the
reticular network (RN), which fills the T cell zone of the LN [92,121,123,225]. It has been reported
that the RN acts as a conduit system, transporting soluble antigen to DCs residing in the LN [208],
and the cells of the RN secrete the T cell survival factor IL-7 [135]. There is experimental evidence
for T cells moving along the RN, and their changes in direction being correlated with branches of
the RN [16, 18, 196].
Donovan and Lythe [73] develop a model in which T cells move along a RN, by first constructing
a network, and then confining all motion to the network. Using a computational approach, they
construct a network by defining sets of vertices and the edges joining them. They assume each
vertex in the network is connected to exactly three edges, motivated by the idea of a network
growing by branches splitting into two. Various hypotheses are considered for the movement of
cells along the edges of the network. They also explore the effect moving on a RN has on the
interactions between T cells and APCs, as some APCs reside on the network [129]. It has also
been proposed that restricting motion to the RN could be a way of increasing the rate of encounters
between cells [56]. It is found that restricting movement to a RN does not necessarily increase the
frequency of encounters, compared to movement by Brownian motion in three-dimensional space.
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2.7 Chapter summary
This thesis focuses on the interactions and dynamics of lymphocytes, within LNs. The stochastic
nature of these interactions will be considered by using spatial and Gillespie models. Chapter
3 investigates the first passage processes of the time a T cell takes to locate an APC within a
LN. Chapters 4 and 5 focus on in vivo imaging experiments, analysing experimental data, and
determining the effects of confinement in a limited sized imaging volume when calculating the
diffusion coefficient of T cells. Chapter 6 makes use of experiments carried out by the Bousso
group, in Paris, to answer the question of, how many DCs are required to initiate a T cell
response? Chapter 7 investigates effector and regulatory T cell interactions by developing a
stochastic formalisation of the deterministic cross-regulation model [49, 133]. Finally, Chapter
8 will make use of mathematical models to investigate the three hypotheses for T cell activation,
proposed in [42].
2.7.1 Chapter 3
The work in Chapter 3 aims to determine the time a T cell takes to first encounter an APC
within a LN. The time for this encounter to occur is of critical importance to the activation of
a T cell response. The chapter builds up on the simple scenario of a particle in a known position
attempting to locate a fixed central target, to the case when a particle in a uniform random unknown
starting position is attempting to locate one ofN fixed targets located in unknown uniform random
positions. This is achieved by solving Poisson’s equation, and making use of Green’s functions.
The work in Chapter 3 greatly benefited from recent theoretical advances in the mathematics
describing diffusing objects in a confined region, with one or more targets [58, 61].
2.7.2 Chapter 4
The effect of confinement in a limited size imaging volume is investigated in Chapter 4. Since
the beginning of the twenty-first century advances have been made in in vivo imaging techniques,
through the development and improvement of TPLSM. These experiments generate extensive data
sets, but are limited by the size of the volume that can currently be imaged. A limited sized
imaging volume causes a confinement effect to be observed at later times in the experiments, as
cells that take looping paths will remain for longer in the imaging volume. Chapter 4 provides an
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estimation of the point at which confinement should be observed, due to a limited volume size.
2.7.3 Chapter 5
Chapter 5 makes use of work carried out in Chapter 4 to analyse data obtained from TPLSM
experiments. The chapter investigates experimental data to determine the type of motion being
observed, and calculate the motility of the cells imaged. A systematic algorithm is developed to
determine the type of motion and calculate a diffusion coefficient of cells in a TPLSM data set.
The work in this chapter, as well as work in Chapter 4, provides an insight into how the shape, and
resolution, of the imaging volume used in TPLSM experiments can be improved to give a more
informative data set.
2.7.4 Chapter 6
Chapter 6 attempts to answer the question of, how many DCs are required to initiate a T cell
response? This work was carried out in collaboration with experimentalists in Paris. Biological
experiments allow the probability of activation to be estimated using large numbers of cells, on
a short timescale. Mathematical modelling allowed extrapolation of the experimental results to
lower cell numbers and longer timescales, enabling a minimum number of DCs required to initiate
a T cell response, to be determined.
2.7.5 Chapter 7
Chapter 7 extends work done by Le´on et al. [49, 133], to investigate the effect of stochastic
fluctuations on the cross-regulation model. The cross-regulation model is a model of three way
interactions between APCs, effector T cells and regulatory T cells. A stochastic model gives
a more realistic description of biological processes, allowing variability to be observed in the
system. This approach reveals aspects of the system previously not observed the the deterministic
model.
2.7.6 Chapter 8
In Chapter 8, three hypotheses of T cell activation [40, 42] are investigated. T cells are known to
undergo three distinct phases in their activation process: (1) transient interactions, (2) long-lived
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interactions, and (3) swarming. Three hypotheses have been proposed to explain this process;
APC changes, T cell signal integration, and a probabilistic approach. Chapter 8 models these
three hypotheses, with an emphasis on the probabilistic approach.
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Chapter 3
First passage processes
3.1 Introduction
First passage processes [184, 226] have relevance to many practical areas, including chemical
[100, 187] and biochemical reactions [30, 31, 63, 138], searching for food by animals [28] and
transport processes on complex networks [3, 4, 29, 166, 169, 222]. Mean first passage times
(MFPTs) associated with a random walker moving in a bounded domain, with one or more
targets are a critical step in transport-limited reactions [187], such as immune cell interactions,
for which the time for cells to encounter each other is a limiting factor in the initiation of an
immune response. MFPTs are also used in other areas of immunology, such as calculating the
arrival time of receptors at localised reactive sites on the surface of immune cells, which is the
key step in the signalling process, and therefore activation [62] of the cell upon encounter. This
chapter focuses on the larger scale of cell-cell encounters.
The aim of this chapter is to derive an equation for the target global mean first passage time
(TGMFPT) of a particle, which represents a T cell, starting in a uniform random position and
moving by Brownian motion within a bounded spherical domain that excludes the volume of the
target, representing a lymph node (LN), to encounter one or more uniformly randomly placed
fixed spherical targets, representing antigen-presenting-cells (APCs). The particles are assumed
to move with a constant diffusivity, and the targets are assumed to be stationary. The domain has
a reflecting boundary, keeping the particle confined, and the target(s) have absorbing boundaries.
Extensive research has been carried out in the area of MFPTs, and important results have been
published regarding the time for a random walker to reach a target site for the first time. This target
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could either be within a bounded domain, or, on the surface of the domain. Other first passage
related quantities have also been derived, such as splitting probabilities, which is the probability to
reach one target before another [3,4,27,31,35,58–62,94,103,149,181,205–207,230]. Particularly
useful to the research in this chapter, Condamin et al. [60] determine starting global mean first
passage times (SGMFPTs), and splitting probabilities, in the presence of one, and two targets, in
both discrete and continuous time, on the interior of two and three-dimensional domains. First
passage processes for more than two targets [58, 59, 62] have also been studied. Results of these
studies are used in this chapter. Other studies have found expansions for the principal eigenvalues
of the Laplacian, MFPT, and splitting probabilities for various domains [59,62], allowing optimal
positions of targets to be calculated in order to minimise search time.
This chapter begins by deriving Poisson’s equation, which is used to calculate a MFPT for a single
target in the centre of a sphere, with a particle undergoing Brownian motion searching for it. A
MFPT for a single target being ‘close’ to the centre of the sphere, where ‘close’ is defined as
being within one target radius, using an approximation proposed by Grigin [93], is investigated.
To calculate a solution for a unifromly randomly placed target within the domain, a review of
papers by Condamin et al. [60] and Chevalier et al. [58], in which they derive an equation for a
target in a fixed position anywhere within the domain, is undertaken. Using this, an equation is
derived for a uniformly randomly placed target, by integrating over all possible starting positions
within the domain. The final step is to derive a TGMFPT for multiple targets, in the domain. This
is accomplished by making use of equations for N targets, in fixed positions within the domain,
derived in [58,60]. Integrating the equation for multiple fixed targets, over the starting position of
each of the targets, results in an equation for multiple unifromly randomly placed targets within a
sphere. All the results in this chapter are tested against numerical results, generated using spatial
codes (Section 2.2.3).
The results obtained in Sections 3.2 and 3.3 have been derived previously for a multitude of
applications. The approximation in Section 3.4 was developed by Girgin [93]. To the best of my
knowledge this approximation has not been previously used to calculate the first passage quantities
derived in Section 3.4. The work in Section 3.5 to 3.8 to calculate the SGMFPT is a review of
work carried out by [58,61]. The calculations to compute the TGMFPT for one and N targets has
not been previously undertaken to the best of my knowledge.
The aim of this chapter is to derive an equation for the time a particle starting in a unifrom random
position, which excludes the volume occupied by the target, and is undergoing Brownian motion,
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takes to encounter a target in a fixed uniform random position. This is analogous to a T cell
attempting to encounter an APC within a LN. Obtaining this equation will allow a rate of encounter
between T cells and APCs to be calculated for a given set of conditions. This rate can then, and
will be, used in this thesis to simulate interactions between T cells and APCs both computationally
and analytically.
The SGMFPT refers to the MFPT for a particle starting in a uniform random unknown position,
which excludes the volume occupied by the target, to locate a target starting in a fixed known
uniform random position. The TGMFPT refers to the MFPT for a particle starting in a uniform
random unknown position, which excludes the volume occuped by the target, to locate a target
starting in a fixed unknown uniform random position.
Description Vector Radius
Initial position of particle rs rs
Target rT rT
Position of particle along path r r
Table 3.1: Table listing the parameters used to represent the positions of particles and targets.
Vector refers to a three-dimensional position and radius refers to the distance from the centre of
the domain.
Description of positions Abbreviation Notation
Prescribed particle, central target MFPT τ0(rs)
Prescribed particle, prescribed random target MFPT τ(rT , rs)
Unprescribed random particle, prescribed random target SGMFPT τ(rT )
Unprescribed random particle, unprescribed random target TGMFPT T
Table 3.2: Table listing notation used to represent first passage processes. Prescribed implies
the starting position is known, unprescribed that the starting position is unknown. All random
positions are uniform random and exclude the volume occupied by the target in the case of the
particles position.
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3.2 Poisson’s Equation [184]
Assuming a symmetric random walk, in one dimension, where there is equal probability of moving
in both directions, on the interval [x−, x+], with time increment δt, the mean time to encounter
the boundary, t(x), starting from position x, is the sum of the times for each exit path, multiplied
by the probability of that path, averaged over all paths.
t(x) =
∑
i
Pi(x)ti(x), (3.2.1)
where ti(x) is the exit time of path i, to the boundary, and Pi is the probability of path i. Figure
3.1 illustrates (3.2.1).
Figure 3.1: Diagram to illustrate (3.2.1). A particle starts at a prescribed position, within the
domain, and moves a distance chosen from a uniform distribution, independent of previous
movements, in fixed discrete timesteps until it crosses the boundary of the domain.
This mean time, obeys the recursion formula
t(x) =
1
2
[t(x+ δx) + δt] +
1
2
[t(x− δx) + δt], (3.2.2)
where δx is the increment moved in the x dimension, and the boundary conditions are t(x−) =
t(x+) = 0: the time to encounter the boundary is zero, if starting at the boundary. The relation
expresses the mean time starting at x in terms of the outcome one step in the future. The walk can
be viewed as restarting at x+ δx or x− δx after time interval δt has passed, each with probability
one half. Using the Taylor expansion on t(x+ δx) and t(x− δx), as δx→ 0, gives
t(x+ δx) = t(x) + δxt′(x) +
1
2
δx2t′′(x) + ... (3.2.3)
t(x− δx) = t(x)− δxt′(x) + 1
2
δx2t′′(x) + ... (3.2.4)
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Substituting equations (3.2.3) and (3.2.4) into equation (3.2.2) gives
t(x) = δt+ t(x) +
1
2
δx2t′′(x) + ... (3.2.5)
Dividing by δt, and rearranging, gives
Dt′′(x) = −1, (3.2.6)
where D is the diffusion coefficient. Brownian motion is the limit of a random walk as δt → 0,
with the limitD = 12 limδt→0
δx2
δt . This can be extended to three dimensions to give Poisson’s equation
D∇2τ = −1, (3.2.7)
where τ is the mean time starting from position rs, which is a three-dimensional vector.
3.3 Central target
A MFPT for a particle moving by Brownian motion, within a sphere, to find a target located in the
centre of the sphere, can be calculated by making use of Poisson’s equation (3.2.7). This problem
is illustrated in Figure (3.2).
Figure 3.2: Diagram showing a Brownian path (blue) to a target (green) located in the centre of a
sphere.
The expected time to encounter a central target, τ0, within a sphere, satisfies Poisson’s equation
(3.2.7), with a reflecting boundary condition on the surface of the sphere, dτ0(rs)drs
∣∣∣
rs=R
= 0, and
an absorbing boundary condition on the surface of the target, τ0(rs = b) = 0, where b is the size
of the target, rs = |rs| is the distance from the centre to the starting position of the particle, and R
is the radius of the spherical domain.
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As the target is in the centre of the sphere there is symmetry in both the azimuthal and polar angles,
therefore τ0(rs) only depends on the distance to the particle’s initial position. Using spherical polar
coordinates Poisson’s equation (3.2.7) becomes
1
r2s
∂
∂rs
(
r2s
∂
∂rs
τ0
)
=
∂2
∂r2s
τ0 +
2
rs
∂
∂rs
τ0 = − 1
D
. (3.3.8)
Equation (3.3.8) has the general solution
τ0(rs) = − 1
6D
r2s −
c1
rs
+ c2, (3.3.9)
where c1 and c2 are integration constants. Using the boundary conditions to find c1 and c2 in
(3.3.9), gives
c1 =
R3
3D
, c2 =
1
6D
(
b2 +
2R3
b
)
,
so that
τ0(rs) =
R3
3Db
− R
3
3Drs
− r
2
s
6D
+
b2
6D
. (3.3.10)
3.3.1 Particle in a random starting position
The SGMFPT for a particle starting in a uniform random position within the sphere, excluding
the volume occupied by the target, to find a central target, can be found by integrating equation
(3.3.10) over all the possible starting positions in the sphere, and dividing by the volume of the
sphere, minus the volume of the target, as follows:∫ 2pi
0
∫ pi
0
sin θ
∫ R
b
r2sτ0(rs)drsdθdφ = 4pi
∫ R
b
τ0(rs)r
2
sdrs, (3.3.11)
as there is spherical symmetry. Now
4pi
6D
∫ R
b
[
2R3(
r2s
b
− rs) + r2sb2 − r4s
]
drs =
2pi
45Db
[
2R5(5R− 9b) + b5(3b− 5) + 10b3R3] .
(3.3.12)
Dividing by the volume of the sphere minus the volume of the target; (4pi(R3 − b3)/3), gives the
equation
τ0 =
R3
R3 − b3
(
R3
3Db
− 3R
2
5D
+
b2
3D
− b
4
6D
+
b5
10D
)
, (3.3.13)
where τ0 is used to represent the SGMFPT. For b R, this becomes
τ0 ≈ R
3
3Db
− 3R
3
5D
. (3.3.14)
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3.4 Target ‘close’ to centre
The aim is to determine an equation for the time a particle moving by random motion, within a
sphere, takes to find a uniformly randomly placed target. This proves to be simple when the target
is in the centre of the sphere, as there is spherical symmetry. However, if the target is not in the
centre there is only symmetry in the azimuthal angle, therefore Poisson’s equation becomes
∇2τ(rT , rs, θ) = 1
r2s
∂
∂rs
(
r2s
∂τ
∂rs
)
+
1
r2s sin θ
∂
∂θ
(
sin θ
∂τ
∂θ
)
= − 1
D
. (3.4.15)
Separation of variable leads to the expression
τ(rT , rs, θ) =
A0
rs
+B0 − 1
6D
r2s +
∞∑
n=0
(Anr
n
s +Bnr
n+1
s )Pn(cos θ), (3.4.16)
where θ, is the polar angle between the particle and target, rT is the position of the target, the
Pn’s are Legendre polynomials, and A0, B0, An and Bn are constants. As a first approximation
(3.4.16) is expanded to order cos θ terms giving
τ(rT , rs, θ) =
A0
rs
+B0 − 1
6D
r2s +
(
A1
r2s
+B1rs
)
cos θ. (3.4.17)
At the surface of the sphere, we have a reflecting boundary condition, which implies
∂τ(rT , rs, θ)
∂rs
= 0 for rs = R, (3.4.18)
as in the previous case. The boundary condition on the surface of the target, is not as straight
forward as in the previous case. A paper by Grigin [93], proposes that an equation for the position
on the surface of a sphere ‘close’ to the centre of another sphere is given by rs = b(1 +  cos θ),
where  is a small parameter given by rT /b, and rT is the distance of the target from the centre of
the sphere. For this approximation to hold, the condition rT < bmust be satisfied (see Figure 3.3).
Therefore, the approximation is only useful when the target is ‘close’ to the centre of the sphere.
Using this approximation, the boundary condition for the surface of the target is given by
τ(rT , rs, θ) = 0 for rs = b(1 +  cos θ). (3.4.19)
Using boundary conditions (3.4.18) and (3.4.19), we find
A0 = −R33D , B0 = 16Db(2R3 + b3),
A1 =
rTR
3
3D
(
b3−R3
2b3+R3
)
, B1 =
2rT
3D
(
b3−R3
2b3+R3
)
.
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Target
b
b
Figure 3.3: Setup of a problem with the centre of a target (green) within one target radius (b,
indicated by dashed line) of the centre of the sphere.
Giving the MFPT equation
τc(rs, rT , θ) =
R3
3Db
− R
3
3Drs
− r
2
s
6D
+
b2
6D
+ (b3 −R3) rT (R
3 + 2r2s)
3Dr2s(2b
3 +R3)
cos θ, (3.4.20)
where the c subscript refers to the ‘close’ approximation. When rT → 0, we approach the case
where the target is in the centre,
τc(rs, rT , θ)→ R
3
3Db
− R
3
3Drs
− r
2
s
6D
+
b2
6D
, (3.4.21)
agreeing with (3.3.10). Equation (3.4.20) can be tested by comparing to spatial simulations
(Section 2.2.3), for varying angles (θ) around the centre. Figure 3.4 shows (3.4.20) is a better
approximation to the MFPT than assuming the target is in the centre, as in (3.3.13).
3.4.1 Random particle starting position
The SGMFPT for a particle, starting in a uniform random position within a sphere, excluding the
volume occupied by the target, to find a target, that has a centre within radius b of the centre of the
sphere, can be found by integrating (3.4.20) over all possible starting positions of the particle, as
follows∫ 2pi
0
∫ pi
0
sin θ
∫ R
b
r2sτc(rs, rT , θ)drsdθdφ = 2pi
∫ pi
0
sin θ
∫ R
(b+rT )
r2sτc(rs, rT , θ)drsdθ.
(3.4.22)
We have the lower limit of (b+rT ) on the integral over rs, to excluded the particle from starting in
a position where the target could be placed. This will lead to a larger volume being excluded than
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Figure 3.4: Comparison of numerical results from spatial simulations to the MFPT equation for a
target in the centre of a sphere (3.3.13) and the MFPT equation for a target ‘close’ to the centre
(3.4.20). Parameters used: b = 0.2, rs = 0.5, rT = 0.05, and D = 0.5. Number of realisations
used to generated each point = 106.
the target occupies, giving a upper bound on the SGMFPT. We must also divide by the volume
in which the particle could be placed, given by the volume of the sphere minus the volume of
(b+ rT ). The solution of (3.4.22) divided by the volume is given by
τ c(rT ) =
3
4pi(R3 − (b+ rT )3)2
∫ pi
0
sin θ
∫ R
(b+rT )
r2sτc(rT , rs, θ)drsdθ
=
R3
R3 − (b+ rT )3
(
R3
3Db
+
r3T
3Db
− 3R
2
5D
+
r5T
10DR3
− r
2
T
2D
+
r4T b
2DR3
+
b2
3D
+
5r3T b
2
6DR3
+
r2T b
3
2DR3
− b
5
15DR3
)
. (3.4.23)
For b R, this implies rT  R, as rT ≤ b, (3.4.23) becomes
τ c(rT ) ≈ R
3
3Db
− 3R
2
5D
, (3.4.24)
which agrees with (3.3.14).
Figure 3.5 compares (3.4.23) to numerical simulations (described in Section 2.2.3). Starting
positions of the target were chosen to satisfy the condition for this approximation, of being within
one target radius of the centre of the sphere. The plots show the equation is a good approximation
to the numerical results. There is very little difference between the three cases, implying that the
target’s position, within the valid domain, does not have a large effect on the SGMFPT.
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(a) rT = 0.0. (b) rT = 0.5b.
(c) rT = b.
Figure 3.5: Comparison of (3.4.23), dotted red line, against numerical simulations, blue, for
varying starting positions as a function of the target size. Parameters used: R = 1.0, andD = 0.5.
Number of realisations used to generate each point ranges from 104 to 105.
3.4.2 Random target within b of centre
The TGMFPT for a target in a uniform random position within the valid region can be found by
integrating (3.4.23) over all possible starting positions for the target, between zero and b. We must
then divide by the volume of this region, 43pib
3, to obtain the TGMFPT,
Tc =
3
4pib3
∫ 2pi
0
∫ pi
0
sin(θ)
∫ b
0
τ c(rT )r
2
TdrTdθdφ
=
3
4pib3
∫ b
0
τc(rT )4pir
2
TdrT
= − 1
10b3D
[
43b5
30
− 37b
2R3
3
− 6
√
3R3
(
b2 + 4bR+R2
)(
tan−1
(
2b+R√
3R
)
− tan−1
(
4b+R√
3R
))
18R3(b−R)(b+R) tanh−1
(
b(3b+R)
5b2 + 3bR+ 2R2
)]
. (3.4.25)
For b R, upon performing a series expansion of the trigonometric terms, (3.4.25) becomes
Tc ≈ R
3
3Db
− 3R
2
5D
. (3.4.26)
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Figure 3.6: Comparison of numerical results and the TGMFPT for a target ‘close’ to the centre of
a sphere. Parameters used: R = 1.0 and D = 0.5. Number of realisations used to generate each
point ranges from 104 to 105.
A comparison of (3.4.25) against numerical results can be seen in Figure 3.6. Equation (3.4.25) is
found to be a good fit to the numerical results, when the target is placed uniformly randomly with
its centre within one target radius of the centre of the sphere and the particle is placed in a uniform
random position, which in the equation is not within b + rT of the centre, and for the numerical
simulations is not within the radius of attraction of the target.
3.5 Randomly placed target
Determining an equation for the MFPT when a target is not in the centre of a sphere proves to be
more difficult. By using a bispherical coordinate system, the boundary conditions on the target
surface can be expressed more easily. However, upon investigation of this method it was found
that the system was very complex to solve, and other methods were investigated.
3.5.1 Solution using Green’s functions
Chevalier et al. [58], derive a formula for the SGMFPT, using Green’s functions, and pseudo
Green’s functions, of a point particle, starting in a uniform random position within a spherical
Chapter 3. First passage processes 48
Figure 3.7: Diagram showing a Brownian path (blue), to a target (green) located in a uniform
random position within a sphere.
domain of radius one, excluding the volume occupied by the target, moving with a diffusivity D,
to find a target sphere of radius b, at a radius rT from the centre of the domain. This is illustrated
in Figure 3.8. This section reviews the work carried out by [58, 61] to derive a SGMFPT. I then
make use of this work to derive a TGMFPT given by (3.5.37).
Target
b
rT
1.0
Figure 3.8: Diagram of the problem setup with a uniform randomly placed target.
The equation found for the SGMFPT [58] is
τ(rT) =
1
3Db
+
4pi
3D
H∗(rT|rT), (3.5.27)
where
H∗(rT|rT) = 1
4pi(1− r2T )
+
1
4pi
log
(
1
1− r2T
)
+
r2T
4pi
− 7
10pi
. (3.5.28)
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Giving
τ(rT) =
1
3Db
+
1
3D
(
1
1− r2T
− log(1− r2T ) + r2T −
14
5
)
. (3.5.29)
The derivation of (3.5.29) is given in the next subsection. As rT → 0, which is the case when the
target is in the centre, equation (3.5.29) becomes
τ(rT) =
1
3Db
− 3
5D
. (3.5.30)
This is equivalent to the case when the target is in the centre (3.3.13), with b R, and R = 1.
To compute the TGMFPT for a particle starting in a uniform random position, which excludes the
volume occupied by the target, to find a target, also placed in a uniform random position, the part
of (3.5.29) that is dependent on rT , must be integrated over all possible locations of the target. Let
us introduce γ as follows
γ =
3
4pi(1− b)3
∫ (1−b)
0
(
1
1− r2T
− log(1− r2T ) + r2T −
14
5
)
4pir2TdrT , (3.5.31)
so that
γ =
3
(1− b)3
∫ (1−b)
0
(
r2T
1− r2T
− r2T log(1− r2T ) + r4T −
14r2T
5
)
drT . (3.5.32)
Equation (3.5.32) can be split into three integrals
I1 =
∫ (1−b)
0
(
r2T
1− r2T
)
drT
=
1
2
(
−2(1− b) + log
(
2− b
b
))
, (3.5.33)
I2 = −
∫ (1−b)
0
r2T log(1− r2T )drT
= −1
9
(2b3 − 6b2 + 12b− 8− 3b(b2 − 3b+ 3) log(b(b− 2)) + 6 log(2− b)) (3.5.34)
I3 =
∫ (1−b)
0
r4T −
14r2T
5
drT
=
(
−b
5
5
+ b4 − 16b
3
15
− 4b
2
5
+
9b
5
− 11
15
)
. (3.5.35)
Combining integrals I1, I2, and I3 gives
γ =
1
30(1− b)3 (30b(b
2 − 3b+ 3) log(b(2− b))− 45 log(b)− 15 log(2− b)− 18b5 + 90b4
− 116b3 − 12b2 + 132b− 76). (3.5.36)
Therefore, the TGMFPT is given by
T =
1
3Db
− γ
3D
, (3.5.37)
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where R = 1. For b 1, this becomes
T =
1
3Db
− 1
90D
(45 log(b) + 15 log(2) + 76). (3.5.38)
3.5.2 Derivation of SGMFPT equation
The following derivation of the SGMFPT equation (3.5.29), is taken from the references by
Chevalier [58], and Condamin [60]. In this section rs, is the starting position of the particle,
rT, is the position of the target, and r is a position along the path of the target, where boldface
represents three-dimensional spatial vectors. This is illustrated in Figure 3.9.
Figure 3.9: Diagram of problem setup. The green circle represents the target, and the blue path is
the path of the particle.
The MFPT, τ(rs), for a particle, starting in position rs, to find a target in a domain, D, satisfies
the following equations [184, 188],
D∇2τ(rs) = −1 if rs ∈ D∗, (3.5.39)
τ(rs) = 0 if rs ∈ ST , (3.5.40)
∂nτ(rs) = 0 if rs ∈ SR, (3.5.41)
where ∂n is the normal derivative to the boundary of the domain. The first equation, (3.5.39), is
Poisson’s equation, and D∗ is the domain D, minus the area occupied by the target. The second
equation, (3.5.40), is an absorbing boundary condition on the surface of the target, ST . The third
Chapter 3. First passage processes 51
equation, (3.5.41), is a reflecting boundary condition on the boundary of the domain, SR. To solve
this problem, the Green’s function G(r|rs) is introduced, which is defined by
−∇2G(r|rs) = δ(r− rs) if r ∈ D∗, (3.5.42)
G(r|rs) = 0 if r ∈ ST , (3.5.43)
∂nG(r|rs) = 0 if r ∈ SR, (3.5.44)
where δ is the Dirac delta function with the property,
∫
D∗ δ(r − rs)dr = 1, and r is the position
of the particle along its path.
Green’s second identity [213] states∫
V
(φ1∇2φ2 − φ2∇2φ1)dV =
∮
S
(φ1∂nφ2 − φ2∂nφ1)dS, (3.5.45)
where the first integral is over the volume of the domain and the second integral is over the surfaces
of the target and domain. We must now choose φ1 and φ2. Let φ1 = τ(r) and φ2 = G(r|rs). This
gives∫
D∗
(τ(r)∇2G(r|rs)−G(r|rs)∇2τ(r))dV =
∫
Sa∪Sr
(τ(r)∂nG(r|rs)−G(r|rs)∂nτ(r))dS.
(3.5.46)
From the boundary conditions (3.5.43) and (3.5.44), the right-hand-side becomes zero. Using
(3.5.39) and (3.5.42), equation (3.5.46) becomes∫
D∗
(−τ(r)δ(r− rs) +G(r|rs) 1
D
)dV = 0. (3.5.47)
From the definition of the Dirac delta function, we get∫
D∗
τ(r)δ(r− rs)dV = τ(rs), (3.5.48)
when r = rs, as rs is not contained within the domain, D∗. Therefore the MFPT is given by
τ(rs) =
1
D
∫
D∗
G(r|rs)dV. (3.5.49)
The function G(r|rs) must now be determined. G(r|rs) is a function constructed from pseudo-
Green’s functions, that gives a constant for the occupation time across all of the domain, except
for a peak in the occupation time at the starting position of the particle, as on average it will spend
the most time there, and a dip in the occupation time near the target, as if the particle is near the
target there is a high probability it will encounter it. G(r|rs) can be written as
G(r|rs) = H(rT|rT)−H(rT|rs) +H(r|rs)−H(r|rT), (3.5.50)
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where
H(r|rT) =

1
4pi|r− rT| +H
∗(r|rT) if |r− rT| > b,
1
4pib
+H∗(rT|rT) if |r− rT| < b,
(3.5.51)
where H∗ will be defined later. The second case is how the H(rT|rT) term is expressed. The
G function in (3.5.50) is a function of three variables constructed from the H functions, which
are functions of two variables. In (3.5.50), the H(r|rs) term accounts for the peak in occupation
time near the starting position and the H(r|rT) term is the dip in occupation time near the target.
The H terms are the pseudo-Green’s function [21], which are needed to allow (3.5.50) to satisfy
(3.5.42)–(3.5.44), and satisfy
−∇2H(r|rs) = δ(r− rs)− 1
V
if r ∈ D, (3.5.52)
∂nH(r|rs) = 0 if r ∈ Sr, (3.5.53)
H(r|rs) = H(rs|r), (3.5.54)∫
D
H(rs|r)drs ≡ 0, (3.5.55)
where the fourth equation can be derived from the previous three and V is the volume of the
domain. The choice of G(r|rs) is the simplest one that satisfies equations (3.5.42)–(3.5.44).
Checking if (3.5.50) satisfies (3.5.42), we get
−∇2G(r|rs) = −∇2H(rT|rT) +∇2H(rT|rs)−∇2H(r|rs) +∇2H(r|rT)
= +δ(rT − rT)− 1
V
− δ(rT − rs) + 1
V
+ δ(r− rs)− 1
V
− δ(r− rT) + 1
V
= δ(r− rs)
using (3.5.52), and that δ(rT − rT), δ(rT − rs) and δ(r − rT) are only non zero in the target
domain, which is excluded from D∗. Checking if (3.5.50) satisfies (3.5.44), we get
∂nG(r|rs) = ∂nH(rT|rT)− ∂nH(rT|rs) + ∂nH(r|rs)− ∂nH(r|rT)
= 0,
using (3.5.53). Equation (3.5.43) can however only be approximately satisfied [58, 60].
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We can now compute (3.5.49),
τ(rs) =
1
D
∫
D∗
G(r|rs)dr
=
1
D
∫
D∗
[H(rT|rT)−H(rT|rs) +H(r|rs)−H(r|rT)] dr
=
1
D
∫
D∗
[H(rT|rT)−H(rT|rs)] dr
=
V
D
[H(rT|rT)−H(rT|rs)] +O(b3G0(b)). (3.5.56)
Using (3.5.54) and (3.5.55), as well as using the fact that the integral over D∗ is almost equal to
the integral over D, with the relative order of magnitude of the correction being b3/V , in three
dimensions, where b is the radius of the target.
Equation (3.5.56) is the MFPT for a particle starting at a position rs. The SGMFPT, for a particle
starting in a uniform random position, which excludes the volume occupied by the target, is
obtained by integrating over the volume of the domain, for all starting positions of the particle, rs,
and is defined as
τ(rT) =
1
V
∫
D
τ(rs)drs
=
1
V
V
D
∫
D
[
H(rT|rT)−H(rT|rs)) +O(b3G0(b)
]
drs
=
1
D
∫
D
[
H(rT|rT) +O(b3G0(b))
]
drs
=
V
D
H(rT|rT) +O(b3G0(b)). (3.5.57)
Again using (3.5.54) and (3.5.55).
In our case the bounded domain, D, is a sphere, for which the pseudo-Green’s function is known
exactly [21] and reads
H(rT|rT) = G0(rT − rT) +H∗(rT|rT), (3.5.58)
with
G0(rT − rT) = 1
4pib
, (3.5.59)
and
H∗(rT|rT) = rT
4pi|rT − r2T rT|
+
1
4pi
logA(rT) +
1
8pi
(r2T + r
2
T )−
7
10pi
, (3.5.60)
where
A(rT) =
2rT
rT − rT (rT · rT) + |rT − r2rT| . (3.5.61)
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Setting rT = |rT|, gives
H(rT|rT) = 1
4pib
+
1
4pi(1− r2T )
+
1
4pi
log
(
1
1− r2T
)
+
r2T
4pi
− 7
10pi
. (3.5.62)
Substituting (3.5.62) into (3.5.57) gives
τ(rT) =
1
3Db
+
1
3D
(
1
(1− r2T )
− log(1− r2T ) + r2T −
14
5
)
,
where R = 1. This is (3.5.29), which we set out to derive.
3.5.3 Testing the random target equation
Equation (3.5.29) can be tested against spatial simulations of a particle moving by Brownian
motion within a sphere, until it encounters a target in a fixed position. Figure 3.10 shows a plot of
the target size, b, against the SGMFPT, τ , multiplied by the size of the target, for varying starting
positions of the target.
Figure 3.10: Target in a known starting position, rT , from the centre of the sphere. Solid lines
represent numerical simulations, and dashed lines represent equation (3.5.29). Parameters used:
D = 0.5 and R = 1. Number of realisations used to produce each point ranges from 3 × 103 to
6× 104.
The aim is to obtain a formula for the TGMFPT of a uniform randomly placed particle, excluding
the volume occupied by the target, to find a uniform randomly located target. Equation (3.3.13)
assumes the target is in the centre of the sphere, and (3.5.37) assumes the target is placed uniform
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randomly, as desired. Figure 3.11 shows these two equations, along with numerical simulations,
plotted for a varying target size, b. From Figure 3.11, it can be seen that (3.5.37) is a much better
fit to the numerical results than (3.3.13).
Figure 3.11: Comparison of (3.3.13) and (3.5.37) to numerical results from spatial simulations
with target and particle placed in uniform random positions. Parameters used: D = 0.5 and
R = 1. Number of realisations used to produce each point ranges from 104 to 2× 105.
3.5.4 The case when R 6= 1
In (3.5.38) it is assumed that the radius of the domain, R, is equal to one, for simplicity. To obtain
an equation in which R 6= 1, a simple scaling of the other two parameters must be performed. b
and D need to be divided by R and R2 respectively to obtain
T =
R3
3Db
− R
2
90D
(
45 log
(
b
R
)
+ 15 log(2) + 76
)
. (3.5.63)
This scaling can be verified by comparing (3.5.63) to numerical simulations. Figure 3.12 shows
the scaling appears to be correct. The numerical results being at higher values than the analytical
equation, is due to the timestep size used not being small enough. The timestep size was chosen
to reduce the computational time required to execute the simulations.
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Figure 3.12: Comparison of (3.5.63), when R 6= 1, to numerical simulations. Parameters used:
R = 0.25, D = 0.5. Number of realisations used to produce each point ranges from 2 × 104 to
2× 106.
3.6 Two fixed targets
The next question to answer is: what is the SGMFPT for a particle to find one of multiple targets?
Let us first consider the case when there are two absorbing spherically symmetric targets, in
the domain. We must construct our Green’s function G(r|rs) from pseudo-Green’s functions,
taking into account that only one of the two targets will be encountered. In order to perform this
calculation we need to introduce splitting probabilities for the probability of encountering target
one before target two, and vice-versa. Splitting probabilities can be found by solving Laplace’s
equation with boundary conditions for the surface of the domain and the targets. The splitting
probability Pi(r), i = 1, 2 [184], for encountering target i, satisfies
D∇2Pi = 0, (3.6.64)
∂nPi(r) = 0 if r ∈ ∂D, (3.6.65)
Pi(r) = 1 if r ∈ ∂Ti, (3.6.66)
Pi(r) = 0 if r ∈ ∂Tj , j 6= i, (3.6.67)
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where ∂n is the normal derivative, ∂D is the surface of the domain, and ∂Ti and ∂Tj are the
surfaces of targets i and j. The Green’s functions for this equation can be written as
D∇2G(r|rs) = δ(r− rs), (3.6.68)
∂nPi(r) = 0 if r ∈ ∂D, (3.6.69)
G(r|rs) = 1 if r ∈ ∂Ti, (3.6.70)
G(r|rs) = 0 if r ∈ ∂Tj , j 6= i. (3.6.71)
Using Green’s second identity (3.5.45), we find
Pi(rs, rT
(1), rT
(2)) = −
∫
∂Ti
∂nG(r|rs)dr, (3.6.72)
G(r|rs) can now be written as a function of pseudo-Green’s functions [61] as follows:
G(r|rs) = ρ0(rs) +H(r|rs)− P1H(r|r1)− P2H(r|r2), (3.6.73)
where ρ0 is yet to be determined, rT(1), and rT(2), are the positions of the two targets. The
H(r|rs) function accounts for a peak in probability near the starting position of the particle, the
negative H terms account for dips in the probability near each target, and the Pi coefficients are
the probability of being at that target. The pseudo-Green’s functions are defined as in (3.5.52)–
(3.5.55). Expression (3.6.73) satisfies (3.6.64) and (3.6.65). Equations (3.6.66), (3.6.67) and
(3.6.73), along with the condition that the splitting probabilities must sum to one, give the
following set of equations [61]:
ρ0 +H1s − P1H11 − P2H12 = 0, (3.6.74)
ρ0 +H2s − P1H12 − P2H22 = 0, (3.6.75)
P1 + P2 = 1, (3.6.76)
where Hij = H(ri|rj), and the solution of the H function is the same as in (3.5.58). Expressions
for P1, P2, and ρ0 can be obtained from (3.6.74)–(3.6.76), giving
P1 =
H1s +H22 −H2s −H12
H11 +H22 − 2H12 , (3.6.77)
P2 =
H2s +H11 −H1s −H12
H11 +H22 − 2H12 , (3.6.78)
ρ0 = P1H11 + P2H12 −H1s, (3.6.79)
Substituting into (3.5.49) gives
τtwo =
V
D
(H11 −H1S)(H22 −H2s)− (H12 −H2s)(H12 −H1s)
H11 +H22 − 2H12 . (3.6.80)
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Averaging over all starting positions of the particle by integrating (3.6.80) over rs, using the fact
that all H functions with an s subscript integrate to zero by (3.5.55), gives
τ two =
V
D
H11H22 −H212
H11 +H22 − 2H12 . (3.6.81)
The results of testing (3.6.81) against numerical simulations are shown in Figure 3.13. In Figure
3.13, dependent target equation, refers to (3.6.81), and independent target equation assumes that
the targets have no influence on each other, and is obtained by calculating the SGMFPT for each of
the targets using (3.5.37), and combining the solutions using the formula 1/(1/τ1 + 1/τ2), where
τ1 and τ2 are the SGMFPTs for target one and two, respectively.
(a) Targets close together. (b) Intermediate case.
(c) Targets far apart.
Figure 3.13: Comparison of (3.6.80) and (3.5.37), to numerical simulations. The three cases
examine the effect of the target’s positions, relative to each other. Parameters used: R = 1 and
D = 0.5. Number of realisations used to produce each point ranges from 5× 103 to 3× 105.
3.7 Equation for multiple targets
A general equation for the time to encounter one of N targets is given in [58] as
τN = τ
(−1)
N + τ
(0)
N + τ
(1)
N , (3.7.82)
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where
τ
(−1)
N =
1
3DS
, (3.7.83)
τ
(0)
N =
4pi
3DS2
 N∑
k=1
∑
j 6=k
bjbkHjk +
N∑
k=1
b2kH
∗
kk
 , (3.7.84)
and
τ
(1)
N =
16pi
3DS3
( N∑
k=1
b2kH
2
kk
)2
+
N∑
l=1
b2lH
2
ll
∑
j 6=k
bjbkHjk
+
S2
4pi
N∑
k=1
∑
l 6=k
P
(1)
j bkHjk − S
 N∑
k=1
∑
j 6=k
bjb
2
kHjkH
∗
kk +
N∑
k=1
b3kH
∗2
kk
 , (3.7.85)
with
P
(1)
j =
4pibj
S2
 N∑
k=1
∑
l 6=k
bkblHlk −
N∑
k=1
∑
l 6=j
bkblHlj −
N∑
k=1
bk(bjH
∗
jj − bkH∗kk)
 , (3.7.86)
in which S =
N∑
i=1
bi, bi is the radius of target i, and H∗ij = Hij −G0(ri− rj). In our case we have
bi = b for all i, so that P
(1)
j = 0 for all j ∈ {1, 2, · · · , N}.
3.7.1 Two randomly placed targets
For N = 2 we get
τ
(−1)
two =
1
6Db
, (3.7.87)
τ
(0)
two =
pi
3D
(
H11 +H22 + 2H12 − 1
2bpi
)
, (3.7.88)
τ
(1)
two = −
2pi2b
3D
(H211 +H
2
22 − 2H11H22), (3.7.89)
using H∗ii = Hii − 14pib . Numerically comparing these expressions to (3.6.81), it is found that the
two expressions, derived by different methods, give approximately the same result. Expressions
(3.7.87)-(3.7.89) will be used in what follows, as they are easier to manipulate and integrate.
To calculate the TGMFPT, averaged over all positions of the two targets within the domain, we
need to integrate (3.7.87)-(3.7.89) over the position of the first target, then the second target, and
Chapter 3. First passage processes 60
divide by the volume of the domain for each of the integrals, with R = 1.(
3
4pi(1− b)3
)2 ∫ 1−b
0
∫ 1−b
0
(4pi)2τ
(−1)
two r
2
1r
2
2dr1dr2 =
1
6Db
, (3.7.90)(
3
4pi(1− b)3
)2 ∫ 1−b
0
∫ 1−b
0
(4pi)2τ
(0)
twor
2
1r
2
2dr1dr2 =
1
2
T − 1
6Db
, (3.7.91)(
3
4pi(1− b)3
)2 ∫ 1−b
0
∫ 1−b
0
(4pi)2τ
(1)
twor
2
1r
2
2dr1dr2
= −bpi
(
1
D(1− b)3β −
3D
4pi
T 2
)
, (3.7.92)
where T is the TGMFPT to find one uniform randomly placed target given in (3.5.37) and
β =
∫ 1−b
0
4piH2TT r
2
TdrT . (3.7.93)
To calculate (3.7.90)–(3.7.92), we make use of the property that when integrating over all starting
positions HTT = Hii, and H2TT = H
2
ii, for all i ∈ {1, 2, · · · , N}. We also use the following
property of the pseudo-Green’s functions∫ 1−b
0
Hijdri = 0, (3.7.94)
given in (3.5.55). Finally we use the result (3.5.37), to write∫ 1−b
0
4pir2THTTdrT = D(1− b)3T. (3.7.95)
Note that in (3.7.90)–(3.7.92), the first two terms sum to give T/2, which was our first
approximation for the TGMFPT of two targets, assuming the targets were independent, implying
the TGMFPT scales linearly. The third term is essentially a correction term that takes into account
the effects of the other targets. Summing the terms (3.7.90)–(3.7.92) gives the TGMFPT for two
targets
Ttwo =
1
2
T − bpi
(
1
D(1− b)3β −
3D
4pi
T 2
)
. (3.7.96)
The 12T in (3.7.96) gives the TGMFPT assuming the targets are independent, and the second term
is a correction term. Using numerical comparisons, it is found that the analytical correction term
(bpi(· · · )) is always positive. Therefore, Ttwo is always less than 12T . This implies that, assuming
the targets are independent results is an overestimation of the TGMFPT. A plot of (3.7.96) is shown
in Figure 3.14(a).
3.7.2 N randomly placed targets
To calculate the TGMFPT for N targets, we again make use of the properties that were used to
calculate (3.7.96). Rewriting (3.7.84) and (3.7.85) in a more general form by combining terms
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that will integrate to give the same result, they can be made easier to integrate (the general form
below is for integration purposes only):
τ
(−1)
N =
1
3DNb
, (3.7.97)
τ
(0)
N =
4pi
3D(Nb)2
(NHii)− 1
3DNb
, (3.7.98)
τ
(1)
N = −
16pi2b
3DN3
(
N(N − 1)H2ii −
N(N − 1)
2
2HiiHjj
)
, (3.7.99)
where i 6= j. This general form is obtained by eliminating all the Hij terms, which will integrate
to zero, and examining the expansion of terms upon computing the sums, to combine terms.
Integrating (3.7.97)–(3.7.99) over the domain N times, for the N targets, and dividing by the
volume of the domain N times, gives(
3
4pi(1− b)3
)N ∫ 1−b
0
. . .
∫ 1−b
0
(4pi)Nτ
(−1)
N r
2
1 . . . r
2
Ndr1 . . . drN
=
1
3DNb
, (3.7.100)(
3
4pi(1− b)3
)N ∫ 1−b
0
. . .
∫ 1−b
0
(4pi)Nτ
(0)
N r
2
1 . . . r
2
Ndr1 . . . drN
=
1
N
T − 1
3DNb
, (3.7.101)(
3
4pi(1− b)3
)N ∫ 1−b
0
. . .
∫ 1−b
0
(4pi)Nτ
(1)
N r
2
1 . . . r
2
Ndr1 . . . drN
= −4pib(N − 1)
N2
(
1
D(1− b)3β −
3D
4pi
T 2
)
. (3.7.102)
Giving a general formula for N uniform randomly placed targets of
TN =
T
N
− 4pib(N − 1)
N2
(
1
D(1− b)3β −
3D
4pi
T 2
)
. (3.7.103)
As N → ∞, (3.7.103) becomes linearly dependent on N , with the second term of (3.7.103)
tending to zero. We must now calculate β. This can be done by computing the integral given in
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(3.7.93) using Mathematica, giving
β =
1
75600pi(b− 2)b2
[
−12600(b− 2)b2Li2
(
b
2
)
+ 2(b(b(b(2b(b(b(27097− 27b(b(25(b− 9)b
+ 707)− 679))− 75845) + 46998) + 525pi2 + 58960)− 1050pi2 − 107693) + 49245)
− 6300) + 105(b− 2)b(−30b(2b((b− 3)b+ 3)− 1) log2(2− b) + (b(8b(b(b(9(b− 5)b+ 58)
+ 21)− 111)− 3049)− 120b(b− 1)3 log(b) + 60) log(2− b)− 300 log(b)
+ b(1824 log((b− 2)2)− 60 log
(
1− b
2
)
log
(
b
2
)
+ log(b)(8b(b(b(9(b− 5)b+ 58) + 21)
−111)− 30(2b((b− 3)b+ 3)− 3) log(b) + 729))− 120(b log(2) + 2) tanh−1(1− b))
]
,
(3.7.104)
where Li2
(
b
2
)
is a polylogarithm, which can be written as a series expansion as follows
Lis(z) =
∞∑
k=1
zk
ks
, (3.7.105)
therefore
Li2
(
b
2
)
=
∞∑
k=1
(
b
2
)k
k2
=
b
2
+
b2
16
+
b3
72
+
b4
256
+ . . . (3.7.106)
The SGMFPT equation given in (3.7.82) was found by [58]. To the best of my knowledge, the
TGMFPT equation given in (3.7.103) has not been previously derived. Equation (3.7.103) is valid
for N targets. However, because the integration for randomising the starting position of each of
the targets has the upper limit of 1 − b, the targets are able to overlap. To obtain an equation
for non-overlapping targets, when integrating over all possible starting positions for a target, the
volume already occupied by the targets that have been placed must be excluded. This proves to be
a more complicated problem to solve, and is not covered in this thesis.
3.8 Testing the N target equation
To determine the accuracy of (3.7.103), we will test it against numerical simulations. The
numerical simulation requires, (1) placing targets uniform randomly within a sphere, of radius 1,
and (2) placing a particle uniform randomly, that moves by Brownian motion, until it encounters
one of the N targets. Plots comparing the numerics for two, three, and four targets, to (3.7.103)
are shown in Figure 3.14.
Figure 3.14 shows a comparison of numerical simulations, with standard error bars, (3.7.103), and
(3.5.37), assuming target independence. Standard error bars are given by the standard deviation
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(a) N = 2 (b) N = 3
(c) N = 4
Figure 3.14: Comparison of (3.7.103), assuming target dependence (red), and (3.5.37) assuming
target independence (green), to numerical results obtained from spatial simulations. Parameters
used: R = 1, D = 0.5. Number of realisations used to produce each point ranges from 5.5× 104
to 5.5× 105.
of the data, divided by the square root of the number of realisations. In all cases, assuming target
dependence (3.7.103) is a better approximation of the numerical results. There is a mismatch
between the numerical results and the analytical solution in the N = 3 and N = 4 case due to
the placement of the targets. The analytical solution assumes the targets are uniformly randomly
distributed, regardless of the position of the other targets. However, the numerical simulations
place the targets uniformly randomly in the domain excluding the volume of the other targets. The
mismatch is greater for higherN as the probability of multiple targets occupying the same domain
increases as N is increased.
Figure 3.15 shows a plot of (3.7.103), assuming dependent targets, and (3.5.37), assuming
independent targets, compared to numerical results, for varying numbers of targets. The figure
shows that the dependent target equation, (3.7.103), is a better approximation to the numerical
results. The numerical results in Figure 3.15 are a better fit than those in 3.14 as the simulations
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Figure 3.15: Comparison of (3.7.103) and (3.5.37), to numerical simulations obtained from spatial
simulations. Parameters used: R = 1, b = 0.02 and D = 0.5. Each numerical point is a mean
taken from 2.5× 105 realisations.
place all the targets in uniform random positions, regardless of the positions of the other targets.
In Figure 3.15, the error bars appear to be quite large. It must be remembered that the TGMFPT
multiplied by the number of targets, is plotted on the y axis, which is exaggerating the difference
between the two equations and the numerical results. If just the TGMFPT is plotted on the y
axis a difference between the numerical results and equation cannot easily be observed and the
error bars are tiny. The numerical results in Figure 3.15 were very computationally expensive to
produce. The program used to produce the numerical results was coded to run efficiently by using
inbuilt python packages, and simulating all ten starting numbers of APCs simultaneously. These
methods are described in Appendix B. However, hundreds of days of computing time were still
required to achieve the results shown. This was only made possible with use of a high performance
computing system (ARC1) made available to me by the University of Leeds. Further computation
could be undertaken to reduce the error bars further, but it can already be seen that the numerics are
agreeing with (3.7.103), making further computation unnecessary. The program used to produce
Figure 3.15 is shown in Appendix B.
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3.9 Summary
In this chapter, Poisson’s equation is used to derive an equation for the mean time it takes a particle,
in a prescribed position, to encounter a fixed target in the centre of a spherical domain. This is
given by
τ0(rs) =
1
6D
(
2R3
(
1
b
− 1
rs
)
+ b2 − r2s
)
.
The particle’s starting position is then averaged over the domain, to give a SGMFPT equation of
τ0 =
1
30Db(R3 − b3)
(
2R5(5R− 9b) + b5(3b− 5) + 10b3R3) .
An approximation proposed by Grigin [93], is used to derive an equation for a target in a position
‘close’ to the centre of the domain, and is found to be
τc(rt, rs, θ) =
1
3Dr
(
−R3 + rs
2b
(2R3 + b3)− r
3
s
2
+
rT
rs
(
b3 −R3
2b3 +R3
)
(R3 + 2r3s) cos(θ)
)
.
Averaging over all possible starting positions of the particle gives
τ c(rT ) =
1
2D(R3 − (b+ rT )3)
(
−R3(R2 − (b+ rT )2) + 1
3b
(2R3 + b3)(R3 − (b+ rT )3)
−1
5
(R5 − (b+ rT )5)
)
.
Averaging over the targets starting position, within the valid region assumed by the approximation,
gives
Tc =
3
4pib3
∫ b
0
τ(rT )4pir
2
TdrT
= − 1
10b3D
(
43b5
30
− 37b
2R3
3
− 6
√
3R3
(
b2 + 4bR+R2
)(
tan−1
(
2b+R√
3R
)
− tan−1
(
4b+R√
3R
))
18R3(b−R)(b+R) tanh−1
(
b(3b+R)
5b2 + 3bR+ 2R2
))
.
Next, an approach to solve the problem of a target in a uniform random position using Green’s
functions is used. This approach is outlined in an article, by Chevalier et al. [58]. The SGMFPT
for a target in a fixed position is given by
τ(rT) =
1
3Db
+
1
3D
(
1
1− r2T
− log(1− r2T ) + r2T −
14
5
)
,
which is the result given in [58]. Averaging the starting position gives the equation
T =
R3
3Db
− R
2
90D
(
45 log
(
b
R
)
+ 15 log(2) + 76
)
.
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An equation for the time to first encounter one of N uniform random targets within a spherical
domain is found to be
TN =
T
N
− 4pib(N − 1)
N2
(
1
D(1− b)3β −
3D
4pi
T 2
)
,
where β is given in (3.7.104). Throughout the chapter the equations are tested against numerical
results generated using a spatial code developed in this thesis 2.2.3. It was found that, for each
improvement implemented to the MFTP equations, the equations become better approximations
of the numerical results.
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Chapter 4
The effects of a limited imaging volume
on in vivo imaging data
4.1 Introduction
Imaging experiments using two-photon microscopy (Section 1.8.1) enables detailed visualisation
of lymphocyte movements in vivo and provide data sets of cell positions over time. Trajectories
of the centres of mass of the cells can be plotted to determine the migratory behaviour of cell
populations. Plots of cell trajectories are commonly represented in two ways. Firstly, the
unshifted coordinates of the cells can be plotted, helping to determine if the cells prefer a particular
region. Alternatively, cell positions can be shifted to start from the origin, while maintaining their
orientation in space, allowing one to determine if the cells have a preferred direction of migration.
If the number of cell tracks observed in all possible directions is approximately equal, it can
be inferred that the cells are undergoing random motion. Plotting cell tracks gives qualitative
information about the cells, such as the type of motion the cells are undergoing. To determine
quantitative information, such as the diffusivity of a population of cells, one must analyse the
dynamics of the cells.
A frequently reported migration parameter is cell migration speed. The mean speed between two
sequential time frames can easily be estimated by dividing the displacement between the two
frames, by the time elapsed in that period. In reality, the trajectory of the cell between two points
will not be exactly straight, therefore the estimated mean speed will be an underestimate of the
actual mean speed of the cells. Longer time periods between successive points will increase the
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error in the estimated mean speed. If the cells are assumed to be undergoing a random walk,
their mean displacement in any one dimension will be zero, therefore, a more useful parameter to
measure is the diffusivity of a cell, defined as the distance squared a cell moves in a given time.
By plotting the mean displacement squared against time, information about the type of migration,
as well as the diffusivity of the cells, can be obtained. A linear increase indicates the cells are
undergoing a random walk type motion. A faster than linear increase indicates the cells are
undergoing directed migration. On long timescales, directed migration could be due to the cells
following a chemokine gradient. A slower than linear mean displacement plot indicates the cells
are somehow confined; this could be due to interactions with other cell types keeping them in a
specific region. If the cells are undergoing random motion, the diffusivity of the cell population
can be determined from the gradient of the mean displacement plot. A mean squared displacement
plot is useful for investigating cell motility, but the underlying mechanism of migration cannot
reliably be inferred from it, due to multiple underlying microprocesses giving rise to very similar
mean squared displacement plots [72, 190, 234]. For example, T cells moving within a lymph
node (LN) in randomly orientated steps of fixed duration and speed [22], result in a similar plot
to that of persistently moving cells that manoeuvre through a densely packed environment with
highly variable speeds [26]. When plotting displacement squared against time, for data obtained
from two-photon laser scanning microscopy (TPLSM) experiments, it must be remembered that
the imaging area is a finite volume, so that cells that are tracked for longer time periods have
remained in the imaging volume for longer. This may be due to the cells having a low diffusivity,
or taking a looping path. Cells that leave the imaging volume can no longer be tracked, meaning
data is only available on them for a short time periods. This results in more data being available
for smaller times, and it also causes a confinement effect, indicated by a plateau forming at later
times due to these being the cells that have remained in the imaging volume. This confinement
effect occurs because the cells that can be tracked for longer times are the ones that are remaining
in the imaging volume.
The aim of this chapter is to calculate the expected squared displacement observed for a population
of cells undergoing a random walk in a limited sized imaging volume. This is accomplished by
first solving the diffusion equation, to calculate a probability density function of the position of
particles at time t. Using the probability density function, the expected mean squared displacement
can be calculated in one and three dimensions. The expectation is then normalised for particles
shifted to have an initial position at the origin. Finally, the expectation is compared to numerically
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simulated results, and a correction developed to compensate for the large time increments used in
biological experiments.
The purpose of this chapter is to be able to estimate the diffusion coefficient of a population of cells
by fitting the expected squared displacement calculated analytically to the squared displacement
of a population of cells imaged in vivo . Comparison of the expected plateau observed due to
the limited size of the imaging volume will allow the type of motion occurring to be determined.
For example, if a plateau is observed at a lower level than the expected plateau due to a limited
size imaging volume, this could be due to the cells being confined by a biological factor, or some
other effect occurring. Previous work has been carried out to determine the effect of a limited
sized imaging volume on calculating binding time of the observed cells [26]. Work as also been
undertake to increase the accuracy of data collected from TPLSM experiments [25]. However,
to the best of my knowledge, the expected squared displacement of a population of cells has not
previously been calculated analytically, as is done in this chapter.
4.2 Expected squared displacement
4.2.1 One dimension
The density function of a particle moving by Brownian motion on the interval [−L,L], can be
found by solving the diffusion equation
∂
∂t
P (x, t) = D
∂2
∂x2
P (x, t), (4.2.1)
where P (x, t) is the density function of being at position x, at time t. We have the initial condition
P (x, 0) = δ(x − x0), where x0 is the starting position of the particle, and δ is the Dirac delta
function: the probability of being at x = x0 at time zero is one, and zero elsewhere. The boundary
conditions are P (L, t) = P (−L, t) = 0, as the particle will be absorbed at ±L. Thus, the
probability of being there is zero.
Equation (4.2.1) can be solved using separation of variables, setting
P (x, t) = X(x)T (t), (4.2.2)
and substituting into (4.2.1). Rearranging gives
T ′
T
= D
X ′′
X
. (4.2.3)
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By setting both sides equal to a constant, a, (4.2.3) can be split into two separable ODEs
X ′′ − aX = 0, (4.2.4)
T ′ − aDT = 0. (4.2.5)
The boundary conditions can only be satisfied, and do not result in a trivial solution, when a > 0.
Let a = k2, then X ′′ − k2X = 0,. This has the solution
X = c1 cos(kx) + c2 sin(kx). (4.2.6)
Applying the boundary conditions gives
X(L) = c1 cos(kL) + c2 sin(kL) = 0, (4.2.7)
X(−L) = c1 cos(kL)− c2 sin(kL) = 0, (4.2.8)
where c1 and c2 are integration constants. Adding these equations gives c1 cos(kL) = 0. If
c1 6= 0, we need cos(kL) = 0. Therefore, we have kL = (2n+1)2 pi, giving k = (2n+1)2 piL , where
n = 0, 1, 2, . . .. Those values of k, give c2 = 0. We have the solution
Xn(x) = c1 cos
(
(2n+ 1)
2
pi
L
x
)
. (4.2.9)
Solving (4.2.5), gives the solution T = c3e−aDt, where c3 is an integration constant. For this part
of the solution we have a = k2 =
(
(2n+1)
2
pi
L
)2
. Therefore
Tn = c3e
−D (2n+1)2
4
pi2
L2
t. (4.2.10)
Alternatively, (4.2.7) and (4.2.8) can be subtracted from each other to give c2 sin(kL) = 0. If
c2 6= 0, we need sin(kL) = 0, therefore we have kL = (n + 1)pi, giving k = (n+1)piL , where
n = 0, 1, 2, . . .. We use (n + 1)pi, rather than npi, to avoid division by zero. Those values of k,
give c1 = 0, giving a second solution to (4.2.4) of the form
Xn(x) = c2 sin
(
(n+ 1)pi
L
x
)
. (4.2.11)
For this part of the solution, for the T equation, we have a = k2 =
(
(n+1)pi
L
)2
. Therefore
Tn = c4e
−D (n+1)2pi2
4L2
t, (4.2.12)
where c4 is a integration constant. The general solution to (4.2.1) is a linear combination of these
two solutions
P (x, t) =
∞∑
n=0
[
an(x0) cos
(
(2n+ 1)
2
pi
L
x
)
e−D
(2n+1)2
4
pi2
L2
t + bn(x0) sin
(
(n+ 1)pi
L
x
)
e−D
(n+1)2pi2
4L2
t
]
,
(4.2.13)
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where the an’s and bn’s are a combination of the integration constants. The an’s and bn’s can be
found by applying the initial condition, P (x, 0) = δ(x), and using a Fourier transform:
an(x0) =
1
L
∫ L
−L
cos
(
2n+ 1
2
pi
L
x0
)
δ(x− x0)dx0. (4.2.14)
By definition,
∫ L
−L δ(x− x0)dx = 1, at x = x0 if x0 ∈ [−L,L]. Therefore, for the case when the
particle starts in the centre, x = 0, we get an(0) = 1/L. For the case when the particle starts at
x = x0, (4.2.14) gives
an(x0) =
1
L
cos
(
2n+ 1
2
pi
L
x0
)
. (4.2.15)
The bn’s are given by
bn(x0) =
1
L
sin
(
(n+ 1)pi
L
x0
)
. (4.2.16)
The mean squared position, x2t , of a particle at time t, given that the particle is within the domain,
is given by
E[x2t ] =
∫ L
−L x
2P (x, t)dx∫ L
−L P (x, t)dx
. (4.2.17)
We have ∫ L
−L
P (x, t)dx =
∞∑
n=0
4L
pi(2n+ 1)
an(x0)(−1)ne−D
(2n+1)2
4
pi2
L2
t, (4.2.18)
and∫ L
−L
x2P (x, t)dx =
∞∑
n=0
4L3
(2n+ 1)pi
an(x0)
(
1− 8
(2n+ 1)2pi2
)
(−1)ne−D (2n+1)
2
4
pi2
L2
t. (4.2.19)
In (4.2.18) and (4.2.19), the terms involving bn(x0) integrate to zero. As time tends to infinity, the
E[x2t ] plateaus due to the finite length of the domain. An equation for the plateau can be found by
setting n = 0 in (4.2.18) and (4.2.19). This gives
lim
t→+∞E[x
2
t ] =
4L3
pi a0(x0)
(
1− 8
pi2
)
e−D
1
4
pi2
L2
t
4L
pi a0(x0)e
−D 1
4
pi2
L2
t
= (1− 8
pi2
)L2. (4.2.20)
Equations (4.2.17) and (4.2.20) can be tested by comparison to results simulated numerical using
a spatial code. Figure 4.1 shows a plot of E(x2t ) starting at (a) x0 = 0, and (b) x0 = L/2, along
with results of spatial simulations.
Random starting position
To determine the expectation of the mean squared position, for a particle starting in a uniform
random position, we need to average the expectation of x2t over all possible starting positions. In
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(a) x0 = 0. (b) x0 = L/2.
Figure 4.1: E[x2t ], from (4.2.17), is shown in red, the plateau of E(x2t ) as t → +∞ (4.2.20),
is shown in green, and results of numerical simulations are shown in blue. In both simulations
L = 1.0 and D = 0.5.
this case, the x0 term occurs in the an term (4.2.15), and the bn term integrates to zero. Therefore,
only the an term needs to be integrated over, giving
a¯n =
1
2L
∫ L
−L
an(x0)dx0 = 2(−1)n 1
L
1
(2n+ 1)pi
. (4.2.21)
The expectation of x2t for a particle starting in a uniform random position can be found by using a¯n
(4.2.21) in (4.2.13), in place of the an(x0) terms. Figure 4.2 shows E[x2t ] with a particle starting
in a uniform random position, with comparison to numerical results.
Figure 4.2: Particle starting in a uniform random position. E[x2t ] from (4.2.17), is shown in red,
the plateau of E[x2t ] as t→ +∞ (4.2.20), is shown in green, and results of numerical simulations
are shown in blue. In this simulation L = 1.0 and D = 0.5.
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4.2.2 Three dimensions
To calculate the mean squared position of a cell in a three-dimensional volume, with dimensions
2Lx × 2Ly × 2Lz , the diffusion equation in three dimensions must be solved. This is given by
∂
∂t
P (x, y, z, t) = D
(
∂2
∂x2
P +
∂2
∂y2
P +
∂2
∂y2
P
)
, (4.2.22)
with the initial condition P (x, y, z, 0) = δ(x)δ(y)δ(z). However, as the particle is moving by
Brownian motion and following a Wiener process, each of the Cartesian components of the Wiener
process in n dimensions is an independent Wiener process (Section 2.2.2). The expectation of the
mean squared position of a particle in a three-dimensional volume is the sum of the x, y and z
expectations in one dimension [8]. In the case when the volume is a cube, E[Xt2] is the sum
of three copies of equation (4.2.17). If the volume does not have equal length in the x, y and z
dimensions, E[Xt2] is the sum of the x, y and z expectations,
E[Xt2] = E[x2t ] + E[y2t ] + E[z2t ], (4.2.23)
where Xt represents a three-dimensional vector, with Xt = x2t + y
2
t + z
2
t . The plateau is given by
the sum of three copies of the one-dimensional plateau (4.2.20), if the size of the volume is equal
in all three dimensions. For unequal lengths in three dimensions, the plateau is giving by
lim
t→∞E[Xt
2] = (L2x + L
2
y + L
2
z)
(
1− 8
pi2
)
, (4.2.24)
where Lx, Ly and Lz are the distances from the origin to the boundary of the volume in the x, y
and z dimensions, respectively. Figure 4.3 shows a plot ofE[X2t ], starting at (a) x0 = y0 = z0 = 0,
and (b) x0 = Lx/2, y0 = Ly/2, and z0 = Lz/2, along with results of numerical simulations.
Figure 4.4 shows E[X2t ] with a particle starting in a uniform random position within a cubic
volume, using a(x0), a(y0) and a(z0) as given in equation (4.2.21). The bn terms integrate to
zero, therefore need not be included.
4.3 Expectation of the normalised displacement squared
In biological experiments, where data is obtained using TPLSM, plots of displacement squared
against time are generated by subtracting a cell’s starting position from its position at time t. To
be able to compare our calculations with these plots, an expectation of the normalised particle
position must be found by subtracting the initial position of the particle, x0.
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(a) x0 = y0 = z0 = 0. (b) x0 = Lx/2, y0 = Ly/2, z0 = Lz/2.
Figure 4.3: Fixed starting positions, in three dimensions. E[X2t ] from (4.2.23), is shown in red,
the plateau of E[X2t ] as t→ +∞ (4.2.24), is shown in green, and results of numerical simulations
are shown in blue. In both simulations Lx = Ly = Lz = 1.0 and D = 0.5.
Figure 4.4: uniform random starting position in three dimensions. E[X2t ] from (4.2.23), is shown
in red, the plateau of E[X2t ] as t → +∞ (4.2.24), is shown in green, and results of numerical
simulations are shown in blue. In this simulation Lx = Ly = Lz = 1.0 and D = 0.5.
4.3.1 One dimension
In one dimension, the expectation of (xt− x0)2 can be calculated by splitting the expectation into
three parts,
E[(xt − x0)2] = E[x2t ]− 2E[xtx0] + E[x20] =
∫ L
−L x
2P (x, t)dx∫ L
−L P (x, t)dx
− 2
∫ L
−L xx0P (x, t)dx∫ L
−L P (x, t)dx
+ x20.
(4.3.25)
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The first term of (4.3.25) is the same as that given in (4.2.18) and (4.2.19). For the second term
we need to compute the integral,∫ L
−L
xx0P (x, t)dx =
∞∑
n=0
bn(x0)
2L2
pi(n+ 1)
(−1)nx0e−
pi2D(n+1)2t
L2 . (4.3.26)
The plateau of the expectation function (4.3.25), as t→ +∞, is given by
lim
t→+∞E[(xt − x0)
2] =
∫ L
−L(x− x0)2P (x, t)dx∫ L
−L P (x, t)dx
= L2
(
1− 8
pi2
)
+ x20. (4.3.27)
Plots of (4.3.25), and the plateau (4.3.27) are shown in Figure 4.5, for specific initial particle
positions, along with comparison to numerical simulations.
(a) x0 = 0. (b) x0 = 0.5.
Figure 4.5: E[(xt − x0)2] from (4.3.25) is shown in red, the plateau of E[(xt − x0)2] as t →
+∞ (4.3.27) is shown in green, and results of numerical simulations are shown in blue. In both
simulations L = 1.0 and D = 0.5.
Random starting position
The E[(xt − x0)2] for a particle starting in a uniform random position can be calculated by
averaging over all possible starting positions, x0, and weighting each starting position by the
survival probability for a particle starting at that position remaining in the domain, [−L,L], at
time t. The survival probability of a particle in one dimension, starting at x0 is given by
S(1)(x0, t) =
∫ L
−L
P (x, t)dx =
∞∑
n=0
4L
pi(2n+ 1)
cos
(
(2n+ 1)pi
2L
x0
)
(−1)ne−D (2n+1)
2
4
pi2
L2
t.
(4.3.28)
Figure 4.6 shows comparison of the survival probability (4.3.28) to numerical results, for varying
Chapter 4. The effects of a limited imaging volume on in vivo imaging data 76
Figure 4.6: Survival probability of particles starting at varying positions, x0, indicated in the
legend. Solid lines show (4.3.28) and dotted lines show numerical simulations. The results for a
uniform random starting position are averaged over multiple realisations.
starting positions in one dimension.
To calculate the mean of E[(xt − x0)2] over all starting positions, weighted by the probability of
starting in that position, we need to compute
E[(xt − x0)2] =
∫ L
−L E[(xt − x0)2]S(1)(x0, t)dx0∫ L
−L S
(1)(x0, t)dx0
, (4.3.29)
where E represents the expectation averaged over all starting positions. This can be computed
directly for the plateau, as t→ +∞, using (4.3.27);
lim
t→+∞E[(xt − x0)
2] =
∫ L
−L
(
L2
(
1− 8
pi2
)
+ x20
)
S(1)(x0, t)dx0∫ L
−L S(x0, t)dx0
= L2
(
1− 8
pi2
)
+
∫ L
−L x
2
0S
(1)(x0, t)dx0∫ L
−L S
(1)(x0, t)dx0
= L2
(
1− 8
pi2
)
+
16L3(pi2−8)
pi4
16L
pi2
= 2L2
(
1− 8
pi2
)
. (4.3.30)
The mean of E[(xt − x0)2] over all starting positions, for all t, cannot be easily calculated
analytically. It can be calculated numerically, by choosing a uniform random x0 within the domain
−L, to L, calculating E[(xt − x0)2], and multiplying by S(1)(x0, t) for that x0. We must then sum
the expectation, multiplied by the survival probability, for numerous x0 and divide this sum by the
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sum of the survival probabilities for the same x0,
E[(xt − x0)2] =
∑
x0
E[(xt − x0)2]S(1)(x0, t)∑
x0
S(1)(x0, t)
. (4.3.31)
A plot of (4.3.31), the plateau (4.3.30), with comparison to numerical simulations is shown in
Figure 4.7.
Figure 4.7: E[(xt−x0)2] (4.3.29), for a particle starting in a uniform random position, is shown in
red, the plateau of E[(xt − x0)2] as t→ +∞ (4.3.30), is shown in green, and results of numerical
simulations are shown in blue. In this simulations L = 1.0 and D = 0.5.
4.3.2 Three dimensions
To calculate E[(Xt − X0)2], the components of the three one-dimensional processes must be
summed, giving
E[(Xt −X0)2] = E[(xt − x0)2] + E[(yt − y0)2] + E[(zt − z0)2], (4.3.32)
where the one-dimensional expectations are given by (4.3.25). The plateau of the three-
dimensional expectation is also given by the sum of three copies of the one-dimensional plateau
in x, y and z, given by (4.3.27),
lim
t→+∞E[(Xt −X0)
2] = (L2y + L
2
y + L
2
z)
(
1− 8
pi2
)
+ x20 + y
2
0 + z
2
0 . (4.3.33)
Figure 4.8 shows a plot of (4.3.32), and the plateau (4.3.33), along with numerical simulations.
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Figure 4.8: E[(Xt − X0)2] in three dimensions (4.3.32) for a particle starting at x0 = Lx/2,
y0 = Ly/2 and z0 = Lz/2 is shown in red, the plateau of E[(Xt −X0)2] as t → +∞ (4.3.33)
is shown in green, and results of numerical simulations are shown in blue. In this simulation
Lx = Ly = Lz = 1.0 and D = 0.5.
Random starting position
For a particle starting in a uniform random position in three dimensions, the expectation must
be weighted by the survival probability in three dimensions. The survival probability in three
dimension is given by the product of the survival probability in each of the x, y and z dimensions:
S(3)(X0) = S
(1)(x0)S
(1)(y0)S
(1)(z0), (4.3.34)
where S(1) is given by equation (4.3.28), and the t argument has been suppressed. A plot of
the survival probability (4.3.34), for various starting positions, is shown in Figure 4.9, with
comparison to numerical simulations.
The plateau for the three-dimensional case is calculated in the same way as in the one-dimensional
case, by multiplying the plateau for a fixed starting position (4.3.33) by the survival probability
(4.3.34), integrating over x, y and z, and dividing by the integral of S(3)(X0).
lim
t→+∞E((Xt −X0)
2) =
∫ Lz
−Lz
∫ Ly
−Ly
∫ Lx
−Lx
(
3L2
(
1− 8
pi2
)
+ x20 + y
2
0 + z
2
0
)
S(3)(X0)dx0dy0dz0∫ Lz
−Lz
∫ Ly
−Ly
∫ Lx
−Lx S
(3)(X0)dx0dy0dz0
= 2(L2x + L
2
y + L
2
z)
(
1− 8
pi2
)
. (4.3.35)
The mean of E[(Xt −X0)2], is given by weighting the expectation for each starting position by
the survival probability for that position. The analytical solution cannot easily be calculated, so a
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Figure 4.9: Survival probability of a particle in a three-dimensional volume, given by (4.3.34),
shown by solid lines, and results of numerical simulations, shown by dotted lines. In these
simulations particles have the same starting position in the x, y and z dimensions, shown in the
legend as α, where X0 = α(1, 1, 1). Lx = Ly = Lz = 1.0 and D = 0.5. The uniform random
starting position has been averaged over multiple realisations.
numerical calculation is performed in the same way as in the one-dimensional case, by summing
over multiple starting positions:
E[(Xt −X0)2] =
∑
X0
E[(Xt −X0)2]S(3)(X0)∑
X0
S(3)(X0)
, (4.3.36)
where the summation is over various starting positions, for multiple realisations. Figure 4.10
shows a plot of the expectation (4.3.36), and the plateau (4.3.35), for a particle starting in a cube,
with comparison to numerical simulations.
4.4 Application to imaging volume
The imaging volume used in TPLSM experiments is larger in the x and y dimensions than in the
z dimension, due to the way the imaging technique works. It is therefore more likely that a cell
will exit via the z boundary than via one of the x or y boundaries. Equation (4.3.36) can be tested
using an imaging volume with a z dimension that is smaller than the x and y dimensions, shown
in Figure 4.11.
Figure 4.11 shows (4.3.36) is correct for an imaging volume with an unequal size in the z
dimension. We now want to test the accuracy of the calculated expectation value when using
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Figure 4.10: E[(Xt−X0)2] in three dimensions for a particle starting in a uniform random position
(4.3.36) is shown in red, the plateau of E[(Xt − X0)2] as t → +∞ (4.3.35) is shown in green,
and results of numerical simulations are shown in blue. In this simulation Lx = Ly = Lz = 1.0
and D = 0.5.
Figure 4.11: Expectation for an imaging volume that is smaller in the z dimension than the x and
y dimensions, with particles starting in uniform random positions. Predicted mean expectation
(4.3.36), shown in red, the plateau of the mean expectation as t→ +∞ (4.3.35), shown in green,
and results of numerical simulations are shown in blue. In this simulation Lx = Ly = 1.0 and
Lz = 0.75 and D = 0.5.
parameters that are similar to those found in biological experiments. Using an imaging volume
of Lx = Ly = 117.275µm, and Lz = 15.4µm, as used in data provided by a research group in
Glasgow, (analysed in Chapter 5), along with a diffusivity of 20µm2min−1, and an imaging time
of 100 minutes, (4.3.36) can be tested.
Chapter 4. The effects of a limited imaging volume on in vivo imaging data 81
Figure 4.12: Predicted mean expectation (4.3.36), shown in red, with comparison to numerical
results generated using a spatial simulation are shown in blue, for an imaging volume of a size
similar to those used in biological experiments, Lx = Ly = 117.275µm, Lz = 15.4µm and
D = 20µm2min−1. Number of realisations = 108.
Figure 4.12 shows the expectation does not reach the confinement plateau by the end of the 100
minutes of imaging, and the numerical results do not extend to the full 100 minutes. There are
no numerical results for higher timepoints due to the z length being much shorter than the x
and y lengths, resulting in particles exiting via the z boundary at earlier times. To remain in the
imaging volume until a later time, with this imaging volume, a particle must move in the x and
y dimensions a lot more than the z. Movement in each dimension is equally likely, therefore this
event is uncommon. This results in a plateau, due to confinement in a limited size imaging volume,
not being observed. Increasing the diffusivity of the cells would result in the expectation reaching
the plateau quicker, however it would also result in cells exiting via the z boundary quicker and
only giving numerical values for even shorter times.
4.5 Comparison to data
Using a spatial code written in python, data equivalent to that obtained using TPLSM can be
generated. The program, placed cells inside an imaging volume of a specified size and moved the
cells following a random walk, recording their position every 30 seconds, as is done in biological
experiments. If a cell leaves the imaging volume, it is removed from the simulation. To compare
to the equation for the expected displacement squared (4.3.36), we need only consider cells that
start in the imaging volume and for only as long as they stay in the volume. Using data generated
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in this way, displacement squared against time plots, in which there will be confinement, can be
created.
Figure 4.13: Predicted mean expectation (4.3.36) is shown in red, and plateau of the mean
expectation as t → +∞ (4.3.35) is shown in green, with comparison to numerical results shown
in blue for an imaging volume of Lx = Ly = Lz = 25µm, with D = 10µm2min−1.
Figure 4.13 shows the mean displacement squared of cells moving in an imaging volume of
50µm× 50µm× 50µm, with a diffusivity of 10µm2min−1. The simulated data fits very well to
the analytical prediction. After a time of 60 minutes, the fit is not quite as good, due to there being
less data for later times, as a result of more cells having exited the imaging volume. The data for
this plot has been gathered by simulating ten million cells.
Figure 4.14: Simulated data for an imaging volume the same size as the imaging volume in the data
provided by a research group in Glasgow (Chapter 5). The predicted mean expectation (4.3.36) is
shown in red, and simulated data is shown in blue.
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Figure 4.14 shows simulated data for an imaging volume of 234.55µm × 234.55µm × 30.8µm,
with a diffusivity of 20µm2min−1. For this simulation, the data does not reach the plateau
expected for the imaging volume, and there is no data for times beyond 80 minutes. This is
due to the z dimension being a lot smaller than the x and y dimensions. If there was data from
enough cells, we should, in theory, see some cells that remain in the imaging volume long enough
to reach the plateau. However, the data used in Figure 4.14 is gathered by simulating ten million
cells, and in biological experiments there are usually around one thousand cells tracked, and this
data set is reduced after sorting. Therefore, in a biological experiment a plateau will not be seen
due to confinement in the imaging volume, when the z dimension is a lot smaller than the x and y
dimensions, which is usually the case.
4.5.1 Underestimation of plateau
When simulating data for Figure 4.13, it was discovered that the plateau the data reached is
affected by the update interval of the simulation. In Figure 4.13 data is recorded every 30 seconds
of simulated time, but the list of cells that are in the imaging volume is updated every time the
cells are moved, this update procedure is required to fit the analytical prediction. However, if the
list of cells in the imaging volume is updated every 30 seconds, the plateau of the simulated
data is overestimated (Figure 4.15(a)). This is due to cells exiting and then re-entering the
imaging volume between the 30 second updates. Therefore, on average, the cells are able to
travel further before they are classified as being outside the imaging volume, resulting in the
displacement squared being greater. The analytical prediction can be corrected by adding half
the mean displacement in one dimensions, of a cell in 30 seconds, to the length of each of the
boundaries of the imaging volume. Half the mean displacement is used as the cell must exit
the imaging volume, then re-enter, for it to continue being tracked. The mean displacement in
one dimension, for a cell moving by Brownian motion, is given by
√
2Dδt, where δt is the
update interval. The adjustment needs to be added to the Lx, Ly and Lz values, to correct for
the overestimation. The correction results in a better prediction of the plateau (Figure 4.15(b)).
The underestimation must be taken into account when predicting the plateau of data obtained
from biological experiments, as cells will be able to exit and re-enter the imaging volume between
rescanning of that section.
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(a) Unadjusted analytical results. (b) Adjusted analytical results.
Figure 4.15: Plots showing, (a) the underestimation of the analytical prediction due to updating
the list of cells in the imaging volume every 30 seconds, and (b) a simple correction to the
underestimation.
4.6 Summary
In this chapter mathematical techniques developed have allowed us to determine the expectation
of the mean squared displacement, as a function of time, and the plateau as t → +∞, of a
displacement squared against time plot, for particles starting in uniform random positions within
an imaging volume of a given size. The aim of this work was to be able to use these predictions
to determine the diffusivity of a set of cells by fitting the predictions to the data. However, due to
the disparity in size of the z dimension of the imaging volume used in biological experiments, the
displacement squared plots will not lead to a confinement plateau. Therefore, the equation for the
plateau cannot be fitted to this type of data. The mean expectation of the displacement squared
can be fitted to biological data, to try and determine the diffusivity of the observed cells. Using
data provided by a research group in Glasgow (Institute of Infection, Immunity and Inflammation,
University of Glasgow), a comparison to biological data could be made. The amount of viable
data available in this experiments is quite small, and other factors effect the interpretation of the
data, such as: persistent motion and noise in the data. The data also does not reach a plateau due to
the shape of the imaging volume. Therefore, fitting the prediction for the mean expected squared
displacement does not result in a better prediction of the diffusivity than fitting a straight line. A
more in-depth discussion and analysis of in vivo imaging data is carried out in Chapter 5.
Although the prediction of the plateau, due to confinement in an imaging volume of limited
size, cannot be used as originally intended, it does allow experimental results to be validated.
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A displacement squared plot with a plateau below the predicted one indicates the cells are in
fact confined, or that there is another factor causing confinement to be observed, such as an
underlying population of cells with a lower diffusivity, as found in Section 5.4.2. Comparison
of the predictions for the displacement squared to numerically simulated imaging experiments
revealed that large intervals in the scanning of the imaging volume cause the predictions to be
underestimated. A simple correction can be implemented to compensate for this problem, by
adding half the mean distance a cell can move in an update interval to each of the boundaries.
The underestimation is most pronounced at the plateau of the displacement squared, but when
using imaging volumes similar to those used in biological experiments, the plateau is not reached.
There will still be a slight underestimation of the slope to reach the plateau, but this will not be as
large as at the plateau. Therefore, the underestimation can most likely be ignored. Numerically
simulated imaging experiments illustrated that large amounts of data are required to achieve
relatively smooth results. In biological experiments the number of cells tracked is not very large,
with usually less than one thousand cells being tracked. To achieve smoother results techniques
will need to be developed to extract more data from the tracks already present, this is discussed in
Section 5.4.3.
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Chapter 5
Analysis of in vivo imaging data
5.1 Introduction
Lymphocytes are constantly moving between, and within, lymph nodes in an attempt to locate
antigen presenting cells (APCs) displaying their cognate antigen, to become activated. The time it
takes for an activation event to occur depends on the number of APCs presenting cognate antigen.
More importantly, it depends on how quickly the lymphocytes attempting to locate the APCs are
moving, and if they are being directed towards their target in some way. Therefore, the big question
in determining lymphocyte activation time is how ‘fast’ do lymphocytes move within the lymph
node.
Advances in imaging technology have allowed lymphocytes to be viewed in vivo, in three-
dimensional space, deep within intact lymph nodes, using two-photon laser scanning microscopy
(TPLSM) [80]. Using these imaging techniques, cell positions over time can be recorded to build
up a data set of cell tracks. From the data, one can easily obtain an ‘apparent velocity’ of the
cells by simply calculating the distance a cell has moved and dividing by the time to make that
movement. However, the ‘apparent velocity’ is not a very useful parameter to report, as time is
recorded in discrete intervals, usually of thirty to sixty seconds. Therefore, in the intervening
time, the cell may have taken any path between the initial and final position. The cell is unlikely
to have taken a straight path, as assumed when calculating a velocity, hence it is often referred
to as an ‘apparent velocity’. A more useful parameter to report is the diffusivity of cells, which
relates to the displacement squared a cell has moved in a given time. The mean diffusivity of a
population of cells can be calculated by plotting a displacement squared as a function of time for
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a population of cells, and is determined from the gradient of this plot. However, due to limitations
and complexity of the imaging technology, and image processing software, this is more difficult
than it first seems. In processing images from TPLSM experiments, it can be difficult to determine
what is a cell, and what is a fragment of a cell. Also, cells that are close together can be mistaken
for one large cell, and one large cell can be mistaken for multiple smaller cells. A snapshot of
an imaging experiment is shown in Figure 5.1, illustrating the ambiguity of what actually is a
cell. For a review of the artefacts commonly found in TPLSM data sets, and ways in which data
analysis can be used to detect and correct these artefacts, I refer the reader to a paper by Beltman et
al. [25]. Using displacement squared against time, as well as other analytical techniques, one can
also attempt to quantify the type of motion a population of cells are moving by. This motion can
be random, directed, persistent or confined [25]. The diffusivity, as well as the type of motion cells
are undergoing, is also highly dependent on the conditions that the cells are exposed to. This will
depend upon the experimental technique used. By analysing the turning angles between successive
movements of a cell, one can quantify if persistent motion is occurring within a population of cells.
Many research groups have attempted to estimate the diffusion coefficient of T cells. These
estimates range from a few micrometers squared per minute, to hundreds of micrometers squared
per minute. A paper by Miller et al. [156], calculates the T cells in their experiment to have
a diffusivity of 67µm2min−1. They find the cells undergo persistent motion on timescales of
one to three minutes, and random motion on longer timescales. In another paper by Miller
[153], they investigate the diffusion coefficient at various times of the T cell activation process.
They found that in the early stage of T cell activation (less than two hours) the cells had a
diffusivity of 9.7µm2min−1, and at a later stage (two to fourteen hours) the diffusivity dropped
to 2.3µm2min−1.
In this chapter, a data set provided by a research group at the University of Glasgow (Institute
of Infection, Immunity and Inflammation, University of Glasgow) is analysed in an attempt
to calculate the diffusion coefficient of the cells imaged, as well as the type of motion they
are undergoing. The chapter begins by analysing basic aspects of the data, such as the total
displacement of tracks, and the total time tracks occur for. The data is then broken down,
erroneous data discarded, and the remain data are re-analysed to obtain an estimate for the
diffusion coefficient of the cells. The analysis enables the development of a systematic method for
determining the diffusivity of a population of cells, which is applied to other data sets.
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Figure 5.1: Snapshot of TPLSM in vivo imaging, at timepoint 0, for the Ear1 data set, described
in Section 5.2. T cells are shown in green.
The aim of determining the type of motion T cells are undergoing is to be able to accurately model
cell movement in silico. If the cells are undergoing random motion, and the diffusivity can be
calculated, this can then be used as a parameter in spatial simulations and in MFTP equations
derived in Chapter 3.
5.2 About the data
The main data set analysed in this chapter is for an imaging period of 100 minutes, with timepoints
taken every 50.8 seconds. The imaging volume is a box with x, y, z dimensions of 234.55µm ×
234.55µm× 30.8µm. It takes two seconds to scan a frame in the x− y plane. Therefore, for this
data, the z frames must be about 1.23µm apart. This value is calculated by determining how many
planes can be scanned in a timestep (50.8 seconds), and dividing the size of the z dimension by
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this value. The other data sets analysed in Section 5.5.1 only, have the following properties: LN2:
has x, y, z dimensions of 234.55µm× 234.55µm× 32.0µm, with a timestep size of 29 seconds,
giving a z plane separation of 2.29µm. The total imaging time is 58 minutes. LN4: has x, y, z
dimensions of 206.53µm× 206.53µm× 22.0µm, with a timestep size of 32 seconds, giving a z
plane separation of 1.38µm. The total imaging time is 32 minutes. Ear1: has x, y, z dimensions of
282.85µm×282.85µm×46.0µm, with a timestep size of 50 seconds, giving a z plane separation
of 1.84µm. The total imaging time is 33.3 minutes. Figure 5.1 shows a snapshot of a z slice in an
imaging experiment carried out to obtain the Ear1 data set.
5.3 Basic analysis
Basic information about the data can be determined by plotting distributions of the displacement
of the cells, the time tracks were imaged for, and the diffusion coefficients of each cell.
(a) Total displacement. (b) Track duration.
(c) Diffusion coefficients.
Figure 5.2: Basic analysis of the whole data set.
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Figure 5.2(a) shows the distribution of displacements of individual cells, from the time they
were first tracked, to the time they were last tracked. There appears to be lots of cells with
small displacements, and fewer cells with larger displacements. A small displacement does not
necessarily mean the cell has not moved far, rather its end position is close to its starting position.
A cell could have a long track length, but end up close to where it started. This can be analysed
further by investigating the confinement ratio of the cells. The confinement ratio is defined as the
ratio of track length and total track displacement, and is sometimes referred to as the meandering
index [25]. A small displacement indicates that the cell could be confined to a certain region,
resulting in the end position being near to the start position, or the cell could not be moving much,
and has not travelled far from where it started. The mean of the total track displacements is 7.77
µm, and the standard deviation is 6.65µm.
Figure 5.2(b) shows the distributions of the duration of cell tracks. This is the time from the point
when the tracking commenced, to the time when the tracking ended. The figure shows a peak
of cells with short durations, and fewer cells with longer durations. A large peak occurs at 100
minutes as this includes all the cells that were tracked for the whole of the imaging period. The
mean of the total track durations is 15.99 minutes and the standard deviation is 22.86 minutes.
Figure 5.2(c) shows the distribution of diffusion coefficients for individual cells. The plot has been
trimmed at ten minutes on the x-axis to allow the plot to be viewed more easily. There are a few
tracks with diffusion coefficients greater than 10µm2min−1 that are not displayed on this plot.
The diffusion coefficient for each cell has been calculated by
Diffusion coefficient =
Displacement2
6× Time interval .
As with the displacement and time interval plots, there are numerous cells with small diffusion
coefficients and few with larger diffusion coefficients. The mean diffusion coefficient for all the
cells is 2.37µm2min−1, and the standard deviation is 4.25µm2min−1.
From this basic analysis it is clear that there is a large amount of variation in the data, with all
parameters investigated having large standard deviations. The data also has lots of cells that appear
to be not moving very far, that are skewing the distributions.
5.3.1 Displacement squared
By plotting displacement squared against time, an attempt can be made to quantify the type of
motion the cells are undergoing, as well as determining an estimate for the diffusion coefficient
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of the population. On a displacement squared against time plot, a straight line indicates Brownian
motion, a line that plateaus indicates confinement, and a line that bends upwards indicates a
directional bias. However, it is not always clear how to distinguish between these effects, as there
are often several competing processes. With our data, confinement is expected, as the cells were
only tracked in a small imaging volume. Therefore, cells that remain in the imaging volume for a
longer period of time will be those that have not moved as far. A mean displacement squared plot
was generated by calculating the displacement squared from each point in a track, to the starting
point of the track, and recording the time in which the calculated displacement squared occurred.
A mean for each time was then taken. This method allows extra data to be extracted from the cell
tracks, rather than just taking the total displacement of the cells.
Figure 5.3: Mean displacement squared against time, with standard error bars. The red line is
fitted to the first five time points, giving a diffusivity of 2.33± 0.10µm2min−1.
Figure 5.3 shows that for small time intervals, approximately less than ten minutes, the cells seem
to be undergoing Brownian motion, as there is a linear increase. For larger time intervals the graph
flattens out, indicating confinement, as expected. A straight line is seen for small time intervals
as the cells have not had enough time to reach the edge of the imaging volume, so confinement
has not yet occurred. The red line on the graph is a line of the form y = a + bx, fitted to the
first five timepoints of the graph, where Brownian motion appears to be occurring. A sixth of
the gradient of this line gives the diffusion coefficient of the cells. The fitted line has a gradient
of 14.0, giving a diffusion coefficient of 2.33µm2min−1. Calculating the standard error in the
least squares fitting procedure gives an error in the gradient of 0.60, corresponding to an error
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in the diffusion coefficient of 0.10µm2min−1, making the estimate of the diffusion coefficient
2.33±0.10µm2min−1. This value of the diffusion coefficient is quite small, and is at the lower
end of the range of diffusion coefficients found in literature [153, 156]. This could be due to
tissue drift, which may occur as a result of the experimental setup moving, and the cells are in
fact stationary. These ‘stationary’ cells would therefore be skewing the diffusivity of the data set,
making it appear smaller than it actually is. This can be investigated further by calculating turning
angles, and scalar product, of the cells, as well as the tissue drift in the experiment. Analysing
the turning angles, and scalar product, will also help determine if the cells are following a random
walk, or moving with persistent motion.
At first glance, the plateau of the displacement squared plot is presumed to be due to the cells being
confined in a limited sized imaging volume. However, the level of the plateau is much smaller than
the expected plateau, calculated using (4.3.35), of about 10500. Therefore, the plateau observed
is not due to the limited sized imaging volume. Upon closer inspection, the ‘plateau’ appears to
be made up of drops, then slow increases. This could be the result of multiple populations of cells
moving with different diffusivities. Cells with a larger diffusivity will reach the boundary of the
imaging volume at smaller times. Once these cells have exited the imaging volume they will no
longer be contributing to the mean displacement. Therefore, if there is a population of cells with
a lower diffusivity remaining, they will have a larger contribution to the mean. This will cause a
drop in the mean squared displacement when the cells with a larger diffusivity exit the imaging
volume.
5.3.2 Turning angles
To determine if cells move in a persistent direction, or turn back on themselves abruptly, the angle
a cell turns between successive time points can be analysed.
In Figure 5.4 a large turning angle (greater than 90◦) indicates a cell has made a shallow turn, and
is continuing in a similar direction. A small turning angle (less than 90◦) indicates a cell has made
a sharp turn, and is moving in a direction not similar to its previous direction. This is illustrated in
Figure 5.5.
Figure 5.4 shows a wide spread of angles, ranging from approximately 0◦, meaning the cell is
going in the opposite direction, to approximately 180◦, meaning the cell is continuing in the same
direction. By fitting a sine distribution for the expected angles to the figure, it can be seen that
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Figure 5.4: Turning angles between successive vectors in tracks for the whole data set. Mean of
data is 89.0◦. Red curve shows the expected distribution of angles.
θ
θ
Figure 5.5: Illustration of turning angles. The left diagram shows a shallow turning angle, with θ
being close to 180◦. The right diagram shows a sharp turning angle, with θ being close to 0◦.
there is more small and large angles than expected, and less angles around 90◦ than expected. This
could be due to cells making small movements back and forth, perhaps due to experimental error.
5.3.3 Persistent motion
Persistent motion can be detected by analysing the scalar product of the ith and i + kth vectors
in a track, where k is the number of vectors further along the track that is being compared. For
example, if k = 1 vectors directly after each other are being compared, and if k = 2 vectors
two timesteps apart are being compared. By taking the mean of these scalar products for each k
it can be determined if there is persistent motion and at what point it occurs. A positive scalar
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product indicates the two vectors are almost parallel. A scalar product equal to zero indicates the
vectors are orthogonal to each other, and a scalar product less than zero indicates the vectors are
almost anti-parallel. The scalar product takes into account the magnitude of a vectors, as well as
the angle between the vectors. If the cells are moving following a random walk, and do not have
any persistent motion, the mean scalar product will be zero. The scalar product is calculated by:
a · b =
n∑
i=1
aibi,
where a and b are the vectors being compared. In this case we are calculating the scalar product
in three dimension, so it is given by the sum of the product of each of the x, y and z components.
Figure 5.6: Mean scalar product between timepoints of varying size, k, in the x, y and z
dimensions. Plot has been scaled to start at one for k = 0.
Figure 5.6 shows for k less than five, the mean scalar product is greater than zero, and for k greater
than and equal to five, the mean scalar product is close to zero. Indicating that for periods of about
four timesteps the cells have persistent motion, but for larger timescales there is no persistent
motion. This is consistent with experimental observations [232], where T cells were found to move
in a series of repetitive lunges. It can be concluded that the cells movement is well approximated
by Brownian motion on timescales of longer than four minutes.
5.3.4 Tissue drift
The data analysed have been obtained from an imaging experiment on a live mouse. Even though
the mouse is anaesthetised, it may still twitch or make other small movements, resulting in a
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shift in the whole imaging volume. Another factor that must be considered is that the whole
experimental setup may move or vibrate, resulting in false movements being observed in the data.
To determine if there is a directional bias in the experimental procedure, the mean movement in
each of the x, y and z directions can be plotted cumulatively. If there is no drift present, the mean
displacement between timepoints should be approximately zero, if the cells are assumed to be
undergoing Brownian motion.
Figure 5.7: Plot of cumulative mean displacement from the mean starting position, as a function
of imaging time.
Figure 5.7 shows there is tissue drift in the experiment. This is more pronounced in the x and y
directions, with the mean cell position being about 6µm from where it started, by the end of the
experiment, in both the x and y dimensions. In the z direction the mean cell position was about
3µm from where it started by the end of the experiment. This artefact can be compensated for by
subtracting the amount of drift that has occurred at a timepoint, from the cell’s x, y and z position,
at that timepoint.
5.4 Further analysis
5.4.1 Sorting data
The software that automatically tracks cell movements obtained by TPLSM is a very useful tool,
but it does have its drawbacks, and it cannot compete with a human in terms of accuracy. However,
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manually tracking cells is very time consuming, so automated software is usually used. One of the
main drawbacks of automatic tracking is that the software often cannot distinguish cells that are in
close proximity. It can track these clusters as one cell, and upon separation it is possible that the
cell identities change. This leads to artefacts occurring in the data, which must be dealt with upon
analysis.
Further analysis reveals the data set contains data from a total of 1121 cells. Some of these cells
have only one data point, which is of no use for analysing cell tracks. Excluding these leaves
734 tracks (Figure 5.8(a)). These are the set of tracks used for the basic analysis in the previous
sections. Of these 734 tracks, some of them only have information up to a timepoint before the
end of the imaging time. This is acceptable if the cell being tracked has left the imaging volume,
however, there are tracks that have ended part way through imaging and are not near the edge of the
imaging volume. Excluding these cells leaves 582 tracks (Figure 5.8(b)). The same situation can
happen in reverse, with tracks starting part way through the imaging time, which are not starting
near the edge of the imaging volume. Excluding these leaves 498 tracks (Figure 5.8(c)). There is
also a subset of tracks that do not have data for all timepoints from the time they are first detected
to the time they are last observed. Theoretically, a track could leave and re-enter the imaging
volume, which would cause a break in the tracking data. However, the software that tracks the
cells is not able to know that a cell entering is one that has previously exited, so would treat the
entering cell as a newly observed cell. To overcome this artefact, all tracks that have breaks in
their tracking of one or more timepoints were excluded. This leaves 245 tracks (Figure 5.8(d)) to
be analysed.
5.4.2 Displacement squared against time
Displacement squared against time plot can now be plotted for the sorted data set.
Figure 5.9(a), in which tissue drift is not accounted for, shows that after 40 minutes the mean
displacement of the cells drops, then slowly increases. In Figure 5.9(b), where tissue drift has
been accounted for, the increase that occurs after 40 minutes no longer occurs. It can be concluded
that this increase is due to tissue drift, and the mean displacement squared of the cells does not
change much after 40 minutes, staying around 15µm2. This equates to the cells mean displacement
after 100 minutes being about 4µm, which is less than the diameter of a T cell, 7µm. The way
the displacement squared increases up until 40 minutes, and then drops, indicates that there is
a population of cells that are barely moving (slow cells), and a population that is moving with
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(a) All tracks. (b) Excluding tracks ending not near the edge.
(c) Excluding tracks starting not near the edge. (d) Excluding track with missing timepoints.
Figure 5.8: Plots of cell tracks in the imaging volume. Box indicates imaging volume at the start
of the imaging period.
(a) Without accounting for tissue drift. (b) Accounting for tissue drift.
Figure 5.9: Plots of displacement squared against time. The red lines have been fitted to the first
few time points, to calculate the diffusivities. In (a), D = 2.93 ± 0.14µm2min−1, and in (b),
D = 2.77± 0.21µm2min−1.
a greater diffusivity. This causes a drop in the mean squared displacement as the faster moving
cells are able to leave the imaging volume at earlier times. This results in the slower cells having
a larger contribution to the mean after the faster cells have left. It also results in the standard
error bars shrinking as there is a smaller amount of variability in the displacement of the cells, as
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they are moving slower. The population of slow cells could be bound to stationary structures in
the lymph node, such as the cytoskeleton, and their small movement could be due to movement
of the cytoskeleton or other factors. In two-photon imaging experiments carried out by Miller
et al. [156], they found a population of cells attached to structures by long membrane tethers,
that were relatively stationary but exhibited probing behaviour. This behaviour suggests the cells
were interacting with unseen elements in the environment. Visualisation of the reticular network
using CMTMR staining, revealed T cells that adhered to, but did not crawl along, the fibres of the
reticular network. In the paper by Miller et al. [156] they define stationary cells to be those with a
displacement in one timestep of less than two micrometers.
To determine the diffusivity of the faster moving set of cells, the slow set of cells must be excluded,
as they will be skewing the mean displacement of the faster-moving set of cells. This was achieved
by calculating the mean distance moved in one timestep for each cell and deciding on a cut-off
to classify the two populations. Closely examining the data, I found excluding cells with a mean
displacement of less than 1.5µm in one timestep, eliminated this slow set of cells. Plots of the two
sets of tracks are shown in Figure 5.10.
(a) >1.5µm. (b) <1.5µm.
Figure 5.10: Tracks with mean displacement in one timepoint, (a) greater than, and (b) less than
1.5µm.
By excluding the slow cells, and re-plotting the displacement squared against time graph, a
diffusivity of 12.22µm2min−1 is obtained (Figure 5.11(a)). The slow population of cells has
a diffusivity of 0.32µm2min−1 (Figure 5.11(b)). These diffusivities are calculated by fitting
straight lines, to the displacement squared plots (Figure 5.11), for points when the cells appear to
be undergoing random motion. The displacement squared of the faster cells (Figure 5.11(a)) drops
after about 15 minutes, and then slowly increases again, indicating there is yet another population
of cells moving slower, that are again going to be skewing the mean of the distribution. Using the
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same process, this population of cells moving with an intermediate diffusivity, can be excluded by
removing all cells with a mean displacement in one timestep of less than 2.5µm. Plotted tracks
are shown in Figure 5.12.
(a) >1.5µm. (b) <1.5µm.
Figure 5.11: Displacement squared against time plots, with lines fitted (red) to calculate the
diffusivity. In (a) D = 12.22± 0.63µm2min−1, and in (b) D = 0.32± 0.02µm2min−1.
(a) >2.5µm. (b) >1.5µm and <2.5µm.
Figure 5.12: Tracks with mean displacement in one timepoint, (a) greater than 2.5µm, and (b)
between 1.5µm and 2.5µm.
Figure 5.13 shows the cells with larger movement in one timestep (fast cells) have a diffusivity of
23.84µm2min−1, and the cells with intermediate movement in one timestep have a diffusivity of
2.90µm2min−1. Figure 5.13(a) shows the displacement squared increases roughly linearly with
time, without the drop and increase seen in the other displacement squared graphs, indicating there
is not another underlying population of cells in this reduced data set. Due to the limited size of the
imaging volume, we would expect the displacement squared to plateau as time tends to infinity.
However, due to the z dimension being a lot smaller than the x and y dimensions, most of the cells
will escape via the z boundary, which will happen at shorter times.
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(a) >2.5µm. (b) >1.5µm and <2.5µm.
Figure 5.13: Displacement squared against time plots, with lines fitted (red), after persistent
motion stops (determined using Figure 5.17), to calculate the diffusivities. In (a)D = 23.84±0.62,
and in (b) D = 2.90± 0.20µm2min−1.
To observe a confinement effect, cells persisting in the imaging volume until later time points, by
moving in the x and y dimensions more, must be observed. To observe these tracks, there would
need to be a large amount of data points. In this subset there are only 45 tracks remaining, due to
sorting the data, which is not enough data to be able to observe these desired tracks. Therefore,
we do not observe a plateau. Instead, the displacement squared increases with time, until the
cells escape, after which point there is no more data. A slower increase in the displacement
squared is observed in Figure 5.13(a) for the first few timesteps, indicating persistent motion in
the population of cells. This can be investigated by analysing the mean turning angle between
successive movements of the cells, and the scalar product between vectors along a cell’s path.
5.4.3 Direction of motion
Using only the tracks with a mean displacement in one timestep greater than 1.5µm, the turning
angles of the cells can be analysed, shown in Figure 5.14(a). This population has a mean of
111.90◦, indicating cells generally move in a persistent direction, and are less likely to abruptly
turn back on themselves. Figure 5.14(b) shows that, cells with a mean displacement in one
timestep of less than 1.5µm, have a mean turning angle of 80.90◦, indicating these cells make
abrupt turns, and are more likely to move back in the direction they came from.
Figure 5.15 shows the analysis of turning angles for tracks with mean displacement in one
timestep, (a) greater than 2.5µm, and (b) between 1.5µm, and 2.5µm. Figure 5.15(a) shows
Chapter 5. Analysis of in vivo imaging data 102
(a) >1.5µm. (b) <1.5µm.
Figure 5.14: Turning angles of tracks with mean displacement in one timepoint, (a) greater than,
and (b) less than 1.5µm. Plot (a) has a mean of 111.9◦, and (b) has a mean of 80.90◦.
(a) >2.5µm. (b) >1.5µm and <2.5µm.
Figure 5.15: Turning angles of tracks with mean displacement in one timepoint, (a) greater than
2.5µm, and (b) between 1.5µm and 2.5µm. Plot (a) has a mean of 124.35◦, and plot (b) a mean
of 102.78◦.
the fast cells to have even less abrupt turning angles, with a mean of 124.35◦. The tracks in Figure
5.15(b) have a mean turning angle of 102.78◦, implying they also travel in a more persistent
direction than the slow cells.
Persistent motion can be detected by calculating the mean scalar product between the ith and
i + kth vectors along the track. Figure 5.16(a) shows the cells with a mean displacement in one
timestep greater than 1.5µm are undergoing persistent motion for the first five timepoints, after
which there appears to be no persistence. Figure 5.16(b) shows the slow cells are not displaying
persistent motion, which is expected for cells that are just moving slightly back and forth. Figure
5.17(a) shows there is again persistent motion for the first five timepoints of the fast cells, after
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(a) >1.5µm. (b) <1.5µm.
Figure 5.16: Dot product between vectors i and i + k, of tracks with mean displacement in one
timepoint: (a) greater than, and (b) less than 1.5µm. Plot has been scaled to start at one for k = 0.
(a) >2.5µm. (b) >1.5µm and <2.5µm.
Figure 5.17: Dot product between vectors i and i + k, of tracks with mean displacement in one
timepoint: (a) greater than 2.5µm, and (b) between 1.5µm and 2.5µm. Plot has been scaled to
start at one for k = 0.
which there is no persistence. For the intermediate cells (Figure 5.17(b)), there is persistent motion
for the first couple of timesteps, but not for subsequent timesteps.
It can be concluded that, there is persistent motion on short timescales (less than six timesteps), but
for longer timescales the cells movement is well approximated by Brownian motion. Ideally, for
this data, to extract the diffusion coefficient from a plot of displacement squared against time, the
displacement needs to be calculated between points separated by five timesteps, to compensate for
the persistent motion in the first five timesteps. In this chapter, displacement squared against time
graphs are generated by calculating the displacement from each point to the starting point of the
track. Compensating for persistent motion in this method would result in the first five timepoints
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being cut off the plot. The line used to calculate the diffusion coefficient is fitted to points after
persistent motion is found to stop. Therefore, removing the points where persistent motion is
occurring would not change the value of the diffusion coefficient calculated from the fitted line.
An alternative method considered for generating displacement squared plots, is to calculate the
displacement from every subsequent point in a track to the first point, then the second point, then
the third point, and so on. This multiple sampling method generates more data, especially for
small time intervals. Using this method would cause a change in the diffusion coefficient if time
points being compared are further apart. However, using this method results in long tracks having
a larger contribution to the mean of the data, due to them being sampled numerous time. For
this reason, this method of multiple sampling was not used in this chapter. This problem could
potentially be compensated for by weighting a track’s contribution to the mean, for example: all
tracks could contribute equal weight to the mean. However, it may be beneficial to take numerous
samples from long tracks, as these are the ones with the most data available, so could be the most
reliable. Short tracks can be suspicious, due to cells being miss tracked, so it may not be desirable
to weight them as heavily as the long tracks.
5.5 Procedure for calculating diffusion coefficient
Analysis of the previous data set enabled the development of a systematic procedure to calculate
the diffusion coefficient. The procedure developed consists of the following steps:
Step 1: Determine the tissue drift in the data, using the method outlined in Section 5.3.4. All
following analysis should be carried out compensating for the tissue drift in the experiment.
Step 2: Exclude all erroneous data, as outlined in Section 5.4.1.
Step 3: Using this sorted data set, plot the displacement squared against time. From this plot,
adjust the cut-off for the minimum mean displacement in one timestep until the plot does not
appear to plateau. The cut-off is generally between two and four micrometers per timestep.
Step 4: Using the trimmed data set, plot the mean scalar product between the ith and i + kth
vectors in the tracks. Using this plot, determine the point at which persistent motion becomes less
apparent (i.e. the mean scalar product is approximately zero).
Step 5: Fit a straight line to the displacement squared against time plot, starting from the timepoint
at which persistent motion is found to stop, until the point at which there is too little data for the
values to be conclusive. Using the fitted line, the diffusion coefficient can be calculated by taking
one-sixth of the gradient.
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5.5.1 Application to data sets
The procedure for calculating the diffusion coefficient can be tested by applying it to three data
sets that were also provided by the research group in Glasgow. Plots for the mean scalar product
and displacement squared, with a fitted line to calculate the diffusion coefficient, are shown in
Figures 5.18 to 5.20.
(a) Mean scalar product plot. (b) Displacement squared plot.
Figure 5.18: Data set LN2. Plots used to determine the diffusivity of the cell population, D =
7.03± 0.46µm2min−1.
(a) Mean scalar product plot. (b) Displacement squared plot.
Figure 5.19: Data set LN4. Plots used to determine the diffusivity of the cell population, D =
43.94± 3.01µm2min−1.
For these data sets, estimates for the diffusion coefficients are found to be: 7.03±0.46µm2min−1,
43.94±3.01µm2min−1, andD = 39.49±2.68µm2min−1, for LN2, LN4 and Ear1, respectively.
The amount of tracks that survive the sorting procedure for the data sets is 96, 145, and 35 tracks,
respectively.
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(a) Mean scalar product plot. (b) Displacement squared plot.
Figure 5.20: Data set Ear1. Plots used to determine the diffusivity of the cell population, D =
39.49± 2.68µm2min−1.
5.6 Processing data
To process the data set provided by the Glasgow laboratory, the programming language python was
used. The data was imported using the package numpy, and assigned a data structure, allowing
different aspects of the data to be easily called. To import the data the following commands were
used:
import numpy as np
dtyp = np.dtype([ (’tc’,np.int), (’id’,np.int), (’tp’,np.int),
(’xpos’,np.float), (’ypos’,np.float), (’zpos’,np.float)])
data = np.loadtxt(’GlasgowData01.dat’, dtype = dtyp)
In which tc is the cell number, id is the cell identity, tp is the timepoint of the data point, and
xpos, ypos and, zpos are the x, y and z position of the cell. Individual cells could then easily
be chosen by creating a boolean mask, which reads true for data relating to a specific cell and false
for all other data values. Applying this mask to the whole data set, leaves a subset of data for a
specific cell. Looping over the whole data set from the minimum to the maximum cell number,
and applying a mask as described, allows analysis of each cell track. The following commands
were used:
for i in range(data[’tc’].min(), data[’tc’].max()):
mask1 = data[data[’tc’]==i]
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5.7 Summary
In all the data sets, the displacement squared plots only have data for part of the total imaging time.
This occurs because the cells are primarily escaping from the imaging volume via the z boundary.
To obtain more accurate results, and be able to track cells for a larger fraction of the imaging time,
an imaging volume with a larger z dimension is required. In TPLSM experiments, the z dimension
is scanned in stacks. An increase in the size of the z dimension can be achieved in several ways.
The separation between stacks could be increased, preserving the size of the time increments at
which a z stack is scanned. However, this could lead to cells residing between the z stacks, and
not being scanned. The number of z stacks could be increased, keeping the size of the separation
between stacks. This would lead to the time increment between scanning a stack increasing, as
there are more stacks to scan. If the time increment is made too large, less information about
cell positions will be available, and cell identities could more easily be mistaken. An alternative
solution to achieve a larger z dimension would be to reduce the size of the x and y dimensions.
In the data analysed in this chapter, a z stack takes about two seconds to scan, if the x and y
dimensions are reduced, this time would be reduced, allowing more z stacks to be scanned in a
given time. This would allow a larger z dimension to be achieved, without compromising on the z
stack separation, or the size of the time increments. By having a more cube like imaging volume,
cells can be tracked for a longer period of time. This seems like a good solution to give more data,
but it has its drawbacks. The imaging is carried out in a LN of a live mouse, by exposing the LN.
The LN has an outer cortex, which must be penetrated to visualise T cell movement occurring
deeper within the LN. If a larger z dimension is used, light must penetrate deeper within the
LN, resulting in more scattering of the light, giving a decreased resolution. This limits the depth at
which imaging can be performed. The imaging technology used in these experiments is constantly
improving, and with future developments a deeper image will be able to be obtained. If a larger
z dimension cannot be used, the next best improvement to make would be to reduce the x and y
dimensions, allowing an increase of the resolution in the z dimension, or the temporal resolution.
To achieve a more accurate analysis of the data, more data points are required. A large amount of
data are lost due to the tracks appearing or disappearing part way through the imaging time, whilst
not being near the edge of the imaging volume. Data are also lost by the exclusion of tracks that
have missing timepoints. To have more data to analyse, these artefacts must be dealt with; it is
possible that this can be done on the existing data by further analysis, or it may need investigating
experimentally. More data could be obtained by carrying out experiments with exactly the same
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setup for the imaging volume and the experimental technique. In this way, data could be merged
to give a larger data set.
Analysis of data from TPLSM experiments enabled the development of a method to calculate the
mean diffusion coefficient of a data set of cell movements. The diffusion coefficients of the four
data sets analysed ranged from 7 to 44µm2min−1. This range could be due to inaccuracy in the
data, such as how many anomalous tracks needed to be excluded. Variability can also occur due
to the experimental setup. This could be due to the size of the imaging volume, the number and
separation of z stacks taken, the time at which timepoints are taken, or the biological setup of the
experiment.
109
Chapter 6
How many dendritic cells are required
to initiate a T cell response?
6.1 Introduction
An adaptive immune response is initiated through encounters between rare naive antigen-specific
T cells, and antigen-bearing dendritic cells (DCs), within the lymph node (LN). However, the
number of DCs required to initiate a T cell response has never been precisely quantified [42].
Two-photon imaging experiments have revealed that, every hour, 500–5000 T cells come in close
proximity with any given DC [42, 51, 153], but only a small proportion of these T cells will be
specific for a given antigen. In the naive repertoire, T cells specific for a particular antigen,
are presented at low precursor frequencies [6, 159], typically between 10−6 − 10−5 [37, 42].
Experiments described in this chapter were carried out by Susanna Celli, Andreas Mu¨ller and
Philippe Bousso, at the Institut Pasteur, Dynamics of Immune Responses Unit, Paris, France.
Experiments were performed in a mouse popliteal LN, which contains approximately 106 T cells.
With this number of cells, the given precursor frequencies corresponds to between one and ten
T cells. Therefore, in the context of local infection, the number of DCs in the lymph node will
influence the probability that a rare antigen-specific T cell becomes activated.
Current experimental techniques are able to measure, in vivo, the proportion of T cells activated
by DCs in a LN. However, the experiments have their limitations and drawbacks. A roughly
known number of DCs can be injected into a mouse, but only a proportion of those will reach the
LN of interest. The proportion that reaches the LN can be estimated using in vivo imaging, but
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methods of counting the DCs are often inaccurate. To accurately measure T cell activation, a large
number of cells must be present. Therefore, experiments must start with hundreds of thousands
of DCs, to enable tens of thousands to reach the LN, which are required to be able to accurately
quantify the proportion of T cells activated, using flow cytometry (Section 1.8.2) or two-photon
imaging (Section 1.8.1). These drawbacks result in current experimental techniques not being able
to determine how many DCs are required to initiate a T cell response. A T cell response is initiated
within twenty four hours. Currently, in vivo imaging data cannot be gathered twenty four hours
after the experiments begin, to determine the proportion of activated T cells, as desired. Using
mathematical modelling, simulations with fewer DCs, and for later times, can be performed.
In this chapter experiments carried out by the Bousso laboratory, in Paris, are reviewed.
The experiments use flow cytometry [42, 55], and two-photon imaging [40]. Analytical and
computational mathematical models are developed, to calculate the recruitment probability for
a T cell. The models are then calibrated using experimental results, allowing extrapolation to
lower DC numbers and later times, which cannot be investigated experimentally. In theory, only
one T cell is required to initiate a T cell response, as once activated a T cell will produce multiple
copies of itself. A model is developed to calculate the probability of at least one T cell becoming
activated, allowing the minimum number of DCs required to elicit an immune response to be
calculated. Knowing the minimum number of DCs required to initiate an immune response is
important for many therapeutic applications, including DC vaccine against cancer.
6.2 Experimental design/results
Biological experiments were carried out by the Bousso laboratory (Institut Pasteur, Dynamics
of Immune Response Unit, Paris, France). They used an experimental approach achieving
synchronisation of antigen presentation [55] in the LN, allowing all the antigen to be presented
at a given time. They injected MHC class two double negative (MHC class II−/−) mice (mice
with no CD4 T cells), with wild type DCs, expressing a mature phenotype, and Marilyn CD4+
T cells. After twenty four hours, the mouse was injected with Dby peptide, resulting in antigen
presentation in the LN by the transferred DCs within minutes of injection (Figure 6.1a). After
thirty minutes, the fraction of CD4+ T cells that had received T cell receptor (TCR) signals
was determined, by measuring c-jun phosphorolation, which is a very early marker of antigen
recognition in T cells. It was found, that the fraction of T cells that received signal increased with
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the number of DCs transferred (Figures 6.1b and 6.2).
(a) Experimental system setup. (b) Results from all experimental repeats.
Figure 6.1: Experiment in which varying number of DCs are injected into mice, and the number
of activated T cells are recorded using phospho c-jun. Reproduced from [53].
Figure 6.2: Results showing flow cytometry output of the number of T cells expressing phospho
c-jun, for varying initial DC numbers. Reproduced from [53].
The number of DCs expressing green florescent protein (GFP), at the time of peptide injection
was measured to determine how many of the injected DCs reached the LN. For example, they
found that 22286 ± 797 DCs were present in the LN one day after injection of 2 × 106 DCs, and
these DCs induced c-jun phosphorolation in 48±7.6% of antigen-specific T cells in thirty minutes
(Figure 6.3).
Two photon laser scanning microscopy (TPLSM) was used to measure the time it takes for T
cells to encounter, and bind, an antigen-bearing DC, in the same conditions, with 20000 DCs. An
accumulation of T cell-DC interactions over time, as more, and more T cells encountered DCs,
was observed. In five to ten minutes 50% of T cells formed a stable contact, increasing to 88% by
thirty minutes (Figure 6.4).
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Figure 6.3: Quantifying number of DCs using GFP labelling. Green dots represent DCs.
Reproduced from [53].
(a) Image from TPLSM in vivo
experiment.
(b) Plot of results from TPLSM
experiments, showing the percentage of
attached/activated T cells as a function
of time. Each coloured line represents
one experiment.
Figure 6.4: TPLSM experiments. Reproduced from [53].
6.3 Mathematical model
To create an mathematical model, for comparison to experimental results, the probability of a T
cell encountering a DC must be calculated. We assume T cells encounter DCs at a constant rate,
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α, given by the inverse of the mean first passage time (3.5.37), which is approximately α ≈ 3Db
R3
,
where D is the diffusivity of the T cells, b is the effective radius of the DCs, and R is the radius of
the LN. The number of T cells that have not encountered a DC will decrease exponentially with
time, giving an exponentially decreasing function for the probability of a T cell not encountering
a DC. The probability that one T cell, chosen at random, does not encounter a DC, before time t,
is given by
P(A T cell does not encounter a DC before t) = e−αNt, (6.3.1)
where t is the imaging time and N is the number of DCs. The probability that one T cell chosen
at random, does encounter a DC, is the complement of (6.3.1), given by
P(recruitment) = 1− e−αNt. (6.3.2)
This is a probability per T cell and is independent of the number of T cells.
The probability that at least one of M T cells encounters a DC, in the imaging period, can
be computed by calculating the probability that no T cells encounter an DC and taking the
complement of this probability, as was done to calculate (6.3.2). This gives
P(At least one T cell encounter an DC before t) = 1− e−αNMt, (6.3.3)
where N , α and t are defined as previously, and M is the number of T cells. This probability
depends on the number of T cells present.
Increasing the diffusivity of the T cells, or the the size of the DCs, will increase the encounter rate
in a linear manner, but increasing the radius of the LN will decrease the encounter rate in a cubed
way. Therefore, changing the size of the LN will have a much greater effect on the probabilities
stated in (6.3.2) and (6.3.3), than changing the diffusivity of the T cells or the effective radius of
the DCs.
6.4 Computational model
Using a variant of the spatial model described in Section 2.2.3, simulations of cells moving in a
LN, until they encounter a DC, can be carried out. Figure 6.5 shows the simulation setup. Figure
6.5(a), is a screenshot of a simulation of a crowded environment, with numerous DCs and T cells,
in the LN. Figure 6.5(b) shows the tracks of T cells moving by Brownian motion, in an attempt to
encounter a DC.
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(a) Model set up. (b) Movement of T cells.
Figure 6.5: Screenshots of spatial model simulations. (a) shows a crowded environment, with
randomly placed DCs (green) and T cells (blue). (b) shows tracks of T cells (blue), moving
by Brownian motion, in an attempt to encounter DCs (green). The DCs and T cells are placed
following a uniform random distribution, but are replaced if they occupy a volume that has already
been occupied by a DC.
6.4.1 Over-crowding effect
The target global mean first passage time (TGMFPT) (3.5.37) calculated for one DC uniform
randomly placed in a LN, assumes that the remaining volume of the LN is unoccupied. This is
the case when there is just one DC, but not when there are multiple DCs. For small numbers of
DCs this does not pose a big problem, as the DCs are a lot smaller than the LN, so the space
occupied by the DCs is negligible. However, when there are thousands of DCs in the LN, the
space they occupy becomes significant, leaving less free space for the T cells to move in, which
causes the TGMFPT equation to break down. The equation derived in Section 3.7.2 can be used
for multiple targets. However, this equation assumes the DCs can overlap, which is not the
case in these simulations. The equation can be used as an approximation, and will be a better
approximation than assuming the DCs are independent, meaning they have no influence on each
other, but the accuracy will decrease as the number of targets increases, due to the DCs having
a higher probability of occupying the same volume, and the amount of free volume for the T
cells to move in decreasing. A simple compensation can be implemented in an attempt to deal
with the reduced amount of free space for the T cells to move within. This is done by using the
Chapter 6. How many dendritic cells are required to initiate a T cell response? 115
effective free volume, being the free space in the LN, rather than the actual volume of the LN.
This is achieved by replacing the R3 term by R3 −Nb3, where N is the number of DCs. Figure
6.6 shows the effect on the TGMFPT equation, by comparing the equation with the effective free
volume adjustment, against the equation without the adjustment.
Figure 6.6: Effect crowding of DCs has on the TGMFPT equation.
6.4.2 Correction of overestimation
In the numerical simulations, used to calculate activation probabilities, an over estimation to the
analytical prediction was found. This occurs because, when placing the T cells, if they are placed
within the zone of attraction of a DC, the position is rejected, and a new position chosen. This
results in the T cell not having a uniform random distribution across the lymph node, which the
equation for the TGMFPT is assuming. To resolve this problem, T cells were placed uniformly
randomly within the lymph node, and replaced if they occupy the effective volume of a DC.
Then the T cells were given a period of time (e.g: 20 minutes) to equilibrate, allowing their
distribution to become approximately uniform random. Any T cells encountering a DC in this
time were removed from the simulation. After the equilibration time, data was recorded assuming
the simulation started with the number of T cells present at the end of the equilibration time.
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6.4.3 Estimation of parameters
Analysis of data sets from imaging experiments carried out by the Bousso laboratory were
performed, as in Chapter 5, to determine the diffusivity of the T cells. Figure 6.7 shows
displacement squared plots of the data, with fitted lines to calculate the diffusivity.
(a) Data set one. (b) Data set two.
Figure 6.7: Analysis of displacement squared. Diffusivities calculated to be (a) 10.26 ±
0.73µm2min−1 and (b) 5.21± 0.16µm2min−1
The data was not as extensive as the data analysed in Chapter 5, resulting in a large amount of
variability in the results. From the analysis, diffusivities of 10.26 ± 0.73µm2min−1 and 5.21 ±
0.16µm2min−1 were found. During the analysis, the data used to produce Figure 6.7(a), was
found to be more reliable. Analysis of the cell tracks for the data used to generate 6.7(b) revealed
all the cells to be remaining in the same z plain throughout the imaging period. For this reason this
data set was judge to not be reliable as this should not be happening. Therefore, a diffusivity of
10µm2min−1 will be used in this chapter. The experiments were performed in a popliteal LN, the
radius of which, was measured to be approximately 400µm, although there is uncertainty in this
parameter, with some literature claiming the popliteal LN is as large as 700µm in radius [164].
The size of the DCs is a lot more uncertain as, due to their dendrites being able to reach out and
contract, their size is constantly changing [17]. T cells are known to have a fairly constant radius
of 3.5µm [1]. After consultation with the Bousso laboratory, a radius of 8µm for the DCs was
agreed upon. This results in an effective radius for the DCs of 11.5µm, and is the value used for
b. The radius of the LN was chosen to be within the range stated above, with a value of 500µm
being used.
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6.4.4 Comparison to experimental results
Experiments carried out by the Bousso laboratory found that in 5-10 minutes, 50% of T cells
had formed a stable contact, increasing to 88% by 30 minutes. Using (6.3.2) with parameters
R = 500µm, b = 11.5µm, D = 10µm2min−1, and N = 2× 105, the probability of recruitment
is found to be 50.0% in 10 minutes, increasing to 87.4% in 30 minutes, which is a very good fit
to the experimental data. The parameters R, b, and D, were chosen within realistic ranges. These
parameters are used to calculate the parameter α.
Figure 6.8: Recruitment probability for 2 × 105 DCs. Equation (6.3.2), is shown by solid lines,
numerical results, with standard error bars, are shown by crosses. Parameters used R = 500µm
and b = 11.5µm.
Figure 6.8 shows a comparison of (6.3.2) to numerical simulations, for diffusivities of
10µm2min−1 and 50µm2min−1. To simulate the numerical results shown in Figure 6.8, 2× 105
DCs were placed in the LN. This proved not to be possible when the DC’s effective volumes are
not allowed to overlap, as placing them uniformly randomly, within the free volume of the LN,
results in a large amount of wasted space. To overcome this problem, the DCs were placed with
a minimum separation between their centres of 2b1, where b1 is the actual radius of a DC. This
results in DC volumes not being able to overlap, but their effective volumes being able to overlap,
as the effective volume takes into account the size of the T cells. This setup is shown in Figure 6.9.
The analytical equation used is (6.3.2), with an effective free volume used as described in section
6.4.1. The numerical results fit surprisingly well to the theoretical equation.
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2b1
b1 + a
R
Figure 6.9: Diagram showing the setup of the computational model. Green circles represent DCs,
with their effective volume shown by a dashed line. The centres of DCs are separated by twice the
DCs actual radius, 2b1, and a is the radius of a T cell, incorporated into the DC’s effective radius.
6.4.5 Extrapolation of experimental results
Encouraged by the good fit between the model and the activation probabilities obtain from
the experimental data, the model was used to calculate recruitment probabilities for lower DC
numbers, and longer times, which can not be investigated experimentally. When using 2 × 105
DCs, in the biological experiments and mathematical model, the recruitment probability almost
reaches 100% in about 30 minutes. These large numbers of DCs are required to carry out biological
experiments, but such large numbers are not necessarily required to invoke an immune response.
Using the biological data, the model parameters could be calibrated, then, using these parameters,
other scenarios can be simulated. The recruitment probability can be calculated for varying
numbers of DCs, after six, twelve and twenty four hours. Using (6.3.2) and numerical simulations,
as shown in Figure 6.10. Figure 6.10 shows in twenty four hours, about one thousand DCs are
required to achieve approximately 100% recruitment probability for a T cell. Twenty four hours
is used, as this is the time an immune response takes to be initiated.
In theory, only one T cell needs to be activated for an immune response to occur, as once activated
the T cell will undergo clonal expansion. Using (6.3.3), the probability of at least one T cell
becoming activated can be calculated, for smaller numbers of T cells, and DCs, than can be
achieved experimentally.
Figure 6.11 shows the probability of at least one T cell becoming activated in twenty four hours,
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Figure 6.10: Recruitment probability per T cell. Equation (6.3.2) is shown by solid lines,
and numerical results, simulated using spatial simulations, by crosses. R = 500µm, D =
10µm2min−1 and b = 11.5µm.
Figure 6.11: Probability of at least one T cell encountering a DC, in twenty four hours. Equation
(6.3.3) is shown by solid lines, and numerical results, simulated using spatial simulations, by dots.
R = 500µm, D = 10µm2min−1 and b = 11.5µm.
compared to numerical simulations, for varying DC numbers, and T cell initial numbers, of
one, ten, and one hundred. These initial values of T cells, correspond to precursor frequencies
of 10−6–10−4. The precursor frequency expresses the fraction of T cells that are specific to a
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particular antigen. A mouse popliteal LN contains approximately 106 T cells. The figure shows
that approximately ten DCs are required to achieve a probability of approximately 100%, that at
least one T cell encounters a DC in twenty four hours, with one hundred searching T cells. This
number increases to approximately one hundred DCs, for ten T cells, and to approximately one
thousand DCs, for just one T cell.
6.4.6 Minimum number of DCs required to initiate an T cell response
Using (6.3.3), the number of DCs required to activate at least one T cell can be determined. Let
us assume a T cell response is initiated if the recruitment probability, in a given time period, is
greater than 50%. The number of DCs required to achieve a 50% recruitment probability, in time
T can be obtained by rearranging (6.3.3), with the recruitment probability set to 12 :
N∗ =
log 2
αNT
. (6.4.4)
Equation (6.4.4) can be used to calculate the minimum number of DCs required to initiate a T
cell response. Typical precursor frequencies of T cells are 10−6–10−5, equate to 1 – 10 T cells.
These values give a minimum number of DCs required to be 174 and 17 respectively, in twenty
four hours. These numbers increase to 698 and 70 respectively in a six hour period. These results
are illustrated in Figure 6.12.
Figure 6.12: Minimum number of DCs required to achieve a 50% probability of at least one T cell
encountering a DC.
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In Figure 6.12, the minimum number of DCs was calculated to achieve a 50% activation
probability. A more general version of (6.4.4) can be derived by including the term p, the
probability of encountering a DC, giving
N∗p =
log
(
1
1−p
)
αNT
. (6.4.5)
Using this equation, the minimum number of DCs required to induce a T cell response can be
calculated as a fraction of the recruitment probability required. For a T cell precursor frequency of
10−5 (10 T cells), the minimum number of DCs required for the probabilities of encounter to be
0.25, 0.5, 0.75 and 0.95, in twenty four hours, are 7, 17, 35, and 75 respectively. This is illustrated
in Figure 6.13
Figure 6.13: Minimum number of DCs required to achieve a probability p, of at least one T cell
encountering a DC.
6.5 Summary
In this chapter, it is found, that a minimum of 174 DCs are required to achieve a probability greater
than 50%, of initiating and immune response, within twenty four hours, and a precursor frequency
of 10−6 T cells. This minimum drops to 17, for a precursor frequency of 10−5 T cells. Values
of one and ten T cells are used, for precursor frequencies of 10−6 and 10−5, as the estimated
number of T cells in a mouse popliteal LN is 106. The dependence on the number of T cells can
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be removed from (6.4.4), by letting ρ equal the density of T cells in the LN, thus ρφ = N/V ,
where V = 43piR
3, and the fraction of antigen specific T cells, or precursor frequency, equals φ.
Doing this, gives the equation
N∗ =
log 2
4pi
1
ρDbT
1
φ
, (6.5.6)
where α ≈ 3Db
R3
. This shows that N∗ is inversely proportional to the precursor frequency. In
humans, naive antigen specific T cells, are also presented at precursor frequencies of 10−6–10−5.
Therefore, the same minimum number of DCs also applies to humans. This result also means
that the number of DCs required to initiate a T cell response depends on the precursor frequency,
but not the volume of the LN. Therefore, it does not matter if the DCs specific to a particular
antigen (A∗) are all in one LN or divided between several LN as long as the precursor frequency
is the same in all LNs. The human body can only accommodate a limited number of T cells.
Therefore, to have a vast coverage by as many antigen specific T cells as possible, only a few T
cells specific to any given antigen can be present [53]. The results in this chapter suggest that
typical precursor frequencies of 10−6–10−5, allow the diversity of T cells to be maximised, but
still allows efficient T cell recruitment by low numbers of DCs. If numbers of DCs fall below this
threshold, stimulation would most likely not take place, due to lack of encounters.
This chapter considers an estimate of the minimum required of DCs needed to initiate a T cell
response, but higher numbers of DCs could further enhance the magnitude of the response, as
well as allowing successive encounter between T cells and DCs [40, 42]. On the other hand, if
chemokines are playing a role, to attract T cells to DCs, fewer DCs will be required to initiate a
response [50, 111]. DC vaccines can be used to elicit an immune response against cancer cells.
This work suggests the efficiency of delivery of DCs may not be of critical importance, as T cell
recruitment by DCs is already an efficient process. Optimising the quality and duration of the
stimulation may be of greater importance to DC vaccines [53].
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Chapter 7
Cross-regulation model
7.1 Introduction
Millions of different clonotypes of T cells are created by a stochastic recombination process during
development [106, 137, 200, 211]. Inevitably some of these clonotypes are self-reactive to the
body’s own antigens. To alleviate this problem, T cells undergo positive and negative selection,
to select out clonotypes that react to the body’s own antigens. Even with this process some self-
reactive clonotypes slip through the net, which is where regulatory T cells (Tregs) play a role.
Although it may have been agreed that Tregs are key players in avoiding autoimmunity, and are
currently the topic of intensive experimental research [44, 179, 199], the mechanism of action of
Tregs is still not fully known.
Several mechanisms for Treg mediated suppression have been suggested [195, 204]. It has
been proposed that suppression by Tregs requires direct cell-cell contact, either between Tregs
and effector T cells [203], or antigen-presenting-cells (APCs), Tregs, and effector T cells
[183, 217, 223]. Experiments in vitro have shown Tregs are unable to suppress the proliferation
of T cells when separated by a semi-permeable membrane [217, 223], and culture supernatant
of antigen-stimulated Tregs is unable to suppress T cell proliferation, indicating direct cell-cell
contact is required. Following direct cell-cell contact, Tregs may kill their target cells by a
granzyme-dependant, or perforin-dependent mechanism, or give a negative signal to the target
T cells, inhibiting their proliferation [38, 48, 89]. How exactly cell-cell suppression occurs is still
unclear. Hypotheses in the literature range from simple competition between Tregs and effector T
cells for conjugation to an APC [136, 229], to more complex interactions in which an APC relays
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a signal from a Treg to an effector cell [52, 215, 216].
Tregs do not produce the cytokine IL-2, but do express the high affinity CD25/IL-2 receptor
(IL-2R), making Tregs efficient absorbers of IL-2, thereby hindering the activation of T cells
that may rely on IL-2 to proliferate [176]. This makes Tregs highly dependent on exogenous
IL-2 for their survival in the periphery [109, 146, 174, 236, 240]. A lack of IL-2 leads to fatal
autoimmune/inflammatory disease, which is mainly due to lack of Treg survival [140]. Treg
suppression via absorption of IL-2 has been shown to be a strong mechanism in vitro [68, 203].
In vivo experiments have shown strong autoimmune responses in mice deficient in IL-2, or the
IL-2 receptor, suggesting IL-2 is essential for Treg proliferation, but is not essential for effector T
cell proliferation [198]. Experiments have shown in vitro and in vivo competition for IL-2 does
occur [20, 68, 127].
The theory of IL-2 suppression appears to disagree with experiments in which a semi-permeable
membrane, separating Tregs from their target cells, prevents suppression [38,48,89], as cytokines
diffuse easily in extracellular medium, and can diffuse hundreds of microns in the timescale of
tens of minutes. However, measurements of cytokine concentrations in cell culture supernatants
are often very low, and very low concentrations are unlikely to trigger cellular responses [33].
Therefore, concentrations of cytokines large enough may only be achieved in micro-environments
surrounding secreting cells. Also, cytokines are taken up locally by other cells, which further
restricts their spatial range [198].
The APCs that provide the proliferation signal to effector T cells are a potential target of Tregs.
Activated Tregs may down-regulate the expression of CD80 and CD86 [197], which provide co-
stimulatory signals, on APCs, as well as causing APCs to express the enzyme indoleamine 2,3-
dioxygenase [95, 172], which breaks down the amino acid, tryptophan to kynurenine, which is
toxic to T cells close to the APC.
The models in this chapter are based on Kalet Le´on and Jorge Carnerio’s cross-regulation model
[49, 133] of interactions between effector (E) cells, regulatory (R) cells, and APCs, and has
received experimental support [218, 219, 239]. Le´on et al.’s model is a deterministic ODE model.
Modelling biological systems using a deterministic approach can lead to unrealistic results, due
to the inherent stochastic nature of biological systems. For example, a steady state with only
a handful of cells could be achieved in a deterministic model, which in reality is likely to go
extinct due to random fluctuations. A more realistic model of a biological system is a stochastic
model, taking into account random fluctuations in the population sizes. A stochastic system can
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be implemented by listing the reactions that occur in a model, and using a Gillespie algorithm
(Section 2.4) to simulate these reactions.
CD4+ T cells are divided into multiple distinct lineages. However, for this chapter only two linages
are considered: Tregs and conventional T helper cells, also known as effector T cells. Effector T
cells control the adaptive immune response by activating, in an antigen specific fashion, other
effector cells, such as CD8+ cytotoxic T cells, B cells and macrophages. Tregs are T cells in
charge of suppressing potentially deleterious activity of conventional T helper cells [64].
As with Le´on et al.’s model, the models in this chapter only consider antigen specific suppression,
and all cells in the models are assumed to be of the same clonotype. The main model examined
assumes a three-way interaction between an E cell, R cell, and APC, is required for suppression
to occur. However, this does not restrict the model to one of just cell-cell contacts, it is also a
reasonable approximation for a model in which IL-2 is secreted by E cells, upon binding with an
APC, and used to proliferate by R cells if they are in close proximity when the E cell is secreting
IL-2. Both cell types would need to be close to the APC, at the same time, for the R cell to absorb
the IL-2 being secreted by the E cell, allowing the R cell to proliferate and preventing the E cell
from proliferating due to lack of IL-2.
In this chapter, three models are considered: Model 1- competition only, Model 2- R cell
suppression only, and Model 3- R cell suppression and E cell promotion. These are the same three
model scenarios that are considered by Le´on et al. For all models ODEs are determined and solved
numerically, with comparison to the stochastic system, solved using a Gillespie algorithm. For the
third model, which proves to be the most interesting, the system is non-dimensionalised, reducing
the number of parameters to two. The effects of varying these parameters are investigated, and
two differing sets of parameter values are used for the analysis, allowing comparison of the system
in two distinct parameter regimes. Steady states are obtained for the chosen parameter sets, and
their stability investigated. The effect of the initial values of cells is investigated by plotting phase
planes, to view the trajectories of the system, and considering the steady states achieved for various
sets of initial cell numbers, allowing a bifurcation in the system to be observed. The stochastic
effects of varying the initial ratio of the two cell types is investigated, and found to be significant
for certain parameter regimes.
The aim of this chapter is to develop a mathematical model that can adequately describe the
activation process of R cells and suppression of E cells by R cells. A stochastic framework is
used to incorporate the inherent stochasticity found in biological system for small cell numbers,
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which can be the case in autoimmunity. It is also hoped that a stochastic model will be able to
reveal interesting aspects of the system that are not observed in an analytical approach.
7.1.1 Model dynamics
In all three models, cells proliferate depending on which other cells have contacted a given APC in
the same time period. The rules determining cell proliferation differ for the three model scenarios
investigated. Each APC is given two binding sites for T cells to bind to, for simplicity. Both E and
R cells bind with APCs at a rate of k+, unbind at a rate of k−, and die with rate µ. In all models,
only free cells are able to die, while cells bound to an APC cannot die for the duration of the APC
contact. The on rate, k+, is given by the inverse of the first passage time for a T cell to encounter
an APC (3.5.37), and the off rate, k−, is given by the inverse of the mean binding time of a T cell
and APC. In the models, T cell proliferation occurs upon unbinding of cells.
E is used to represents effector cells and R to represent regulatory cells. The state of an APC is
expressed as Aij , where i is the number of E cells bound, and j is the number of R cells bound
to that APC. Each APC is assumed to have two binding sites. There are six basic populations
of APCs: A00, A10, A01, A11, A20 and A02. In model 2, there are extra APC populations in
which E cells are suppressed, and in model 3 there are APC populations in which R cells have
been promoted. When an E or R cell unbinds from A11, it leaves the remaining cell suppressed
(if it is an E cell, models 2 and 3) or promoted (if it is an R cell, model 3). To distinguish these
populations from A10 and A01, APCs that have an E cell bound, which has been suppressed and
will not proliferate on unbinding, are written as A∗10, and APCs that have an R cell bound, which
has been promoted and will proliferate upon unbinding, are written as A#01. The case in which
an E or an R cell binds to one of these suppressed/promoted populations of APCs, must now be
considered. If an E cell binds to A∗10, this is represented as A∗20, indicating one of the E cells has
been suppressed and the other has not. The same concept applies to an R cell binding to give
A#02. If an E cell binds to A
#
01 it becomes A11, and if an R cell binds to A
∗
10 it becomes A11, as
it does not matter if a cell has previously been suppressed or promoted when the A11 complex is
formed. For the purpose of writing ODEs, the APC populations can be written in the form nk.
These populations are expressed in Table 7.1, along with the parameters used in this chapter.
In the systems investigated, the steady states obtained can be split into three categories: extinction,
in which no cells remain, autoimmunity, in which only E cells remain, and tolerance, in which both
E and R cells remain.
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Aij nk Number of cells bound
A00 n00 No cells
A10 n10 1 E cell
A01 n01 1 R cell
A20 n20 2 E cells
A02 n02 2 R cells
A11 n11 1 E cell, 1 R cell
A∗10 n∗10 1 suppressed E cell
A#01 n
#
01 1 promoted R cell
A∗20 n∗20 2 E cells, 1 suppressed
A#02 n
#
02 2 R cells, 1 promoted
Rate Equals
k+ Binding rate
k− Unbinding rate
µ Death rate
NA Total number of APCs
t Time
κ+ k+NA/µ (dimensionless binding rate)
κ− k−/µ (dimensionless unbinding rate)
τ tµ (dimensionless time)
Table 7.1: Tables showing notation and rates used in this chapter.
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7.2 Model 1: competition only
Firstly, we consider a model in which cells compete for the binding sites of the APCs, with no
suppression or promotion. In this model both E cells and R cells proliferate upon unbinding from
an APC, regardless of which other cells are bound to the given APC.
7.2.1 Reactions
The interactions between cells, in Model 1, can be represented as a system of reactions as follows
E
µ−→ ∅
R
µ−→ ∅
A00 + E
k+−→ A10
A00 +R
k+−→ A01
A10 + E
k+−→ A20
A10 +R
k+−→ A11
A01 + E
k+−→ A11
A01 +R
k+−→ A02
A10
k−−→ A00 + 2E
A01
k−−→ A00 + 2R
A20
2k−−→ A10 + 2E
A02
2k−−→ A01 + 2R
A11
k−−→ A01 + 2E
A11
k−−→ A10 + 2R
7.2.2 ODEs
These reactions can be written as the following system of ODEs:
dnE
dt
= 2k−(n10 + 2n20 + n11)− nEµ+ k+nE(n20 + n02 + n11 −NA), (7.2.1a)
dnR
dt
= 2k−(n01 + 2n02 + n11)− nRµ+ k+nR(n20 + n02 + n11 −NA), (7.2.1b)
dn10
dt
= k−(−n10 + 2n20 + n11)− k+(n10(2nE + nR) + nE(n01 + n20 + n02 + n11 −NA)),
(7.2.1c)
dn01
dt
= k−(−n01 + 2n02 + n11)− k+(n01(nE + 2nR) + nR(n10 + n20 + n02 + n11 −NA)),
(7.2.1d)
dn20
dt
= −2k−n20 + k+n10nE , (7.2.1e)
dn02
dt
= −2k−n02 + k+n01nR, (7.2.1f)
dn11
dt
= −2k−n11 + k+(n10nR + n01nE). (7.2.1g)
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(a) Equal proportions of E and R cells (b) Three times as many E cells as R cells.
Figure 7.1: Plots showing the solution of ODEs and Gillespie algorithm for Model 1. Parameters
used: k+ = 1.2 × 10−5minutes−1, k− = 1/60minutes−1, µ = 10−5minutes−1, and NA = 25.
Gillespie results averaged from 100 realisations in both plots.
This model is symmetric, as the populations of E and R cells can be interchanged without effecting
the dynamics of the model, therefore neither population has an advantage over the other if the
system starts with equal numbers of E and R cells. Figure 7.1 shows for (a) equal initial numbers
of E and R cells, the steady state for both cell types is equal, and for (b) unequal initial numbers of
E and R cells, the steady state achieved contains cell numbers in equal proportions to the starting
proportions of each cell type. In both Gillespie simulations, an average is taken over multiple
realisations, and compared to the ODEs. In Figure 7.1(a), the Gillespie results do not agree exactly
with the ODEs, this is due to not enough realisations have been carried out. This has been done
purposely so the Gillespie and ODEs solutions can be distinguished.
The steady state value of E and R cells can be calculated by first determining the carrying capacity
of the system. The carrying capacity is the total number of E and R cells the system can support
due to the limited number of APCs and binding sites. The carrying capacity can be found by
assuming either the E or R cells go extinct, and solving the system with the other cell type. This
gives
Carrying capacity =
k−
(
k+NA − µ+
√
k2+N
2
A − µ2
)
k+µ
. (7.2.2)
The steady state value of E and R cells is given by the initial fraction of each of the cell types
multiplied by the carrying capacity (7.2.2) of the system. This occurs because the system is
symmetric, so neither population has an advantage over the other.
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7.3 Model 2: R suppression only
We now consider a model in which R cells are able to suppress E cells, but do not require the E
cells to be able to proliferate. In this model, if an R cell binds to an APC, it receives a signal to
proliferate, regardless of what other cells are bound to that APC. If an E cell binds to an APC, and
if no R cells are bound to the same APC, it will proliferate. However, if an R cell is bound to the
APC at any time during the E cell’s binding, the E cell is suppressed and will not proliferate after
unbinding.
7.3.1 Reactions
The interactions in this model can be represented by the following system of reactions
E
µ−→ ∅
R
µ−→ ∅
A00 + E
k+−→ A10
A00 +R
k+−→ A01
A10 + E
k+−→ A20
A10 +R
k+−→ A11
A01 + E
k+−→ A11
A01 +R
k+−→ A02
A10
k−−→ A00 + 2E
A01
k−−→ A00 + 2R
A20
2k−−→ A10 + 2E
A02
2k−−→ A01 + 2R
A11
k−−→ A01 + E
A11
k−−→ A∗10 + 2R
A∗10
k−−→ A00 + E
A∗10 + E
k+−→ A∗20
A∗10 +R
k+−→ A11
A∗20
k−−→ A∗10 + 2E
A∗20
k−−→ A10 + E
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7.3.2 ODEs
These reactions can be written as the following system of ODEs:
dnE
dt
= k−(2n10 + n∗10 + 4n20 + 3n
∗
20 + n11)− nEµ+ k+nE(n20 + n∗20 + n02 + n11 −NA),
(7.3.3a)
dnR
dt
= 2k−(n01 + 2n02 + n11)− nRµ+ k+nR(n20 + n∗20 + n02 + n11 −NA), (7.3.3b)
dn10
dt
= k−(−n10 + 2n20 + n∗20)
− k+(n10(2nE + nR) + nE(n∗10 + n01 + n20 + n∗20 + n02 + n11 −NA)), (7.3.3c)
dn∗10
dt
= k−(−n∗10 + n∗20 + n11)− k+n∗10(nE + nR), (7.3.3d)
dn01
dt
= k−(−n01 + 2n02 + n11)
− k+(n01(nE + 2nR) + nR(n10 + n∗10 + n20 + n∗20 + n02 + n11 −NA)), (7.3.3e)
dn20
dt
= −2k−n20 + k+n10nE , (7.3.3f)
dn∗20
dt
= −2k−n∗20 + k+n∗10nE , (7.3.3g)
dn02
dt
= −2k−n02 + k+n01nR, (7.3.3h)
dn11
dt
= −2k−n11 + k+((n10 + n∗10)nR + n01nE). (7.3.3i)
Solving these ODEs using an Euler method, as well as the Gillespie algorithm, for this system
gives the plots shown in Figure 7.2. Figure 7.2 shows the R cells drive the E cells to extinction,
which is expected, as there is no restriction on the number of R cells by suppression from the
E cells. The autoimmune steady state, with only E cells, can be achieved by setting the initial
number of E cells to be much greater than the number of R cells.
7.4 Model 3: R suppression E promotion
Finally, we consider a model in which R cells are able to suppress the proliferation of E cells, and
R cells require promotion by E cells to undergo proliferation. In this model, upon an E or an R
cell binding to an APC, they proliferate following the rules outlined below, and in Figure 7.3.
For E cells:
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Figure 7.2: Dynamics of Model 2 with k+ = 1.2 × 10−5minutes−1, k− = 1/60minutes−1,
µ = 10−5minutes−1, and NA = 25, and initial values of E and R cells set to 100. Purple dotted
line shows the steady state of the system. Gillespie results averaged from 100 realisations.
• The E cell proliferates if and only if no R cells have bound to APC in the time the E cell has
been bound.
For R cells:
• The R cell proliferates if and only if an E cell has bound to the APC at any point during the
time the R cell has been bound. We call this promotion of R cells by E cells.
In this model, there are 10 populations of APCs, plus the free E cells and free R cells. The total
number of APCs is constant, therefore the A00 population can be constrained, giving a total of
11 populations, 24 reactions and 3 rates. A system of reactions for this model can be written,
following the rules of Figure 7.3, with two binding sites per APC.
7.4.1 Reactions
The interactions in Model 3 can be expressed by the following set of reactions.
Death: In principle, we can have separate death terms for E and R cells, but for simplicity both
death rates are set to be equal. We represent these as
E
µ−→ ∅ R µ−→ ∅ (7.4.4)
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Key
Dead cell
Effector cell
Regulatory cell
APC
Figure 7.3: Diagram of interactions that can occur in Model 3, blue circles represent E cells, red
circles represent R cells, dashed circles represent dead cells, green circles represent APCs, line in
shape of ‘T’ indicates suppression of the cell contacting the flat end, and curved arrow indicates
promotion.
Binding to an empty APC: An E, or an R cell, can bind to an empty APC with rate k+. Although
there are two binding sites available, the rate of a T cell encountering an APC is independent of
the number of free binding sites.
A00 + E
k+−→ A10 A00 +R k+−→ A01 (7.4.5)
Binding to A10:
A10 + E
k+−→ A20 A10 +R k+−→ A11 (7.4.6)
Binding to A01:
A01 + E
k+−→ A11 A01 +R k+−→ A02 (7.4.7)
Unbinding of E cells: Unbinding and proliferation of E cell to produce two E cells, as suppression
has not occurred. Rates are multiplied by the number of cells that can potentially unbind.
A10
k−−→ A00 + 2E A20 2k−−→ A10 + 2E (7.4.8)
Unbinding of R cells: Unbinding of an R cell, without proliferating, to produce one R cell, as
promotion has not occurred. Rates are multiplied by the number of cells that can potentially
unbind.
A01
k−−→ A00 +R A02 2k−−→ A01 +R (7.4.9)
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Unbinding from A11: The # indicates the remaining R cell is promoted, and the ∗ the remaining
E cell is suppressed.
A11
k−−→ A#01 + E A11
k−−→ A∗10 + 2R (7.4.10)
Unbinding of suppressed/promoted cells:
A∗10
k−−→ A00 + E A#01
k−−→ A00 + 2R (7.4.11)
Binding to A∗10: It must be noted that the complex resulting from the first reaction has an E cell
that has been suppressed, represented by the ∗. For the A11 case, the E cell is always suppressed,
therefore the ∗ is not required.
A∗10 + E
k+−→ A∗20 A∗10 +R
k+−→ A11 (7.4.12)
Binding to A#01: Again, it must be noted that one of the resulting complexes has an R cell that has
been promoted, which is represented by the #.
A#01 + E
k+−→ A11 A#01 +R
k+−→ A#02 (7.4.13)
Unbinding from A∗20: Either the suppressed, or unsuppressed E cell can unbind.
A∗20
k−−→ A10 + E A∗20
k−−→ A∗10 + 2E (7.4.14)
Unbinding from A#02: Either the promoted, or un-promoted R cell can unbind.
A#02
k−−→ A01 + 2R A#02
k−−→ A#01 +R (7.4.15)
These reactions can be represented as a diagram, shown in Figure 7.4.
7.4.2 Effector cell dynamics
Let us first consider the simple case when there are no R cells, but only E cells and APCs. The
variables of the model are the number of free E cells and the numbers ofA00,A10 andA20, denoted
as nE, n00, n10 and n20, respectively. In this case, we have the following system of ODEs:
dnE
dt
= k−(2n10 + 4n20)− k+(n00 + n10)nE − µnE, (7.4.16a)
dn00
dt
= k−n10 − k+nEn00, (7.4.16b)
dn10
dt
= 2k−n20 + k+n00nE − k−n10 − k+nEn10, (7.4.16c)
dn20
dt
= k+nEn10 − 2k−n20. (7.4.16d)
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A00
A20
A10
A01
A02
A11
A∗10
A#01
A∗20
A#02
Key
* Suppressed E cell
# Promoted R cell
E cell, bidirectional
E cell, uni-directional
R cell, bidirectional
R cell, uni-directional
Figure 7.4: Diagram showing the reactions that occur in Model 3. Uni-directional refers to a
reaction that occurs in only one direction, and bidirectional to a reaction that is reversible.
The total number of APCs is constant, therefore one of the populations can be eliminated as
follows:
NA = n00 + n10 + n20.
Writing n00 = NA−n10−n20, the equation for n00 (7.4.16a) can be eliminated, leaving a system
of three ODEs:
dnE
dt
= k−(2n10 + 4n20) + k+(n20 −NA)nE − µnE, (7.4.17a)
dn10
dt
= k−(−n10 + 2n20)− k+(2n10 + n20 −NA)nE, (7.4.17b)
dn20
dt
= −2k−n20 + k+n10nE. (7.4.17c)
This system can be non-dimensionalised by setting, k+ =
κ+µ
NA
, k− = κ−µ, t = τµ and ni =
NAxi. By non-dimensionalising, the number of parameters in the system is reduced. This yields
the following dimensionless equations:
dxE
dτ
= κ−(2x10 + 4x20) + κ+(x20 − 1)xE − xE , (7.4.18a)
dx10
dτ
= κ−(−x10 + 2x20)− κ+(2x10 + x20 − 1)xE , (7.4.18b)
dx20
dτ
= −2κ−x20 + κ+x10xE , (7.4.18c)
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where x is used to represent the dimensionless variables. Non-dimensionalising reduces the
system to two parameters, κ+ and κ−. The real, non-negative, steady state solutions of (7.4.18)
are
{xE , x10, x20} = {0, 0, 0}, (7.4.19)
and
{xE , x10, x20} =
{
κ−
κ+
(
κ+ − 1 +
√
κ2+ − 1
)
,
1
κ+
(
−κ+ + 1 +
√
κ2+ − 1
)
, 1− 1
κ+
}
.
(7.4.20)
The stability of the steady states can be investigated by writing the ODE system (7.4.18) in matrix
form. The values of xE , x10 and x20 can then be set to the steady state value and eigenvalues of
the system found. If these eigenvalues are all negative, the system is stable. Analysing the stability
of these steady states reveals the zero steady state to have eigenvalues:
−2κ−,
−1
2
(
κ− + κ+ + 1 +
√
κ2− + κ−(6κ+ − 2) + (κ+ + 1)2
)
,
−1
2
(
κ− + κ+ + 1−
√
κ2− + κ−(6κ+ − 2) + (κ+ + 1)2
)
,
which are all negative. Therefore the steady state is stable when κ+ < 1. The eigenvalues of the
non-zero steady state are rather long, and are not expressed here, but are only real, negative and
therefore stable for κ+ > 1.
This simplified system of ODEs can be plotted, and are compared to stochastic simulations
generated using the Gillespie algorithm, shown in Figure 7.5
7.4.3 Regulatory cell dynamics
A non-zero steady state with no E cells and only R cells, is not possible, as the R cells rely upon
the E cells to proliferate. This can be shown by forming a system of ODEs with only R cells,
giving the following system of three ODEs:
dxR
dτ
= −xR + κ−(x01 + 2x02) + κ+xR(x02 − 1), (7.4.21a)
dx01
dτ
= κ−(−x01 + 2x02)− κ+xR(2x01 + x02 − 1), (7.4.21b)
dx02
dτ
= −2κ−x02 + κ+x01xR. (7.4.21c)
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Figure 7.5: Figure showing the ODEs (7.4.17), compared to a Gillespie simulation, for a system
with only E cells. κ+ = 3 and κ− = 500/3. Gillespie results averaged from 10 realisations.
Setting the three equations equal to zero, and solving for xR, x01 and x02, the only steady state
found is the zero state, therefore R cells cannot exist on their own. Analysing the stability of this
steady state, gives the eigenvalues:
−2κ−,
−1
2
(
κ− + κ+ + 1 +
√
(κ− + κ+ + 1)2 − 4κ−
)
,
−1
2
(
κ− + κ+ + 1−
√
(κ− + κ+ + 1)2 − 4κ−
)
,
which are all negative, and therefore the zero steady state is stable for all parameter values.
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7.4.4 ODEs with effector and regulatory cells
Dimensionless differential equations can be written for the full system, with both E and R cells, for
the mean number of cells in each populations, in which x represents the dimensionless variables:
dxE
dτ
= −xE + κ−(2x10 + x∗10 + 4x20 + 3x∗20 + x11)
+ κ+xE(x20 + x
∗
20 + x02 + x
#
02 + x11 − 1), (7.4.22a)
dxR
dτ
= −xR + κ−(x01 + 2x#01 + 2x02 + 3x#02 + 2x11)
+ κ+xR(x20 + x
∗
20 + x02 + x
#
02 + x11 − 1), (7.4.22b)
dx10
dτ
= κ−(−x10 + 2x20 + x∗20)
− κ+(x10(2xE + xR) + xE(x∗10 + x01 + x#01 + x20 + x∗20 + x02 + x#02 + x11 − 1)),
(7.4.22c)
dx∗10
dτ
= κ−(−x∗10 + x∗20 + x11)− κ+x∗10(xE + xR),
dx01
dτ
= κ−(−x01 + 2x02 + x#02) (7.4.22d)
− κ+(x01(xE + 2xR) + xR(x10 + x∗10 + x#01 + x20 + x∗20 + x02 + x#02 + x11 − 1)),
(7.4.22e)
dx#01
dτ
= κ−(−x#01 + x#02 + x11)− κ+x#01(xE + xR), (7.4.22f)
dx20
dτ
= −2κ−x20 + κ+x10xE , (7.4.22g)
dx∗20
dτ
= −2κ−x∗20 + κ+x∗10xE , (7.4.22h)
dx02
dτ
= −2κ−x02 + κ+x01xR, (7.4.22i)
dx#02
dτ
= −2κ−x#02 + κ+x#01xR, (7.4.22j)
dx11
dτ
= −2κ−x11 + κ+(x10 + x210)xR + κ+(x01x∗01)xE . (7.4.22k)
7.5 Analysis of Model 3
This system can be analysed using Mathematica, to find steady states. A solution cannot be found
for the general case, but steady states can be calculated for specific sets of parameter values.
To choose parameters to use in the model, the TGMFPT equation (3.5.37) was used, and a rate
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obtained from the inverse of the TGMFPT. Using realistic values for R, D and b, of 500µm,
40µm2min−1 and 11.5µm, gives a value for k+ of approximately 1.2× 10−5minutes−1. A value
for k− of 1/60minutes−1 was chosen, corresponding to a mean binding time of 60 minutes. A
death rate, µ, of 10−4minutes−1 was chosen, corresponding to a mean life span of 104 minutes,
which is approximately one week. These parameters give the dimensionless parameters κ− =
500/3, and κ+ = 0.12NA. We will investigate two values for the number of APCs, NA, of 25 and
100, corresponding to κ+ = 3 and κ+ = 12. For κ+ = 3 the following steady states are found:
• Extinction: E = R = 0.
• Autoimmunity: E = 6706, R = 0.
• Tolerant: E = 6060, R = 202 (unstable).
• Tolerant: E = 1064, R = 1106 (stable).
For κ+ = 12 the following steady states are found:
• Extinction: E = R = 0.
• Autoimmunity: E = 31887, R = 0.
• Tolerant: E = 31766, R = 40 (unstable).
• Tolerant: E = 398, R = 3008 (stable).
The steady state numbers stated are actual cell numbers, rather than the non-dimensionalised
values. Analysis of these steady states reveals for both values of κ+, the extinction steady state is
unstable, the autoimmune steady state is a stable node, and one of the tolerant steady states is a
stable spiral and the other is unstable, indicated in parentheses.
7.5.1 Carrying Capacity
To determine the total number of E and R cells that can be supported by the system the carrying
capacity can be calculated. The carrying capacity of the system can be calculated by setting
dxE
dt =
dx10
dt =
dx20
dt = 0 and xR = x01 = x02 = x11 = x
∗
10 = x
#
01 = x
∗
20 = x
#
02 = x11 = 0, as
the carrying capacity of the system is reached when there are no R cells, and the E cell numbers
are able to grow to the carrying capacity of the system. The only populations that will be non zero
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are xE , x10 and x20, and when the number of E cells reaches the carrying capacity, this will be a
steady state, implying the rate of change of these populations will be zero. Using these conditions
the carrying capacity of the system is found to be
xE =
κ−
κ+
(
κ+ − 1 +
√
κ2+ − 1
)
, (7.5.23)
for κ+ > 1.
7.5.2 Solution of ODEs and Gillespie algorithm
The ODEs can be solved numerically, using an Euler method. The system can also be solved using
the Gillespie algorithm, allowing stochastic effects to be studied.
Figure 7.6: Comparison of ODE model to Gillespie algorithm. Horizontal green dashed line
represents the stable tolerant state. Parameters used κ+ = 12 and κ− = 500/3. Initial cells
numbers, E = R = 100. Gillespie results averaged from 100 realisations.
Figure 7.6 shows for κ+ = 12 the ODEs, and the average of numerous Gillespie simulations give
the same results, and settle in the stable tolerant steady state. The results for the Gillespie model are
averaged over multiple realisations to form a smooth curve. In Figure 7.6, the Gillespie algorithm
agrees exactly with the ODEs for this value of κ+, indicating stochastic effects do not change the
steady state achieved in this case, and the ODEs can be used as a mean field approximation to the
stochastic system. In the case with κ+ = 3 stochastic effects have a greater contribution, resulting
in the Gillespie algorithm settling in different steady states for different realisations, due to the
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smaller number of APCs required to give κ+ = 3. Therefore, an average of multiple realisations
could not be compared with the ODEs. Figure 7.7(a) shows the ODEs tend to the unstable tolerant
(a) ODEs.
(b) Gillespie giving the autoimmune steady
state
(c) Gillespie giving the stable tolerant steady
state
Figure 7.7: Figures showing results of (a) the ODE model and (b),(c) two different realisations
of the Gillespie algorithm in which different steady states are reached. Horizontal lines represent
the steady states. Stable tolerant state: green dashed, unstable tolerant state: green dotted, stable
autoimmune state: purple dashed. Parameters used κ+ = 3 and κ− = 500/3. Initial cells
numbers, E = R = 100.
steady state, but then move away from this steady state and approach stable tolerant steady state.
Figures 7.7 (a) and (b) show two different realisations of the Gillespie algorithm for κ+ = 3, in
which different steady states are reached.
7.5.3 Effector and regulatory cell dynamics
Plotting the number of E cells against the number of R cells allows the dynamics of the system
to be explored. In the case with κ+ = 12, the dynamics are similar for both the ODEs and one
realisation of the Gillespie algorithm (Figure 7.8), showing stochastic effects are small for large
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κ+. Figure 7.8 shows the system is attracted towards the stable tolerant steady state.
Figure 7.8: Comparison of number of E cells and R cells for ODEs and Gillespie algorithm. Blue
line indicates the trajectory of the ODEs and the yellow line the trajectory of one realisation of
the Gillespie algorithm. Stable steady states are shown by dots and the unstable steady state by a
cross. Parameters used κ+ = 3 and κ− = 500/3. Initial cells numbers, E = R = 100.
For κ+ = 3, the steady state achieved depends upon stochastic fluctuations of the system, with
two steady states being observed. Figure 7.9 shows in all cases the system approaches the unstable
(a) ODEs. (b) Gillespie autoimmune steady
state.
(c) Gillespie tolerant steady state
Figure 7.9: Comparison of number of E cells and R cells for (a) the ODE model and (b),(c) two
different realisations of the Gillespie model in which different steady states are reached. Stable
steady states are shown by dots, and the unstable steady state by a cross. Parameters used κ+ = 3
and κ− = 500/3. Initial cells numbers, E = R = 100.
tolerant steady state, but then settles in either the stable tolerant or the autoimmune steady state.
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Figures 7.7 and 7.9 illustrate stochastic fluctuations affect the steady state reached, for small values
of κ+. ODEs can be used as a mean field approximation, and will be used in this chapter. However,
it must be remembered that stochastic fluctuations play a role, and the steady state achieved in
the mean field approximation will only occur in a proportion of the realisations of the stochastic
model.
7.5.4 Phase portrait
A phase portrait can be used to view the trajectories of the ODE solutions for various initial
conditions. Phase portraits were generated using the same code used to solve the ODEs, as used
to generate Figures 7.8 and 7.9(a), but for a range of sets of initial conditions. The ODEs were
solved for a set number of time steps, and the number of E cells versus R cells for each set of initial
conditions was plotted, allowing information about the speed at which the system approaches the
steady states, dependent on where in the phase space you are, to be visualised.
(a) κ+ = 3. (b) κ+ = 12.
Figure 7.10: Phase portraits of the ODE system. Cyan dots indicate different initial conditions of
the trajectories. Steady states are indicated by coloured dots/crosses.
Figure 7.10 shows the system is attracted towards the unstable tolerant steady state, in both cases,
and then moves, more slowly, towards either the autoimmune steady state or the stable tolerant
steady state.
The steady state various sets of initial conditions settle in can be examined in more detail. This is
achieved by calculating the steady state a set of initial conditions settle in, using an Euler method,
and plotting the initial condition as dot, with a colour to indicate the steady state it has settled in.
Chapter 7. Cross-regulation model 144
This is then done for multiple sets of initial conditions. Figure 7.11 shows this for (a) κ+ = 3 and
(b) κ+ = 12.
Figure 7.11(a) shows, no set of initial conditions examined settle in the unstable tolerant steady
state, and there is a bifurcation point at which the system switches from the autoimmune steady
state to the stable tolerant steady state.
Figure 7.11(b) shows, only sets of initial conditions with very low initial numbers of R cells settle
in the autoimmune steady state, all other sets of initial conditions examined settle in the stable
tolerant steady state, excluding those starting with zero E cells, which go extinct.
(a) κ+ = 3. (b) κ+ = 12.
Figure 7.11: Plots showing the steady states different sets of initial conditions settle in (dots).
Steady states are indicated by black crosses. Extinction: yellow, autoimmunity: purple, tolerance:
green.
7.5.5 Effect of κ+ and κ−
The importance of the various parameters regimes can be viewed by examining the steady states
obtained for the various regimes. By non-dimensionalising the system the number of parameters
has been reduced to two, κ+ and κ−. These parameters can be used to investigate the steady
states obtained for various set of parameters. Figure 7.12 was generated by solving the ODEs,
using Mathematica, for various pairs of parameters. The steady state achieved for a specific pair
of parameters is represented as a coloured dot, where the colour indicates the type of steady state,
being either extinct, autoimmune, or stable tolerant. In the regimes where the autoimmune steady
state is observed, the extinction state is also observed, and likewise, in the regimes where the
tolerant steady state occurs, the other two steady states also occur. Therefore, in Figure 7.12
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a yellow dot indicates the extinction steady state only, a purple dot indicates the extinction and
autoimmune steady states, and a green dot indicates all three steady states are observed.
Figure 7.12: Plot showing the steady states obtained for varying values of κ+ and κ−. Yellow dots
indicate the extinction steady state, purple indicate the extinction and autoimmune steady state,
and green indicates the extinction, autoimmune and stable tolerant steady states.
Figure 7.12 shows the unbinding rate, κ−, has no effect on the steady state obtained, and the
binding rate, κ+, is the only parameter that effects the steady state. The value of κ+ at which the
system switches from the extinction steady state, to the autoimmune steady state can be calculated
by setting the carrying capacity given in (7.5.23) to zero, and is given by
κ+ = 1.
The number of E cells in the autoimmune steady state is given by the carrying capacity of the
system (7.5.23).
From Figure 7.12, the number of APCs required to achieve the autoimmune, and the tolerant
steady state can be determined. Using the parameters defined in Section 7.5, we have κ+ =
0.12NA, where NA is the number of APCs. The autoimmune steady state exists for κ+ ≥ 1. This
corresponds to a minimum of 9 APCs being required to achieve the autoimmune steady state. The
stable tolerant steady state occurs for κ+ ' 2.15. This correspond to a minimum of 18 APCs
being required to achieve the stable tolerant steady state.
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7.5.6 The effect of κ+ on cell numbers
The effect of κ+ on the number of E and R cells can be investigated by solving the ODEs, using
the Euler method.
Figure 7.13: Plot showing how the steady state numbers of E and R cells change with varying the
value of κ+. A value of 500/3 was used for κ−. Initial values of E = R = 100 were used.
Figure 7.13 shows the number of E and R cells present in the system at the steady state, for various
parameter regimes. In the region corresponding to the extinction steady state in Figure 7.12, there
are no E or R cells. As the system moves into the autoimmune steady state observed in Figure 7.12,
there are still no R cells, but now the number of E cells at steady state increases as κ+ increases.
This increase continues until the region corresponding to the tolerant steady state in Figure 7.12
is reached, at which point a bifurcation occurs, resulting in a sudden drop in E cells and increase
in R cells, and co-existence of both E and R cells. In this region, the autoimmune steady state still
occurs, but is not the stable steady state for the set of initial conditions used.
Figure 7.13 shows the steady state achieved for initial numbers of E and R cells set to be
100. If different initial cell numbers are used, different steady states can be achieved. Using a
Mathematica code, all the steady states that occur for a specific parameter regime, regardless of
the initial conditions, can be generated, and their stability determined. Results are shown in Figure
7.14.
In Figure 7.14 the black crosses in both plots correspond to the same unstable steady state. The
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Figure 7.14: Plot showing the number of E and R cells in the various steady states as the value
of κ+ changes. Blue/red dots indicate stable steady states, black crosses indicate unstable steady
states. A value of 500/3 was used for κ−.
red dots in the bottom plot, that are not on the x-axis, correspond to the lower blue dots in the
top plot. The upper blue dots in the top plot, equate to the autoimmune steady state, and their
corresponding points on the bottom plot lie on the x-axis.
Figure 7.14 shows the extinction steady state is stable only for κ+ < 1, after which point it
becomes unstable. The autoimmune steady state exists for all values of κ+ ≥ 1, and is always
stable. The tolerant steady state is stable, and is the same tolerant steady state seen in Figure 7.13,
and a second unstable tolerant steady state is observed, in which there is a smaller number of R
cells and larger number of E cells. As κ+ increases, the unstable tolerant steady state approach
the autoimmune steady state.
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7.5.7 Stochastic effects of initial ratio of cells
To test the effect of stochastic fluctuations on the system, multiple realisations of the Gillespie
algorithm can be computed, to determine the probability of being in a specific steady state, for
varying initial ratios of E and R cells.
(a) Varying starting ratio. (b) Ratios used.
Figure 7.15: Plot (a) shows the effect of varying the starting ratio of E and R cells for κ+ = 3.
Total number of cells (E+R) is 200. Plot (b) shows the steady state the ODEs settle in for various
pairs of initial cell numbers, with black dots indicating the initial ratios used in (a). Extinction:
yellow, autoimmunity: purple, tolerance: green.
Figure 7.15(a) shows stochastic effects are present in the system, which are not observed in the
deterministic model. The initial ratio of E and R cells determine the most dominant steady state
seen, but for all initial ratios both the autoimmune and tolerant steady states were observed. The
extinction steady state was not observed in any of the simulations. Figure 7.15(a) was obtained
using the Gillespie algorithm, running simulations until either the E or R cells went extinct, or
the number of E and R cells were within 5% of the stable tolerant steady state. At this point
it was assumed the system would settle in that state. Solving the system using the ODEs, for
this parameter range and the same initial conditions, gives the autoimmune steady state when the
fraction of R cells is less than or equal to 0.2, and the tolerant steady state for higher fractions of
R cells, as shown in Figure 7.15(b).
Figure 7.15(a) shows increasing the fraction of R cell reduces the probability of autoimmunity
occurring, up until a fraction of R cells of 0.8, at which point the probability of autoimmunity
increases again. This can be investigated by examining individual realisations of the Gillespie
algorithm, for specific R cell starting ratios, shown in Figure 7.16.
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(a) R cell ratio 0.9. (b) R cell ratio 0.8. (c) R cell ratio 0.6.
Figure 7.16: Realisations of the Gillespie algorithm for high initial ratios of R cells. The green
cross indicates the unstable tolerant steady state.
The increase in the probability of autoimmunity appears to be due to the large number of R cells
present, resulting in them occupying the majority of the APC binding sites. This results in the R
cells not being able to proliferate, as they are not receiving signal from the E cells, and the E cells
dying off quicker as only free cells can die. Thus, the R cells die, as there are fewer E cells to
stimulate their proliferation. As the cell numbers drop, the E cells are able to recover quicker as
they do not depend upon the R cells to proliferate. As the E cells recover, the R cells can then
also recover, but the population levels have dropped to be near the bifurcation point of the system.
This results in more realisations settling in the autoimmune steady state, as the system is closer to
the bifurcation seen in Figure 7.11(a). Thus, only a small stochastic fluctuation is required to push
the system towards the autoimmune steady state. Figures 7.16(a)-(c) show that for larger ratios
of R cells, the cell numbers drop to lower levels, and spend longer near the bifurcation point, and
for medium ratios of R cells, the system quickly rises above the bifurcation point. The anomalous
points in 7.11(a) are caused by this effect.
In the simulations, with lower fractions of R cells (0.1 and 0.2), the system starts below the
bifurcation point, hence the ODEs settle in the autoimmune steady state. This explains the higher
probability of autoimmunity in Figure 7.15. This is illustrated in Figure 7.17
Performing a similar analysis of the steady states in the case with κ+ = 12, reveals that for all
initial R cell ratios, only the tolerant steady state is observed. This occurs because the bifurcation
of the system is at a very low level, as shown in Figure 7.11(b). Therefore, very few initial R cell
ratios are near the bifurcation point.
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(a) R cell ratio 0.1. (b) R cell ratio 0.2.
Figure 7.17: Realisations of the Gillespie algorithm for low initial ratios of R cells. The green
cross indicates the unstable tolerant steady state.
7.6 Summary
In this chapter the cross-regulation model proposed by Le´on et al. [49,133] has been investigated,
and a deterministic and stochastic version of the model formulated and studied. The chapter
investigates three model variants, which were also investigated by Le´on et al.: competition only,
R cell suppression only, and R cell suppression and E cell promotion. The first two models do not
exhibit any interesting dynamics, with the competition model settling in a steady state dependent
on the initial ratio of cells. In the R suppression model, E cells are driven to extinction in all
cases, except when the initial number of E cells is much greater than that of R cells, in which
case the R cells go extinct. The third model, in which R cells regulate the number of E cells,
and E cells provided a division stimulus to the R cells, proves to be the most interesting from
an immunological and mathematical perspective. The model developed by Le´on et al. is a purely
deterministic model, and does not consider stochastic effects. The deterministic models developed
in this chapter were formulated in a different way to Le´on et al.’s models. They were formulated
by using the reactions of the system used for the Gillespie model. This allowed direct comparison
of the deterministic and stochastic models in this chapter.
In model three, the number of steady states obtained, that are real and positive, is dependent on
the value of κ+ only, and has no dependence on κ−. For κ+ ≤ 1, only the extinction steady
state exists. For 1 < κ+ / 2.15, where the upper boundary is approximate, as it can only be
determined numerically, the extinction steady state and one autoimmune steady state exist. For
2.15 / κ+ four steady states exist: the extinction state, the autoimmune state, and two tolerant
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steady states, one of which is stable, and the other unstable. These states agree with the findings
of Le´on et al. [49,133], in which they also find the same four types of steady states. They find the
unstable tolerant state to have a large number of E cells, and a small number of R cells, agreeing
with the findings of this chapter. They find the stable tolerant steady state to have a small number
of E cells and a large number of R cells, which is what is found in this chapter, for larger values
of κ+. For the parameters chosen in this chapter, to achieve the tolerant steady state eighteen
APCs are required, and to achieve the autoimmune state nine APCs are required. Below nine
APCs, extinction occurs. It must be noted that the parameters used were chosen to be biologically
significant, but there are other parameter combinations that could be chosen, which will also be
biologically significant, giving different numbers of APCs required to achieve tolerance.
The parameter κ+ equals k+NA/µ, therefore if the interaction rate, k+, of the cells is too low,
autoimmunity or extinction will occur. This makes sense biologically, as if cell interactions occur
very infrequently, they will not receive a signal to proliferate, and will die out. If the number of
APCs, NA, is too low, autoimmunity or extinction will occur. The number of APCs being low
reduces the global encounter rate between T cells and APCs, resulting in less T cells proliferating,
and T cells being more likely to die out. Finally, if the death rate, µ, is too high, this will also
result in autoimmunity or extinction, as the T cells will die before they can encounter an APC to
receive a signal to proliferate. A combination of these three parameters, that gives a large enough
κ+, are required to prevent autoimmunity or extinction.
Our investigation of stochastic effects in the cross-regulation model has revealed that for large
values of κ+, stochastic effects are not significant. However, for smaller values of κ+, that are still
within the tolerant regime, stochastic effects play a significant role, and can cause the steady state
achieved to differ for different realisations. For κ+ = 3, the system was found to settle in either
the autoimmune or tolerant steady state. This occurs because there is a bifurcation at which the
system switches between the states. For large κ+ the bifurcation occurs at very low cell numbers,
as observed in Figure 7.11(b). But, for smaller values of κ+, the bifurcation occurs at larger cell
numbers, as observed in Figure 7.11(a). Stochastic fluctuations can cause the system to move
across the bifurcation point, which would not occur in a deterministic model. The probability of a
specific steady state occurring in the stochastic system, was found to depend on the initial ratio of E
and R cells. For roughly equal initial proportions of E and R cells, the probability of autoimmunity
is low. Decreasing the proportion of R cells, increases the probability of autoimmunity, to the point
where the tolerant steady state is rarely seen. For low initial R cell ratios, the ODEs also predict
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autoimmunity. For high initial R cell ratios, the ODEs predict tolerance. Yet the stochastic model
reveals there is still a significant probability of autoimmunity. Le´on et al. [49, 133] also found for
low R cell ratios, autoimmunity occurs. For large R cell ratios, the ODEs give the tolerant steady
state, however, the stochastic model reveals a slight increase in the probability of autoimmunity,
occurring due to stochastic fluctuations. This is not observed by Le´on et al., due to the purely
deterministic nature of their model.
In patients with conditions which reduce their T cell numbers, such as HIV, autoimmunity is
unlikely to occur if the ratio of E and R cells remains constant. However, if the number of APCs
is depleted, or the death rate of T cells becomes too large, autoimmunity or even extinction could
occur. If only a patient’s R cells are depleted, this is likely to result in autoimmunity. In IPEX
syndrome, which causes a mutation in the FOXP3 gene [237], resulting in R cells not functioning,
autoimmunity is observed, which is also found in the model in this chapter for the same situation,
with no, or few, R cells.
Upon first devising the models in this chapter, a probability of productive binding for E cells, and
R cell was used. If a cell has a weak/unproductive binding, it cannot suppress or promote other
cells, and if a cell has a strong/productive binding, it can. Having these parameters allowed an
advantage to be given to one of the cell types if desired. This resulted in two extra populations of
cells, as in the A11 population it must be remembered if a cell has been promoted or suppressed,
depending on the strength of its binding. After initial analysis of the system, it was noticed that
there was a way for cells to have multiple chances of having a strong/weak binding. Allowing a
cell to change its binding strength during a binding is undesirable. Comparing the system to an
agent based model revealed this problem was significant. To overcome the problem the binding
state and suppression/promotion state of each cell in a complex must be recorded, resulting in over
twenty populations. This added complexity did not result in a better model, and it was decided
to keep a simpler model, in which all bindings are productive. Alternative models in which the
binding rate of one cell type was multiplied by a factor were investigated. Doing this allowed an
advantage to be given to one of the cell types, but again this did not prove to add anything extra to
the model.
Model 3, devised in this chapter, has shown interesting results, with only two parameters. Effects
not observed by Le´on et al. [49, 133] are also found, by investigating the effects of stochastic
fluctuations on the system. The increased probability of autoimmunity for small numbers of APCs,
observed in Figure 7.15(a), due to stochastic effects, was observed in Model 3 in this chapter and
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was not found by Le´on et al.’s deterministic approach.
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Chapter 8
Mechanisms of T cell activation
8.1 Introduction
It is believed that T cells need to undergo sustained signalling to become activated [88]. However,
it is still unclear whether sustained signalling requires a prolonged interaction, or can be generated
by multiple shorter encounters with different antigen-presenting-cells (APCs) [46]. New insights
into cell-cell interactions have been gained using two-photon laser scanning microscopy, to view
these interactions in vivo [41, 43, 156]. Several studies have tracked the dynamics of T cell-APC
contacts upon antigen recognition [42,110,152,154,212]. It has been proposed that the interactions
of T cells and APCs can be split into three phases: transient interactions, long-lived interactions,
and swarming [42, 152, 154, 212]. A study has found that the minimum contact time between T
cell receptors and APCs for activation of naive T cells is in the range of 20 hours [112]. In another
study, the duration of TCR signalling required by naive cells was found to be lower in the presence
of mature APCs, being in the range of 6 hours [131].
During phase 1: transient interactions, T cells have productive, but brief (less than ten minutes in
duration) serial encounters with APCs displaying foreign peptide [42, 110, 152, 156, 201, 212]. T
cells do not stop completely, but instead crawl on the surface of the APC. These contacts are almost
indistinguishable from those made with non-cognate APCs, but evidence suggests they are not
‘null’ and result in some level of activation, with up-regulation of CD69 activation marker being
detected [152]. Transient contacts dominated early stages of T cell-APC interactions, occurring in
the first 8 hours after antigen presentation [110, 152, 154].
In phase 2: long lived interactions, T cells arrest on APCs, forming contacts lasting several hours.
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During these contacts, conjugates appear either completely static or more dynamic, presumably
owing to the rapid motion of APCs and/or low level of T cell crawling. This stage is thought to be
the key event in T cell activation, and has been observed in all experimental conditions associated
with priming. Long lived contacts are mostly observed between 6 and 24 hours after initial antigen
presentation. The signalling occurring during sustained interactions is thought to be of functional
importance [42].
The final stage: swarming, occurs approximately 25 to 30 hours after initial antigen presentation.
T cells undergo rapid motion and brief interactions [152]. In this stage, T cells display looping
patterns around APCs [154,156,219], and remain in a confined area of the lymph node. Swarming
is thought to occur as a result of APCs releasing the antigen they have been presenting to T cells.
It must be noted that the immunological evidence presented in this section has been gathered
from experiments carried out by different laboratories, using different experimental techniques.
Hence, various and sometimes contradicting results are observed, with switches from short to
long bindings at differing times and differing durations of binding times are reported.
Three types of mechanism have been proposed to explain the three phase interaction process:
APC changes, signal integration, and a probabilistic approach [40,42]. The next three subsections
review these mechanisms. This chapter investigates the three mechanisms proposed to explain
the three stage activation process. Various mathematical models are proposed and investigated for
each of the mechanisms.
The aim of this chapter is to develop a model that can adequately describe the experimental
observations outlined above. The hope is that one of the mechanisms investigated will be able
concisely explain the experimental observations significantly better than the other mechanisms.
This would allow a mechanism for T cell activation to be proposed. Knowing the mode of T cell
activation will allow immunological models involving activation of T cells to accurately mimic
reality. It would also allow more specific targeting of therapeutic treatments.
8.1.1 APC changes
The APC changes model assumes different phases of interactions are due to the state of maturation
of the APCs. These changes could be due to the amount of antigen presentation, or co-stimulatory
molecule presentation, on the surface of the APCs. It has been suggested that APCs need to mature
before they can form long lived interactions. Experiments by Hughes and colleagues [110] found T
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cells showed a phase of transient interactions with APCs for the first 15 hours after immunisation
with antibodies, followed by a phase of stable interactions. However, when APCs were given
extra time to mature in vivo T cells were able to rapidly establish long lived contacts with APCs,
suggesting APCs and not T cells control the timing of arrest [110]. The increased expression of
adhesion molecules and co-stimulatory molecules accompanying APC maturation is thought to
contribute to the gradual ability of APCs to induce T cell arrest.
8.1.2 Signal integration
The signal integration approach proposes that T cells integrate signals they receive during the
initial phase of brief interactions with APCs, and a certain cumulative threshold of signals must be
achieved before T cells can gain the ability to arrest on APCs [54, 74, 98, 147, 152, 210]. Studies
have found T cells re-encountering APCs in the lymph node were more likely to express the high
affinity IL-2 receptor and produce IFN-γ, which is a sign of T cell activation.
8.1.3 Probabilistic approach
The probabilistic approach suggests T cells have a defined probability of arresting on an APC,
following an encounter with an antigen, determined by the strength of stimulation and the affinity
of the TCR for the antigen. If the probability is low, T cells will engage in numerous unsuccessful
binding attempts before arresting on an APC. T cells that establish long lived contacts will reside
on the APC for hours. Therefore, long lived contacts are expected to progressively accumulate
until they become the dominant type of interaction.
8.1.4 T cell swarming
T cell swarming behaviour after a long binding event is not easily modelled. A potential method
of achieving swarming is to lower the diffusion coefficient of a T cell upon unbinding, causing
it to remain near an APC for longer, but this would not necessarily result in T cells swarming
around an APC, as a T cell may move in a straight line away from the APC. T cells could be
confined to an area around an APC, but this would be forcing the T cells to stay near the APC
and would not be very natural. Attraction towards an APC could be implemented by adding a
chemokine gradient, which T cells respond to after undergoing a long binding, causing them to
continually move back towards the APC. However, this would prevent them exiting the lymph
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node (LN). A better approach is to give a T cell a probability of moving towards an APC rather
than making a random movement, determined by the distance between the T cell and APC. In the
models proposed in this chapter swarming will not be considered and only the first two stages of
activation will be investigated.
8.2 Modelling approaches
In this section, methods for mathematically modelling the three activation mechanisms outlined in
the introduction, are proposed.
8.2.1 APC changes
The binding time of a T cell on an APC can be modelled to depend on APC changes in various
ways. The maturation of APCs could depend on the time an APC resides in a LN. Either the APC
must be residing in the LN for a specific amount of time before long lived interactions can occur,
or the length of the binding time is determined by the time an APC has been residing in the LN.
A model can be implemented in which APCs must achieve a certain number of short interactions
before they are able to engage in long lived interactions. Similarly, an APC may need to achieve
a certain cumulative binding time before a long lived interaction can occur, or a combination
of cumulative interaction time and number of bindings may be required. Below six models are
proposed using the ideas mentioned.
Model IA: APCs are required to reside for a specific amount of time in the LN before they mature
and long bindings occur. Before the threshold time T cells interacting with the specific APC will
have short bindings, lasting τs, and after the threshold has been reached a T cell will have long
bindings, lasting τl. Each APC will act independently, becoming mature after a set amount of time
residing in the LN regardless of the state of the other APCs.
Model IB: The time a T cell spends bound to an APC is set to be a function of the time the APC
has resided in the LN. The binding time will be set to follow a specific distribution, such as an
exponential distribution. A maximum binding time can be specified and all binding times given as
a fraction of this.
Model IC: The cumulative time an APC has spent bound to a T cell is recorded. When this time
is greater than a given threshold value, the binding switches from short lived interactions to long
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lived interactions.
Model ID: This model operates in the same way as Model IC, but instead of a threshold of
cumulative binding time, there is a threshold that must be reached on the number of bindings
an APC has undergone.
Model IE: This model is a combination of Models IC and ID. In this model both a threshold value
on the cumulative binding time and the number of bindings must be reached before a long binding
can occur.
Model IF: The time a T cell spends bound to an APC is a function of either the number of bindings
an APC has undergone, or the cumulative time an APC has spent bound to a T cell. An upper limit
on the binding time can be set, and all binding times given as a fraction of the upper limit.
In Models IA, IC, ID and IE, the dwell time can be either a fixed value for the short bindings, and
another value for the long bindings, or a value drawn from a distribution, such as an exponential
or log-normal distribution, with a given mean for each type of binding.
After consultation with experimentalists (Dr. P. Bousso, Paris), it has been advised that APC
maturation occurs due to time events rather than binding events. It has been suggested that Model
IA, followed by Model IC, are the most realistic and will therefore be investigated.
8.2.2 Signal integration
Signal integration assumes T cells sum the signals they receive from interactions with APCs.
Signal integration by T cells from encounters with APCs can be modelled in various ways. The
amount of time a T cell has been bound for can be summed, and a long binding occurs if the
summed time is greater than a given threshold. The number of contacts a T cell has undergone
can be summed, and again if this sum is greater than a set threshold a long binding will occur. A
combination of these methods can be implemented, or a binding time that depends on the time a
T cell has already spent bound, or the number of interactions that have already occurred, could be
used. Below four potential models are proposed.
Model IIA: T cells start by undergoing short bindings, with a given binding time, τs. The binding
time of a T cell is added to a cumulative total for that specific T cell. Once the cumulative binding
time exceeds a given threshold, the specific T cell will undergo long bindings on subsequent
encounters, with binding time τl.
Model IIB: This model operates the same as Model IIA, but instead of summing the binding times
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the number of bindings are summed. It may also be desirable to add the requirement of a binding
being greater than a set duration for it to be classified as productive and contribute to the number
of bindings undergone.
Model IIC: This model is a combination of Models IIA and IIB. In this model a T cell must have a
certain number of bindings and a certain cumulative binding time before a long binding can occur.
Model IID: In this model, instead of having a long and short binding time, the binding time of a
T cell is continuous, determined by either: the number of bindings it has already undergone, or
the cumulative binding time of the T cell. The binding time is given by a function of the chosen
parameter, with an upper limit on the length of a binding.
In Models IIA, IIB and IIC the length of the short and long bindings can either be a fixed value, or
more realistically, a value chosen form a distribution, such as an exponential or log-normal, with
a given mean for short and long bindings.
After consultation with experimentalists (Dr. P. Bousso, Paris), it has been agreed that this
approach should be based on a cumulative binding time rather than the number of bindings that
have occurred, with Models IIA and IID being chosen.
8.2.3 Probabilistic approach
The simplest approach of creating a probabilistic model is to give each cell a fixed probability
of forming a long binding upon encountering an APC, regardless of the properties of the APC.
By setting long bindings to last a few hours an accumulation of long bindings will occur as time
progresses. Further complexity can be added by giving each T cell and/or APC a ‘strength’,
which determines the probability of a long binding. The strength could be made to depend on the
number of short bindings a T cell has undergone. T cells could be given specificities and their
binding probability made dependent on the similarity of the T cell and APCs specificities. Adding
extra complexity to the model is only beneficial if a simple model cannot reproduce the desired
outcome. We will therefore begin with a simple model and add complexity if required.
8.3 APC changes approach
In this section, APC changes Models IA and IC are examined. These models were chosen as they
are thought to be the most realistic. The number of T cells undergoing short bindings with APCs
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will be referred to as ‘short bound cells’, and the number of T cells undergoing long bindings with
APCs will be referred to as ‘long bound cells’.
8.3.1 Model IA
In Model IA, APCs must spend a specific amount of time in the LN before they mature and can
participate in a long binding. Before this threshold time, short bindings will occur. This time
represents the time it takes for an APC to up-regulate co-stimulatory, and adhesion molecules on
its surface. Upon encountering an APC, binding times are chosen from an exponential distribution
with mean τs for short bindings and τl for long bindings. Upon unbinding from an APC a T cell
is replaced uniformly randomly within the valid domain.
Figure 8.1: Spatial simulation of Model IA with an APC maturation time of 500 minutes.
Parameters used: R = 400µm, b = 11.5µm, D = 50µm2min−1, τs = 5 minutes, τl = 240
minutes, APCs = 200, and T cells = 9857 after equilibration.
Figure 8.1 shows results of a spatial simulation of Model IA, in which the number of cells
undergoing a short binding, at a given time, is shown in blue and those undergoing a long binding
in red. In this simulation the time for an APC to mature is set to be 500 minutes, chosen to give a
switch from short to long bindings at a point after 8 hours, as found in the literature [110,152,154].
The simulation shows a switch, at 500 minutes, in the dominant type of bindings from short to
long. Before the switch point there are only short bindings. After the switch point the number
of short bindings decays exponentially to zero, and the number of long bindings increases until it
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reaches a steady state. In this model the point at which the system switches from the dominant
type of binding being short to long is only dependent on the maturation time of APCs.
8.3.2 Model IC
In Model IC, APCs must achieve a specific cumulative binding time with T cells before they
mature and can undergo long bindings. Before this threshold of cumulative binding times, an
APC will undergo short bindings. Each APC acts independently of the other APCs in the LN,
therefore APCs will mature at different times rather than simultaneously, as in Model IA. Upon
encountering an APC, binding times are chosen from an exponential distribution with mean τs for
short bindings and τl for long bindings.
Figure 8.2: Spatial simulation of Model IC with a cumulative binding time needed to undergo
long bindings of 500 minutes. Parameters used: R = 400µm, b = 11.5µm, D = 50µm2min−1,
τs = 5 minutes, τl = 240 minutes, APCs = 200, and T cells = 9857 after equilibration.
Figure 8.2 shows results of a spatial simulation of Model IC. In the simulation APCs must have
a cumulative binding time, with T cells, of 500 minutes before they can undergo a long binding.
Short binding times are exponentially distributed with a mean of 5 minutes, therefore a mean of
100 bindings will be required to achieve a cumulative binding time of 500 minutes. However,
as multiple T cells are able to bind to an APC simultaneously, a cumulative binding time of 500
minutes can be achieved in less than 500 minutes. The figure shows an initial increase in the
number of short bound cells with no long bound cells initially. The number of short bound cells
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then begins to decay, until they reach zero, and the number of long bound cells increases to a
steady state. The switch in the dominant type of binding is seen around 6 hours. In this model
APC mature by being in contact with T cells. Therefore, if more T cells are bound to an APC, it
will mature faster. This makes the model highly dependent on the number of T cells available to
provide maturation signal and the number of APCs competing for the signal from the T cells, as
well as the threshold of binding times required. An additive effect of multiple T cells binding to
an APC may not be the best approach to take. It may be better to have an APC receive maturation
signals at a set rate, regardless of the number of T cells bound to it.
8.4 Signal integration approach
In this section, signal integration Models IIA and IID are examined. These models were chosen
as they are thought to be the most realistic from an immunological perspective.
8.4.1 Model IIA
In Model IIA, each T cell acts independently, moving by Brownian motion, in an attempt to
locate an APC. Each T cell keeps a record of the cumulative time it has been bound for. Upon
encountering an APC, a T cell will undergo a short binding if the cumulative time is below a
given threshold, and a long binding if it is above the threshold. Binding times are chosen from an
exponential distribution with mean τs for short bindings and τl for long bindings. Once a T cell’s
cumulative binding time is above the switching threshold, all its bindings will be long, and there
is no way in this model for the bindings to revert to being short again.
Figure 8.3 shows the results of a spatial simulation of Model IIA. The figure shows for a cumulative
T cell binding time needed for long bindings to occur of 35 minutes, there is a switch in the
dominant type of binding from short to long at around 8 hours. The switch point in this model
depends on the interaction rate between T cells and APCs, the number of APCs, the length of short
bindings, and the cumulative binding time required for a long binding to occur. The cumulative
binding time is chosen to be 35 minutes to achieve a switch, from short to long bindings, at around
8 hours, as observed experimentally [110, 152, 154].
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Figure 8.3: Spatial simulation of Model IIA with a cumulative binding time required for long
bindings to occur of 35 minutes. Parameters used: R = 400µm, b = 11.5µm, D =
50µm2min−1, τs = 5 minutes, τl = 240 minutes, APCs = 200, and T cells = 8025 after
equilibration.
8.4.2 Model IID
In Model IID, cells do not have long and short binding as in Model IIA, instead they have a
binding time that is a function of the cumulative time a T cell has spent bound to an APC. Upon
encountering an APC, a T cell binds for a time given by the function
tb = tmax exp
(
− 1
ξ(tc + 1)
)
, (8.4.1)
where tmax is the maximum binding time that can be assigned, tc is the cumulative time a T
cell has spent bound, and ξ is a scaling parameter. All binding times are given as a fraction of
the maximum binding time to prevent binding times becoming too large. ξ is used to adjust the
binding times, with a smaller value giving a slower growth rate. The plus one in the denominator
is required for an initial binding to occur.
Figure 8.4 shows an initial increase in the number of short bound cells, followed by a decrease
in short bound cells and an increase in the number of long bound cells. In this model a binding
time of less than ten minutes is defined as a short binding, and a binding time of greater than ten
minutes as a long binding. Ten minutes was chosen for the threshold, as literature states short
bindings last less than ten minutes [42,110,152,156,201,212]. However, the literature also states
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Figure 8.4: Spatial simulation of Model IID with a maximum binding time of 360 minutes, and
ξ = 0.15min−1. Parameters used: R = 400µm, b = 11.5µm, D = 50µm2min−1, APCs = 200,
and T cells = 8062 after equilibration.
long bindings last hours [42]. It is therefore not clear how to classify bindings in the intermediate
range, and it may be that bindings of intermediate length should not be occurring. The value of ξ
used in this simulation was chosen to give a reasonable plot, but it is not clear how to choose ξ,
or the maximum binding time, or even the function itself. This model has lots of uncertainties and
it seems unlikely the binding time will be determined by a continuous process. It is more likely a
discrete process caused by up-regulation of receptors on the surface of the T cells.
8.5 Probabilistic approach
In this section, two probabilistic models are considered. In the first model (IIIA), upon encounter
with an APC, a T cell will undergo a long or short binding with set probabilities. In the second
model (IIIB), T cells have the same binding dynamics. However, upon unbinding they enter an
inactive state in which they are able to move freely but not bind with APCs until they leave the
inactive state and return to being free cells. This inactive state is introduced to make the model
more biologically realistic.
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8.5.1 Model IIIA
In this model, T cells encounter APCs and have a long binding with probability p, or a short
binding with probability 1 − p. The rate of T cells encountering APCs, k, is given by the inverse
of the fist passage time for a T cell to encounter an APC in a spherical LN, α (3.5.37), multiplied
by the number of APCs in the LN. α is approximately equal to R3/3Db, in which R is the radius
of the LN, D the diffusion coefficient of the T cells, and b the effective radius of the APCs. T
cells are not able to die in this model as only short timescales are considered. T cells have binding
times of τs for short bindings and τl for long bindings. The unbinding rate is given by the inverse
of the binding times.
This model has three populations: nf , mean number of free cells, ns, mean number of short
bound cells, and nl, mean number of long bound cells. There is no death in this model, so the
total number of T cells is fixed at M , allowing one of the populations to be constrained by setting
nf = M − ns − nl.
We have the ODEs:
dnf
dt
= −knf + 1
τs
ns +
1
τl
nl, (8.5.2a)
dns
dt
= k(1− p)nf − 1
τs
ns, (8.5.2b)
dnl
dt
= kpnf − 1
τl
nl. (8.5.2c)
Eliminating nf results in two ODEs:
dns
dt
= k(1− p)(M − nl)− ns
(
1
τs
+ k(1− p)
)
, (8.5.3a)
dnl
dt
= kp(M − ns)− nl
(
1
τl
+ kp
)
. (8.5.3b)
A steady state can be obtained by setting dnsdt =
dnl
dt = 0 and is found to be
n∗s =
k(1− p)Mτs
1 + k(p(τl − τs) + τs) , n
∗
l =
kpMτl
1 + k(p(τl − τs) + τs) . (8.5.4)
Analysing the stability of the steady state reveals it is stable for τl > τs, which always holds. Thus,
the steady state is always stable. The eigenvalues are real given that τl > τs, implying the steady
state is a node. From (8.5.4), the ratio of the mean number of short and long bound cells is given
by
n∗l
n∗s
=
p
1− p
τl
τs
. (8.5.5)
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Solutions of the ODEs
The ODEs (8.5.3) can be written in matrix form as
d
dt
 nl
ns
 =
 −kp−
1
τ l −kp
−k(1− p) −k(1− p)− 1τs

 nl
ns
+
 Mkp
Mk(1− p)
 . (8.5.6)
The system can be solved by first finding the solution of the homogeneous part, then solving the
inhomogeneous part. The homogeneous part of the system is solved by finding the eigenvalues
and eigenvectors of the 2× 2 matrix in (8.5.6), given by
λ1 = −
(
γ + β
2η
)
, λ2 = −
(
γ − β
2η
)
, (8.5.7)
and 
α+β
ω
1
 ,

α−β
ω
1
 , (8.5.8)
where
γ = τl + τs + kτlτs, (8.5.9a)
ζ = 1 + k(p(τl − τs) + τs), (8.5.9b)
η = τlτs, (8.5.9c)
β =
√
γ2 − 4ζη, (8.5.9d)
α = −k(1− 2p)η − τl + τs, (8.5.9e)
ω = 2k(1− p)η. (8.5.9f)
The general solutions of the homogeneous part of (8.5.6) is n
hom
l (t)
nhoms (t)
 = c1

α+β
ω
1
 eλ1t + c2

α−β
ω
1
 eλ2t. (8.5.10)
A solution must now be found for the inhomogeneous part of the system. We guess a solution of
the form  nl
ns
 =
 a1
a2
 . (8.5.11)
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The derivative with respect to time of (8.5.11) is the zero vector. We must therefore solve 0
0
 =
 −kp−
1
τ l −kp
−k(1− p) −k(1− p)− 1τs

 a1
a2
+
 Mkp
Mk(1− p)
 . (8.5.12)
This gives  a1
a2
 =

kMpτl
ζ
kM(1−p)τs
ζ
 . (8.5.13)
We are able to write the general solution to the system as nl
ns
 = c1

α+β
ω
1
 eλ1t + c2

α−β
ω
1
 eλ2t +

kMpτl
ζ
kM(1−p)τs
ζ
 , (8.5.14)
where c1 and c2 are constants. The eigenvalues λ1 and λ2 are always negative for τs < τl. Thus,
the exponentials in (8.5.14) tend to zero as time tends to infinity, leaving the part of the solution
that is not dependent on time, which is the steady state given in (8.5.4). c1 and c2 can be found by
applying the initial conditions of the number of short and long bound cells at time zero to be zero,
nl(0) = 0, ns(0) = 0. (8.5.15)
We find
c1 = −kM
2βζ
((−α+β)τs+p(ωτl+(α−β)τs)), c2 = kM
2βζ
(−(α+β)τs+p(ωτl+(α+β)τs)).
(8.5.16)
Analysis of Model IIIA
The number of bound and unbound cells as a function of time can be viewed by solving the ODEs,
Gillespie algorithm (see section 2.4), and a spatial code. Results of these simulations are shown in
Figure 8.5.
Figure 8.5 shows an initial increase in the number of short bound cells, caused by a higher
probability of short bindings occurring. The number of long bound cells quickly takes over,
as although this type of binding is less probable, cells that undergo a long binding remain
bound for a greater time, allowing long bindings to accumulate. By twenty hours the system
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(a) Spatial simulation. (b) Gillespie simulation.
Figure 8.5: Plots showing Model IIIA, simulated using (a) one spatial simulation and (b) the
Gillespie algorithm, in both cases with comparison to ODEs, shown by dashed lines. (b) shows
the average of one hundred Gillespie simulations. The steady state of the system (8.5.4) is shown
by dotted lines. Parameters used: R = 400µm, b = 11.5µm, D = 50µm2min−1, τs = 5
minutes, τl = 240 minutes, p = 0.2, APCs = 200, and T cells = 8060 after equilibration.
approaches a steady state, with the number of long bindings being much greater than the
number of short bindings. The results of these simulations show that, at very early times short
bindings dominate. However, long bindings dominate at earlier times than observed in biological
experiments [110, 152, 154]. The parameters were chosen to be similar to those used in previous
chapters, which are thought to be biologically relevant. The short and long binding times were
thought to be reasonable according to literature [42,110,152,156,201,212]. With these parameters,
for short bindings to dominate at times earlier than 8 hours [110,152,154], a probability of a long
binding occurring must be set around 0.022. With this probability, long bindings dominate at later
times but are only slightly more numerous than short bindings. If long bindings are taken to have
a length of 20 hours, as found by [112], a probability of a long binding occurring of 0.011 is
required to achieve a switch from short to long bindings at a time shortly after 8 hours, shown in
Figure 8.6.
In the spatial simulation shown in Figure 8.5(a), binding times are drawn from an exponential
distribution, with mean set as τs or τl, depending on the type of binding occurring. To initialise
the simulation, T cells are placed in uniform random positions within the domain, excluding the
volume occupied by the APCs. This results in a distribution of T cells that is not uniformly
randomly distributed across the whole domain as the volume of the APCs is excluded. The
parameter k assumes a uniform random distribution across the whole domain. To allow cells to
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Figure 8.6: Figure showing a case in which there is a shift from short to long binding dominance
just after 8 hours. Parameters used: R = 400µm, b = 11.5µm, D = 50µm2min−1, τs = 5
minutes, τl = 1200 minutes, p = 0.011, APCs = 200, and T cells = 10000.
become approximately uniformly randomly distributed the T cells are placed within the domain,
excluding the volume occupied by APCs, then an equilibration time is given in which cells move
following a random walk, allowing cells to become randomly distributed through the domain. Any
T cells encountering an APC during the equilibration time are removed from the simulation. Upon
a T cell unbinding from an APC, in the spatial model, it is replaced in a valid ‘random’ position
within the domain. This is done to achieve a more accurate comparison to the first passage time
equation.
Figure 8.7 shows the trajectory the system follows to reach the steady state. The green and yellow
lines represent the nullclines, where the rate of change of short and long bound cells is zero,
implying one population is in equilibrium for the corresponding value of the other population.
The figure shows the number of short bound cells increases to the nullcline, where the rate of
change of short bound cells is zero. The system then approaches the steady state.
8.5.2 Model IIIB
In Figure 8.5(a) the spatial model allows an equilibration time to compensate for a not truly
uniform random distribution of T cells at the beginning of the simulation. To prevent T
cells immediately rebinding after an encounter with an APC, in Model IIIA they are replaced
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Figure 8.7: Plot showing the trajectory of Model IIIA (blue), for long and short bound cells.
Yellow and green lines indicate the nullclines, when the rate of change of long and short bound
cells is zero. The intersection of the nullclines is the steady state of the system. Parameters used
are the same as in Figure 8.5.
‘randomly’ in a valid position within the domain. This behaviour is unrealistic biologically as a
T cell cannot move from one position to another instantaneously. Also, the position the T cell is
placed in will not be truly uniform random across the domain as it excludes the volume occupied
by the APCs. To alleviate both of these problems, in Model IIIB, cells become inactive after
unbinding from an APC for an amount of time drawn from an exponential distribution. During
this inactive time a T cell will continue to move, but will not be able to bind to APCs. This
allows the T cells to return to a roughly uniform random position within the LN, before they can
rebind to an APC. An ODE model can be setup to simulate an inactivation time by adding an extra
population to the previous ODE system (8.5.3) to include the inactive cells.
In this model there are four populations: nf , mean number of free cells, ns, mean number of
short bound cells, nl, mean number of long bound cells, and ni, mean number of inactivated cells.
The total number of T cells is given by M , allowing one of the populations to be eliminated:
nf = M −ns−nl−ni. Upon unbinding a T cell enters an inactive state for a time τi, after which
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it returns to the population of free T cells. We have the following ODEs:
dnf
dt
= −knf + 1
τi
ni, (8.5.17a)
dns
dt
= k(1− p)nf − 1
τs
ns, (8.5.17b)
dnl
dt
= kpnf − 1
τl
nl, (8.5.17c)
dni
dt
=
1
τs
ns +
1
τl
nl − 1
τi
ni. (8.5.17d)
Eliminating nf gives the three ODEs:
dns
dt
= k(1− p)(M − nl − ni)− ns
(
1
τs
+ k(1− p)
)
, (8.5.18a)
dnf
dt
= kp(m− ns − ni)− nl
(
1
τl
+ kp
)
, (8.5.18b)
dni
dt
=
1
τs
ns +
1
τl
nl − 1
τi
ni, (8.5.18c)
in which the parameters are the same as in (8.5.3), with the addition of an inactivation time given
by τi. The steady state for this system is found to be:
ns =
kM(1− p)τs
1 + k(τi + pτl + (1− p)τs) ,
nl =
kMτl
1 + k(τi + pτl + (1− p)τs) ,
ni =
kMτi
1 + k(τi + pτl + (1− p)τs) . (8.5.19)
Analysis of the eigenvalues reveals the steady state to be a stable node.
A plot of the solution of the ODEs can be seen in Figure 8.8, with comparison to a spatial
simulation and the mean of one hundred Gillespie simulations of the system.
Figure 8.8 has the same dynamics as Figure 8.5 for the short and long bound cells. The added
population of inactive cells does not result in the spatial model being a better fit to the ODEs.
However, the behaviour of the two models is qualitatively the same, and Model IIIB is a more
realistic version of the biological system. Further investigation is required to determine the cause
of the difference between the spatial model and ODEs in Figure 8.8(a).
8.6 Summary
In this chapter, three activation mechanisms are investigated: APC changes, signal integration,
and probabilistic approach, motivated by hypotheses in literature [40, 42]. For APC changes, two
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(a) Spatial simulation. (b) Gillespie simulation.
Figure 8.8: Plots showing Model IIIB, simulated using (a) a spatial simulation and (b) the Gillespie
algorithm, in both cases with comparison to ODEs, shown by dashed lines. (b) shows the average
of one hundred Gillespie simulations. The steady state of the ODE system (8.5.19) is shown by
dotted lines. Parameters used: R = 400µm, b = 11.5µm, D = 50µm2min−1, τs = 5 minutes,
τl = 240 minutes, τi = 60 minutes, p = 0.2, APCs = 200, and T cells = 8260 after equilibration.
models are developed. The first model (Model IA) assumes APCs must spend a specific amount of
time in the LN before they mature and are able to undergo long bindings with T cells. This results
in a switch from short to long bindings at a set timepoint, and depends on no other parameters in
the model. The second model (Model IC) assumes APCs mature due to contacts with T cells and
must have a specific cumulative binding time with T cells before they can undergo long bindings.
This model has a more gradual shift from short to long bindings than Model IA, and is dependent
on the cumulative binding time required, as well as the number of T cells and APCs in the system.
This allows manipulation of the system by adding more T cells or APCs, which could in principle
be tested experimentally. This model can be developed further by considering how APCs receive
maturation signal from the T cells. For example, APCs may not be able to receive signals from
multiple T cells simultaneously, as assumed in Model IC.
Two models are considered for the signal integration approach. The first model (Model IIA)
assumes T cells record the cumulative time they have spent bound to an APC and when this value
exceeds a given threshold, the specific T cell that has exceeded the threshold can undergo long
bindings. This model depends upon the rate of encounter between T cells and APCs, the number
of APCs, and the cumulative time required for long bindings to occur. In principle, this system can
be investigated experimentally by manipulating the number of APCs. The second model (Model
IID) assumes a T cell’s binding time is a function of the time a T cell has already spent bound to
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APCs. A function was created to give binding times as a proportion of a maximum binding time.
This model proved difficult to calibrate and did not produce the results desired. This model could
be expanded by considering different functions for the binding times.
A probabilistic approach was considered by developing two models. The first model (Model IIIA)
assumes that upon encountering an APC T cells undergo a long binding with probability p or a
short binding with probability 1 − p. In this model, to achieve a switch in the dominant type of
binding from short to long, at a time around 8 hours as stated in the literature [110, 152, 154],
with a long binding time of 20 hours [112], a probability of a long binding occurring must be
set as 0.011. A long binding time of 20 hours seems quite long considering long bindings are
observed to occur between 6 and 24 hours after initial antigen presentation [110, 201]. If 20 hour
bindings start occurring 6 hours after initial antigen presentation, they will still be occurring 24
hours after the start of antigen presentation. Using a lower long binding time can still achieve a
long binding dominance around 8 hours, but the difference between the number of short and long
bindings is small. A second probabilistic model (Model IIIB) was developed with the aim of being
more biologically realistic. Model IIIA places T cells, after unbinding, approximately uniformly
randomly within the domain, which is unrealistic. To alleviate this problem, an inactivation state
was added in Model IIIB, which T cells transfer to after unbinding. T cells in the inactive state
can move freely but cannot bind, allowing them to return to a roughly uniform random position
before being able to bind again. This did not qualitatively change the model from Model IIIA,
it did however make the model more realistic. The probabilistic models considered do not seem
to be able to satisfactorily explain the experimental observations presented in the introduction,
and a more complex model may be required. A model in which T cells return to undergoing
shorter bindings should also be investigated, and may be what is required to better explain the
experimental results.
This chapter outlines basic models of investigating the programme of activation of T cells. Due to
time constraints further investigation could not be undertaken during my PhD. It is my hope that
future work, by both mathematicians and experimentalists, will allow the programme of activation
of T cells to be determined.
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Chapter 9
Concluding remarks
This chapter provides a summary of the work in Chapters 3-8, and considers if the initial objectives
of the thesis, outlined in Section 1.9, have been fulfilled.
This thesis is concerned with the dynamics and interactions of lymphocytes within lymph nodes
(LNs). It focuses on determining how T cells move, and the diffusion coefficient they move with.
The diffusion coefficient is a key parameter in mean first passage time (MFPT) equations, used to
determine the time a T cell moving following a random walk take to encounter uniformly randomly
placed antigen-presenting-cells (APCs). The interaction rate of T cells and APCs determines the
time an immune response requires to be initiated. The number of APCs presenting antigen to
T cells is a limiting factor to the initiation of an immune response. This thesis also investigates
the minimum number of APCs required to initiate a T cell response. The result of interactions
between lymphocytes is considered in the cross-regulation model, in Chapter 7, which investigates
three-body interactions between APCs, effector T cells, and regulatory T cells, as a mechanism of
effector T cell suppression of autoimmunity. The rate of interaction of T cells and APCs is critical
to initiating an immune response, but the way in which T cells are activated, upon encountering
APCs, is still unknown. Finally, Chapter 8 investigates various hypotheses of T cell activation.
Chapter 3 of this thesis considers first passage processes. Firstly, a MFTP is derived for a particle
in a prescribed initial position to locate a fixed target in the centre of a spherical domain, using
Poisson’s equation. This is generalised to a uniformly randomly placed target to obtain a starting
global mean first passage time (SGMFPT). To derive a target global mean first passage time
(TGMFPT), for a particle and target located in uniform random initial positions, which excludes
the volume occupied by the target, using Poisson’s equation, an approximation for the surface of
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the target, and a coordinate transformation to bispherical coordinates are considered. The first
approach proves to be of limited use, and the second approach proved to be very complex to
solve. Making use of recent mathematical advances in the area of first passage processes [58], a
method to derive a SGMFPT, involving Green’s and pseudo Green’s functions was implemented.
This resulted in a solution that could be integrated to obtain a TGMFPT. The method was then
extended to include multiple uniformly randomly placed targets, to give an equation for the mean
time a particle takes to encounter one of N uniformly randomly placed targets.
Imaging experiments carried out in vivo are limited to a finite volume. A limited sized volume
results in cells that remain in the volume for a long period of time, being those that are either
not moving very fast, or are taking looping paths, making them appear confined. Confinement
is observed in displacement squared against time plots as a plateau at later times. Chapter 4
calculates the expectation of the squared displacement of cells, within a cubic domain, to predict
the displacement squared as a function of time, for a given set of parameters. It is found that,
in imaging volumes smaller in the z axis than the x and y axes, as used in in vivo imaging
experiments, a plateau is not observed due to particles exiting via the z boundary. It can be
concluded that, in imaging experiments where a confinement plateau is observed, for typical sized
imaging volumes, it is not due to a limited sized imaging volume but rather some other form of
confinement. This other form of confinement would most likely be immunological confinement,
due to chemical signals or other biological factors confining the cells to a particular region.
Chapter 5 analyses data obtained by in vivo imaging experiments. Mathematical techniques
are applied to determine the type of motion the imaged cells are undergoing, and calculate the
diffusion coefficient of the cells. A systematic method is developed to analyse a given data set
and determine a diffusion coefficient of the population of cells imaged. It is found that, due to
the small size of the z axis used, viable data is not observed at later imaging times. We conclude
that more useful information could be obtained by using a larger z dimension, or an increased z
or time resolution.
Chapter 6 investigates the minimum number of dendritic cells (DCs) required to initiate a T cell
response. A simple model is devised to calculate the probability of T cell activation in a given time,
and experimental results are used to calibrate the model. Mathematical modelling allows longer
times and lower T cell numbers to be investigated than can be done experimentally. An extension
to the model is developed to include the number of T cell searching for DCs in an attempt to
become activated. This model is used to calculate a minimum number of DCs required to initiate
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a T cell response, in twenty four hours, for typical human T cell precursor frequencies.
Chapter 7 develops a stochastic version of the cross-regulation model, first developed
deterministically in [133]. The cross-regulation model postulates that regulatory T cells
suppress effector T cells via a three way interaction with APCs, as a mechanism of preventing
autoimmunity. A stochastic model is developed showing stochastic effects are present, and
significant, for initial ratios of regulatory/effector T cell with a high fraction of regulatory T
cells. It is found that, when the initial regulatory T cell ratio is low, there is a high probability
of autoimmunity. This probability decreases as the initial ratio of regulatory T cells increases.
When the initial ratio of regulatory T cells is very large the probability of autoimmunity is found
to slightly increase due to saturation by regulatory T cells. This effect is not observed in a
deterministic approach. The binding rate of T cells is found to be the key parameter in determining
the steady state of the system, with the other parameters only affecting the timescale.
Chapter 8 investigates three mechanisms proposed to explain the three stage activation process of
T cells [40,42]. These mechanisms are: APC changes, T cell signal integration, and a probabilistic
approach. For each of the mechanisms two models are considered. We have been able to show that
all models can explain the first two stages of the activation process. However, the third stage of the
process is not covered in the scope of these models. The simple probabilistic model devised is able
to explain experimental results observed, but not as convincingly as could have been hoped for.
It is concluded that a more complex probabilistic model is required to explain the experimental
results, and the third stage of activation must also be investigated.
In Section 1.9, the initial objectives of this thesis were introduced. The success of this thesis
at completing these initial objective will now be analysed. The first objective was to derive an
equation for the time a uniformly randomly located particle, within the domain that excludes
the volume occupied by the target, moving by Brownian motion, takes to encounter a uniformly
randomly placed spherical target, within a spherical domain. Chapter 3 addresses this problem and
derives the desired equation, which had not been previously found. An equation is also derived for
the time it takes a particle to encounter one of N uniformly randomly placed targets, which again
has not been previously developed. Therefore, the first objective is met and exceeded, having
derived an equation beyond what was initially intended.
The second objective was to determine the effects of confinement in a limited sized imaging region.
Chapter 4 determines an equation for the expected squared displacement of cells as a function of
time, and the expected confinement plateau. This allows results of a given experimental setup to
Chapter 9. Concluding remarks 178
be predicted and quantified by determining the mean squared displacement plot and plateau that
should be observed and comparing to the mean squared displacement plot that is observed. From
the work in Chapter 4 and 5, ways of optimising the size and resolution of an imaging volume can
be proposed. It can be concluded that objective two has been achieved through this work.
Objective three was to develop a method of calculating the diffusion coefficient of data sets
obtained through in vivo imaging experiments. This was investigated in Chapter 6, and a method
was developed. The method developed is able to calculate the diffusion coefficient of a population
of cells in a given data set. I believe there is still scope for further development of the method
in the hope of being able to extract more information from the limited sized data sets. Objective
three has therefore been partially met, but there is still room for improvement.
The fourth object was to determine the minimum number of DCs required to initiate a T cell
response. Through collaboration with experimentalist (Dr. P. Bousso, Paris), and the development
of mathematical models, this objective was fulfilled and resulted in a publication in the Blood
journal [53]. This work is contained in Chapter 6.
Objective five was to investigate the effects of stochastic fluctuations on the cross-regulation
model. In Chapter 7, a stochastic formulation of the cross-regulation model is developed.
Stochastic effects were observed that were not seen in the deterministic model. For example, very
high initial ratios of regulatory T cells were found to increase the probability of autoimmunity.
This fulfils objective five and shows stochastic effects cannot be dismissed in biological models
when modelling small numbers of cells.
Finally, the sixth objective of determining the method of T cell activation was addressed in Chapter
7. Various models of T cell activation were investigated. These models were able to explain the
first two stages of the T cell activation process: transient interactions and long lived interactions.
However, the third stage of the activation process, swarming, was not investigated. As all the
investigated models were able to explain the experimental results, to some extent, for the first
two stages of the activation process, the activation method that is occurring biologically cannot be
determined. To be able to distinguish one of the activation methods as being able to better explain
the experimental data, the third stage of the activation process must be considered. Thus, the sixth
object was not met. Further work is required in this area to add the third stage of the activation
process to the models.
This thesis covers several interlinked projects, which have been investigated to varying degrees.
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All areas in this thesis have the potential to be expanded upon, and a few extensions will be
outlined here. In Chapter 3, an equation for the time a particle takes to locate one of N targets is
derived. However, the equation assumes the targets can overlap, which is unrealistic. For a small
number of targets, in a large domain, the error resulting from this assumption will be very small.
But, as the number of targets is increased, the error will also increase. This work can be extended
by developing an equation for non-overlapping targets. A further extension would be to add an
exit to the domain and determine the time to locate the exit and the probability of encountering
a target before exiting the domain. The work in Chapter 5 develops a method of calculating the
diffusion coefficient of cells from in vivo imaging experiments. This work can be developed by
extracting more information from the data available. Instead of just using measurements from a
point along a cell track to the start of the track, new sample tracks can be created by segmenting
existing tracks into smaller tracks. Segmentation of tracks is achieved by taking a time point and
creating a sample track from that timepoint to timepoint 2, 3, 4, etc. Then the next time point along
the track can be taken as the starting point and more sample tracks created. However, this results
in the contribution of a track to the mean squared displacement being dependent on the length of
the track. Therefore if there is an anomalous track it would be exaggerated. A method would
need to be developed to prevent this scenario occurring. Chapter 8 introduces basic methods
of investigating the hypotheses of T cell activation, but due to time constraints these methods
could not be investigated to their full potential. This work could be extended by adding further
complexity to the models developed in Chapter 8 and investigating the models proposed but not
developed, as they may result in interesting features not previously considered. To fully answer
the question of how T cells are activated, the third stage of activation must also be modelled. Also,
in the models considered in chapter 8, APCs are assumed to have an infinite number of binding
sites. This work could be extended by investigating the effect of limiting the number of binding
sites.
The work in Chapters 5, 6 and 8 was carried out using data from or in collaboration with
immunologists. Further development of work in this thesis, and the area of mathematical
immunology, is only possible by working closely with immunologists. Mathematical models can
be motivated and developed by work carried out by immunologists. In turn, the modelling efforts
of mathematicians can be used to feedback to immunologists aspects of systems that are found to
be interesting from a mathematical point of view, which could then be investigated experimentally.
Work carried out by mathematicians can also be used to suggest ways of improving current
experimental procedures, as was achieved by the work of Chapters 4 and 5.
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Appendices
A Spatial modelling
To implement a spatial model of cell movements and interactions within a LN, the programming
language python has been used. Sections A.1 to A.6 show the algorithms used to generate various
aspects of the spatial model.
A.1 Random placement of cells
To generate uniform random coordinates for a cell within a sphere of radius R, we must do the
following. A uniform random position in a cube is generated of radius R. The position is then
checked to determine if it is contained within a sphere of equal radius to the cube, if it is, the
position is accepted, if not a new position is generated. This process continues until a valid position
is chosen.
import numpy as np
def randomstart(R):
rsnow = 2*R*R
while rsnow > R*R:
x = np.random.uniform(-R, R)
y = np.random.uniform(-R, R)
z = np.random.uniform(-R, R)
rsnow = x*x + y*y + z*z
return x, y, z
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A.2 Non-overlapping APCs
To create N non-overlapping APCs, we can make use of the python package ‘numpy’. This
enables linear algebra operations to be implemented. In this example, numpy allows the distance
to every APC to be calculated simultaneously. Using numpy instead of a loop to calculate the
distance to each APC allows a quicker implementation of the algorithm. To a generate non-
overlapping position we first select a uniform random position for the APC within the domain.
If this is the first APC to be placed the position need not be checked, otherwise we must check
the distance from the other APCs that have already been placed. If the minimum of the array of
distances to the nearest APCs is greater than double the effective radius of the APC, 2b, the position
is accepted, if not a new position is generated. This process continues until valid positions have
been chosen for all the APCs needing to be placed. This generates a distribution of APC positions
which is not truly uniformly randomly distributed, as each additional APC is placed following a
uniform random distribution with the domain that is not already occupied by APCs, rather than
the whole domain.
import numpy as np
Ax = np.array([])
Ay = np.array([])
Az = np.array([])
for i in range(N):
nearestdist = 0.0
while nearestdist < 2*b:
x, y, z = randomstart(R-b)
nearestdist = R
if len(Ax) !=0:
distance = np.sqrt( (x-Ax)*(x-Ax) + (y-Ay)*(y-Ay)
+ (z-Az)*(z-Az) )
nearestdist = min( nearestdist, distance.min() )
else:
nearestdist = 2*b
Ax = np.append(Ax, x)
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Ay = np.append(Ay, y)
Az = np.append(Az, z)
A.3 Unbinding
To unbind cells, we must first determine if the time passed since the last unbinding or binding
event is greater than the minimum binding time of all the cells bound. If this condition is met, we
firstly deal with the cells that are going to unbind. To determine which cells these are we create
a mask to exclude the cells that are not bound and another mask to determine which cells have a
binding time less than tpassed. Multiplying these two masks gives the cells that need unbinding.
We now reset those cells binding times to zero, and replace them in ‘random’, valid positions. To
subtract tpassed from the remaining bound cells we need to create a mask of the cells that have a
binding time greater than tpassed, and subtract this mask multiplied by tpassed from the array of
binding times. We now determine the time until the next unbinding event occurs by finding the
minimum of the binding times. This algorithm must also be implemented if a new cell binds.
import numpy as np
if tpassed > unbind:
mask1 = bindingtime > 0
mask2 = bindingtime < tpassed
bindingtime = bindingtime - bindingtime*mask1*mask2
replace = mask1*mask2
for i in range(N):
if replace[i] == 1:
Tx[i], Ty[i], Tz[i] = randomstart(R-a)
Tclosest[i], Tdist[i] = closest(Tx[i], Ty[i],
Tz[i], Ax, Ay, Az, R)
mask3 = bindingtime > tpassed
bindingtime = bindingtime - tpassed*mask3
nz = bindingtime*(bindingtime > 0)
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unbind = nz.min()
tpassed = 0.0
A.4 Cell movement
Moving cells can be done individually for each cell or using the python module numpy, by vector
operations. To do this we generate an array of random movements, from a Gaussian distribution,
in each of the x, y and z dimensions, and add these to the cells positions. We now move any cells
that have crossed the boundary of the sphere back into the sphere. This is done by calculating the
distance of all the cells from the centre, and creating a mask of those cells that have a distance
greater than the radius of the sphere. The adjustment factor needed to reflect these cells back into
the sphere is calculated, and an array created to multiply the cell positions by, making use of our
mask.
import numpy as np
def move(x, y, z, D, dt, R):
size = len(x)
x += np.random.normal(0, np.sqrt(2*D*dt), size)
y += np.random.normal(0, np.sqrt(2*D*dt), size)
z += np.random.normal(0, np.sqrt(2*D*dt), size)
rsnow = x*x + y*y + z*z
mask = rsnow > R*R
mod = ((2*R)/sqrt(rsnow))-1
mult = np.ones(size)
mult[mask] = mod[mask]
x = mult*x
y = mult*y
z = mult*z
return x, y, z
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A.5 Closest APC
To find which APC is closest to a given T cell, the distance from the T cell to each APC is
calculated and the minimum of this array of distances is found. The index of the closest T cell
is determined using the where command. The index and the minimum distance to an APC is
returned from this algorithm. The minimum distance can then be used to determine if a T cell has
encountered an APC or not.
import numpy as np
def closest(x, y, z, Ax, Ay, Az, R):
distance = np.sqrt((x-Ax)*(x-Ax) + (y-Ay)*(y-Ay)
+ (z-Az)*(z-Az))
dist = distance.min()
jj = np.where(distance == dist)
return jj[0][0], dist
A.6 Encounter during a timestep
To calculate the probability of a T cell encountering an APC during a timestep, the position of
each T cell to its nearest APC must be calculated before and after the timestep. We firstly form an
array of the distance before the timestep by copying the array of distances from the previous loop
of the program. Arrays for the x, y, and z coordinates of the nearest APC to each T cell are created
by indexing the arrays of APC positions by the array of the indexes of the closest APC to each T
cell. Using these arrays of the coordinates of the closest APCs, the distance for each T cell to its
closest APC can be calculated after the timestep. Using the distances before and after the timestep
the probability of encountering an APC during a timestep, for each T cell, is calculated, using the
equation given in Section 2.3.1. These probabilities are tested to determine if they are greater than
a uniform random variable, between zero and one, a positive result is given for encountering an
APC.
import numpy as np
prevdist = np.copy(Tdist)
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CloseAPCx = Ax[Tclosest]
CloseAPCy = Ay[Tclosest]
CloseAPCz = Az[Tclosest]
Tdist = np.sqrt((Tx - CloseAPCx)*(Tx - CloseAPCx) +
(Ty - CloseAPCy)*(Ty - CloseAPCy) + (Tz - CloseAPCz)*(Tz-CloseAPCz))
probhit = np.exp(-((prevdist-bb)*(Tdist-bb))/(D*dt))
Random = np.random.random(N)
foundAPC = Random < probhit
B Code for encountering one of N targets
In this appendix, the code used to calculate the time for a particle to encounter one of N targets
is shown. This code was used to produce Figure 3.15. The code is able to calculate a time to
encounter one of one, two, three, up to N targets, simultaneously. In this code N is set to be
ten. This is achieved by placing the targets and one particle ‘randomly’, as described in A.1. The
particle is not placed within a target, and the targets are able to overlap, as is assumed in (3.7.103).
Each of the targets is assigned a number from one to N . The particle moves using exponential
timestepping, and the distance to each target is calculated every timestep. An algorithm is used
to determine if the particle has encountered a target. If an encounter has occurred, the number
of the target is checked, and a encounter time recorded for that number of targets, and all the
targets with a greater number. For example, with ten targets, if target seven is encountered the
time the encounter occurs at is recorded as the encounter time for seven, eight, nine and ten
targets. These targets are then removed and the simulation continues with the remaining targets,
in the example given this would be targets one to six. This procedure continues until a encounter
time has been found for all targets. If target one is the first target to be encountered, the same
encounter time would be given for all the targets and the simulation would end. By using this
procedure of numbering the targets, it allows encounter times to be found for one of N targets
simultaneously, rather than running individual simulations for each number of targets. This greatly
reduces the computational time required to execute the program. The program also becomes
quicker to execute a timestep as targets are encountered and removed, as there are less targets for
the particle to check if it has encountered. To achieve an accurate TGMFPT numerous realisations
of the program are required. Making the program used as efficient as I could, allowed more
realisations to be computed in a given time. Even with making the program efficient, Figure 3.15
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required vast amounts of computing power. I was fortunate to have access to the Leeds University
high performance computing system, Arc1. Utilising this system, over a years worth of computing
time was required to produce Figure 3.15.
import numpy as np
import math as m
R = 1.0 # Radius of sphere
D = 0.5 # Diffusion coefficient for particle
NR = 10000 # Number of realisations
b = 0.02 # Radius of targets
dt = 0.0001 # Timestep size
N = 10 # Number of targets
filename = ’MultRandom_sim’+str(sim)+’_N’+str(N)+’b’+str(b)
+’_dt’+str(dt)+’.dat’
## Random starting position algorithm ##
def randomstart(R):
rsnow = 2*R*R
while rsnow > R*R:
x = np.random.uniform(-R, R)
y = np.random.uniform(-R, R)
z = np.random.uniform(-R, R)
rsnow = x*x + y*y + z*z
return x, y, z
## Exponential timestepping algorithm ##
def ExpStep(nu):
urv = np.random.random()
sgs = m.sqrt(-2*m.log(1-urv))
g1 = np.random.normal(0, 1)
g2 = np.random.normal(0, 1)
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g3 = np.random.normal(0, 1)
mod = sgs*m.sqrt(g1*g1+g2*g2+g3*g3)/nu
urv = np.random.random()
dz = (2*urv-1)
angle = 2*m.pi*np.random.random()
dx = m.sqrt(1-dz*dz)*m.cos(angle)
dy = m.sqrt(1-dz*dz)*m.sin(angle)
return mod*dx, mod*dy, mod*dz
## Algorithm to calculate distance to nearest target ##
def distance(tx, ty, tz, ax, ay, az):
distance = m.sqrt((tx-ax)**2+(ty-ay)**2+(tz-az)**2)
return distance
nu = 1.0/m.sqrt(dt*D)
N_arg = np.arange(N)
j = 0
while j < NR:
j += 1
## Arrays to store data in ##
APCHit = np.zeros(N)
Tdb = np.ones(N)*R
Tda = np.ones(N)*R
dist = 0
## Set initial conditions inside sphere for the target ##
wx = np.array([])
wy = np.array([])
wz = np.array([])
for i in range(N):
x, y, z = randomstart(R-b)
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wx = np.append(wx, x)
wy = np.append(wy, y)
wz = np.append(wz, z)
## Random initial condition inside sphere for the particle ##
while dist < b:
Tx, Ty, Tz = randomstart(R)
Dist = np.sqrt((Tx-wx)*(Tx-wx) + (Ty-wy)*(Ty-wy)
+ (Tz-wz)*(Tz-wz))
dist = Dist.min()
nstep=-1
## Dynamics of system ##
while len(wx) > 0:
nstep += 1
## Distances before movement ##
Tdb = np.sqrt((Tx-wx)*(Tx-wx) + (Ty-wy)*(Ty-wy)
+ (Tz-wz)*(Tz-wz))
Rdb = m.sqrt(Tx*Tx + Ty*Ty + Tz*Tz)
## Move particle ##
dx,dy,dz = ExpStep(nu)
Tx += dx
Ty += dy
Tz += dz
## Distances after movement ##
Tda = np.sqrt((Tx-wx)*(Tx-wx) + (Ty-wy)*(Ty-wy)
+ (Tz-wz)*(Tz-wz))
Rda = m.sqrt(Tx*Tx + Ty*Ty + Tz*Tz)
## Check if encounter has occurred ##
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r = np.minimum(Tdb, Tda)
prob = np.exp(-nu*(r-b))*m.sinh(nu*b)/np.sinh(nu*r)
hit = np.random.random(len(wx)) < prob
## Records encounter times ##
for i in range(len(wx)):
if hit[i] == 1:
ZeroEntry = (APCHit == 0)
gti = (n_arg) >= i
to_add = gti*ZeroEntry*nstep*dt
APCHit += to_add
wx = wx[:i]
wy = wy[:i]
wz = wz[:i]
break
## Check if particle has hit the outer boundary ##
dw = Rda-Rdb
urv = np.random.random()
maxx = dw/2.0 + m.sqrt(dw*dw - 2*dt*m.log(urv))/2.0
if Rda + maxx > R:
newR = dw - maxx + R
Tx *= newR/Rda
Ty *= newR/Rda
Tz *= newR/Rda
Rda = newR
## Stores results ##
f = open(filename, ’a’)
print >> f, ’ ’.join(str(cell) for cell in APCHit)
f.close()
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